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Thesis summary 
Chronic and severe irritability is an impairing condition associated with poor clinical 
and functional outcome. However, little is known about its nature, pathophysiological 
markers, and risk factors, which are essential to develop effective interventions. 
These knowledge gaps could be best addressed in youths with Attention Deficit 
Hyperactivity Disorder (ADHD). Chronic and severe irritability is highly prevalent in 
this population, leading to greater impairment than those with ADHD alone. 
Additionally, cognitive deficits seen in severely irritable youths greatly overlap with 
those observed in individuals with ADHD. Thus, investigating chronic and severe 
irritability in this population might also help understand the problematic heterogeneity 
of ADHD, which is observed at clinical, cognitive, and aetiological levels, that impact 
upon both clinical and research practice. 
 
This thesis had three main aims. The first aim was to explore the possible bi-
dimensional nature of chronic and severe irritability, composed of phasic and tonic 
dimensions, in a clinical sample of children with ADHD. This was achieved by 
comparing the extent to which phasic and tonic irritability were associated with cross-
sectional and longitudinal correlates of ADHD. Findings failed to support a clear 
distinction between these two dimensions, due to their similar pattern of associations, 
the strength of which did not differ between irritability dimensions. Chronic and severe 
irritability was thus considered unidimensional in the following studies of this PhD 
project. Nonetheless, both phasic and tonic irritability were associated with a poor 
clinical functioning, supporting the clinical relevance of this phenotype in those with 
ADHD. The second aim of this thesis was then to explore pathophysiological markers 
of chronic and severe irritability, possibly leading to impairments in this population. 
The hypothesis was that chronic and severe irritability measured at baseline predicted 
poor Hot (as opposed to Cool) cognitive functioning at follow-up; however, this was 
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not supported by the results obtained. The third and final aim of this thesis was to look 
at common genetic risk associated with irritability in relation to chronic and severe 
irritability symptom severity (measured at baseline) and Hot cognitive functioning 
(measured at follow-up). Investigating pathophysiological markers of chronic and 
severe irritability at a different level of analysis (i.e., biological underpinnings) led 
however to similar conclusions. Although common genetic risk for irritability seemed 
to influence the symptom presentation of this phenotype, it was not associated with 
Hot cognitive functioning. 
 
Taken together these results seem to suggest that chronic and severe irritability is a 
marker of severity in those with ADHD, and that future interventions should not target 
Cool or Hot cognitive functioning. However, considering the pioneering nature of 
these studies, more research is needed to draw stronger conclusions, possibly using 
a comprehensive measure of irritability, and addressing other cognitive markers; this 
might yield different results. 
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General Introduction 
 
1.1 Irritability 
Irritability is a cross-diagnostic symptom included in both internalising and 
externalising conditions. In particular, it is included within the DSM (Diagnostic and 
Statistical Manual of Mental Disorders) diagnostic criteria for Oppositional Defiant 
Disorder (ODD), Antisocial Personality Disorder (APD) (externalising conditions), 
Generalised Anxiety Disorder, Major Depressive Disorder (MDD), and Bipolar 
Disorder (BD) (internalising conditions) (American Psychiatric Association, 2013). 
Chronic and severe irritability is also the core symptom of Disruptive Mood 
Dysregulation Disorder (DMDD), a recent diagnostic category introduced in the DSM-
5 (American Psychiatric Association, 2013) as a reflection of the increasing interest 
in this phenotype. This section of the thesis aims to illustrate the current state of 
research on irritability, suggesting the importance of addressing this phenotype, 
defined as chronic and severe and conceived dimensionally, in psychiatric research. 
The clinically relevance of this phenotype stems from being one of the most common 
reasons children are referred to psychiatric care and its impairing clinical correlates 
and outcomes (Brotman, Kircanski, & Leibenluft, 2017; Stringaris, Vidal-Ribas, 
Brotman, & Leibenluft, 2018; Vidal-Ribas, Brotman, Valdivieso, Leibenluft, & 
Stringaris, 2016) as illustrated in the following sections.  
 
1.1.1 Definition  
Irritability is defined as a propensity to react with intense anger under a minor 
provocation, and this reacting is disproportionate compared to peers at the same 
developmental stage (Buss & Durkee, 1957; Caprara et al., 1985; Snaith & Taylor, 
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1985; Stringaris et al., 2018). Despite this seemingly clear definition, irritability in the 
literature is operationalised in a variety of ways: in its facets (i.e., anger and 
aggression), as a dimensional construct (i.e., Emotional Lability/Emotional 
Dysregulation), as part of ODD and as a syndrome (i.e., Severe Mood Dysregulation); 
whilst these different terminologies are often used interchangeably to refer to 
irritability. 
Anger is the core emotion accompanying irritability, and this emotional state can be 
expressed as aggressive behaviours, such as temper outbursts, although, 
grumpiness, grouchiness, and easy annoyance are also behavioural manifestations 
of irritability that do not involve aggression (Brotman, Kircanski, & Leibenluft, 2017; 
Leibenluft, Blair, Charney, & Pine, 2003; Vidal-Ribas et al., 2016). Thus, despite anger 
and aggression being interrelated constructs with irritability, it appears clear that they 
are just facets of this phenotype. Additionally, severe irritability is also included within 
the broader constructs of “Emotional Lability” and “Emotional Dysregulation”. 
Emotional Lability refers to sudden and rapid swings across different negative 
emotional states, and includes irritable symptoms such as anger, temper outbursts 
and hot temper, as well as sadness; these symptoms are disproportionate to the 
situation and inconsistent with the developmental level (Liu et al., 2019; Sobanski et 
al., 2010). Similarly, Emotional Dysregulation refers to an individual’s inability to 
change an emotional state that thus interferes in goal directed activities, hindering the 
possibility to achieve a goal (Shaw, Stringaris, Nigg, & Leibenluft, 2014). Emotional 
Dysregulation includes irritability alongside intense, context-inappropriate and poorly 
controlled emotionality. It also includes Emotional Lability and symptoms of anxiety 
and depression (Shaw et al., 2014; Stringaris et al., 2018). Thus, Emotional Lability 
and Dysregulation are more complex dimensional constructs that include irritability 
within a broad range of emotional symptoms.  
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Oppositional Defiant Disorder is a condition mostly characterised by argumentative, 
vindictive and defiant behaviours, as well as irritable symptoms (American Psychiatric 
Association, 2013; Stringaris & Goodman, 2009b). It is also in developmental 
continuity with Conduct Disorder (CD) which can be conceptualised as a severe 
disruptive behaviour disorder characterised by violent and antisocial behaviours 
(American Psychiatric Association, 2013). ODD is consistently shown to have two 
dimensions: a defiant and argumentative dimension and an irritable dimension, 
composed of symptoms of feelings of anger, touchiness and temper outbursts (Evans 
et al., 2017; Stringaris & Goodman, 2009b). The irritable dimension of ODD has been 
consistently investigated in the literature to understand its developmental trajectories 
and outcomes (Evans et al., 2017). However, irritability within ODD is composed of 
only three symptoms and it is part of a specific diagnostic category, which fails to 
recognise its cross-diagnostic prevalence (American Psychiatric Association, 2013; 
Leibenluft, 2011). Thus, ODD cannot be used interchangeably to refer to severe 
irritability, suggesting that this phenotype should be considered separately (Burke et 
al., 2014; Stringaris & Goodman, 2009b, 2009a).  
 
In an attempt to target a clinically relevant phenotype of irritability, Severe Mood 
Dysregulation (SMD) syndrome was created including clinical cut-offs related to 
frequency, pervasiveness and temporal stability (Leibenluft, 2011). In addition to the 
severe and abnormal irritable mood and behaviours, such as temper tantrums, verbal 
rages or physical aggression, SMD is also characterised by angry or sad mood and 
hyperarousal, composed of symptoms of insomnia, agitation and inattention 
(Leibenluft, 2011).  
 
Thus, whilst several constructs are used synonymously with irritability, none of these 
constructs or features target irritability specifically. This is particularly relevant as with 
the release of the DSM-5 (2013), a narrow phenotype of irritability (i.e., DMDD), 
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operationalised as chronic and severe, has acquired a greater clinical and public 
health interest. However, findings obtained looking at previously discussed related 
constructs to irritability are inappropriately used to infer underpinnings of this chronic 
and severe phenotype (e.g., Brotman, Kircanski, & Leibenluft, 2017; Brotman, 
Kircanski, Stringaris, Pine, & Leibenluft, 2017). This lack of consistency in the 
terminology ultimately hinders the ability to comprehensively study and gather 
generalisable empirical evidence on the nature of chronic and severe irritability and 
its related features. This lack of empirical evidence led the Developmental 
Translational Research Division of the National Institute of Mental Health (NIMH, 
USA) to organise a workshop (2014) aimed at collecting the current knowledge 
specifically on chronic and severe irritability in youth. Among all the aspects thought 
to be overlooked, this panel stressed the need to investigate specifically the nature, 
pathophysiological markers and genetic underpinnings of chronic and severe 
irritability (Leibenluft & Avenevoli, 2014). These investigations are the focus of this 
thesis. 
 
1.1.2 Historical context & surrounding debate 
Historically, the increased interest in irritability started in the late 1990s when 
psychiatrists reported the challenge of formulating a diagnosis of Bipolar Disorder in 
childhood (Biederman, Klein, Pine, & Klein, 1998). Clinicians observed an increase in 
a noncanonical presentation of BD with affected children showing chronic and severe 
irritability, dysphoria and agitation, as opposed to the classic presentation of episodic 
elated mood and mania (Biederman et al., 1998). This led to a consistent increase in 
the US diagnostic rates of paediatric Bipolar Disorder in children and adolescents over 
an eight year period (1996-2004), with an overall stable rate of BD diagnoses in adults 
(Blader & Carlson, 2007). To ascertain the validity of this subtype of childhood BD, 
this condition was operationalised as Severe Mood Dysregulation (described in 
section 1.1.1); a clinical phenotype characterised by chronic and severe irritability in 
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the form of temper outbursts and negative mood (i.e., anger or sadness) between 
such outbursts, with a hyperarousal component expressed for instance as agitation, 
distractibility or racing thoughts (Leibenluft, Charney, Towbin, Bhangoo, & Pine, 
2003). SMD and classic BD were then compared on family correlates, longitudinal 
outcomes and pathophysiological markers; results revealed consistent differences 
between these two phenotypes on all these external validators (Leibenluft, 2011). In 
particular, in youths with SMD long terms outcomes were an increased risk of 
developing depression and anxiety disorders (Leibenluft, 2011). These trajectories 
are in contrast to youth with classic BD who more likely developed manic episodes 
over time, the core symptom of BD (Leibenluft, 2011). Family history for individuals 
with SMD revealed only a small proportion of cases with BD, unlike the high familial 
rates of BD in the classic BD group (Leibenluft, 2011). Finally, neurocognitive markers 
showed different patterns of impairment across the two phenotypes (Leibenluft, 
2011). Taken together, these results suggested that SMD is consistently different, and 
not an atypical presentation of Bipolar Disorder in childhood. Thus, a revised version 
of SMD was included in the DSM-5 as Disruptive Mood Dysregulation Disorder, within 
the Mood Disorder category, conferring chronic and severe irritability a unique 
diagnostic status (American Psychiatric Association, 2013). The core feature of 
DMDD is chronic and severe irritability in the form of intense, frequent and impairing 
temper outbursts, that are inconsistent with developmental level, as well as severe 
irritable mood that persists between these outbursts (American Psychiatric 
Association, 2013). The hyperarousal component included in SMD was dropped, due 
to the overlap with Attention Deficit Hyperactivity Disorder core symptoms that 
complicated the differential diagnosis between ADHD and SMD (Brotman, Kircanski, 
& Leibenluft, 2017). The introduction of DMDD within the DSM-5 was subject to some 
criticism over whether or not it has diagnostic validity over and above psychiatric 
disorders already included in the DSM (Evans et al., 2017; Frances & Nardo, 2013; 
Frances & Widiger, 2012; Wakefield, 2016). Notably, it is not included in the eleventh 
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and most recent version of the International Classification of Diseases (ICD) (2018). 
Individuals with DMDD very often receive diagnoses of disruptive behaviours (e.g., 
ADHD, ODD, CD) and depression, and there is only a small number of individuals 
endorsing DMDD alone (Evans et al., 2017; Frances & Nardo, 2013; Frances & 
Widiger, 2012; Wakefield, 2016). An alternative way to adequately describe those with 
chronic and severe irritability was suggested by Evans and colleagues (2017) and 
simply requires adding a specifier to the ODD diagnosis to include those who show 
severe irritability. ODD widely overlaps with DMDD and it has a heterogeneous 
presentation with symptoms crossing either an irritable or a defiant domain, with a 
less consistent evidence for a hurtful domain (Evans et al., 2017; Stringaris & 
Goodman, 2009b). However, it should be considered that there are individuals with 
DMDD without ODD, albeit a small number (Axelson et al., 2012; Evans et al., 2017; 
Mayes, Waxmonsky, Calhoun, & Bixler, 2016), and that DMDD also includes irritable 
mood symptoms that are not well captured by ODD, which is purely considered as a 
behavioural disorder. In light of the reported clinical relevance of chronic and severe 
irritability but the questionable utility of a diagnostic category, a continuous 
conceptualisation of this phenotype may be more promising to study the nature, 
pathophysiological markers and genetic underpinnings of chronic and severe 
irritability. This dimensional approach was encouraged by the 2014 workshop 
conceptualising irritability (Leibenluft & Avenevoli, 2014) and is an approach utilised 
in this thesis. 
 
1.1.3 Epidemiology and developmental course of irritability  
Symptoms of irritability are quite common in clinical samples and among pre-
schoolers, with a greater endorsement of temper tantrums compared to other irritable 
symptoms, such as irritable mood (Axelson et al., 2012; Carlson, Danzig, Dougherty, 
Bufferd, & Klein, 2016; Copeland, Angold, Costello, & Egger, 2013; Margulies, 
Weintraub, Basile, Grover, & Carlson, 2012). Irritable symptoms are also very 
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prevalent in children and adolescents from the general population, with up to 91% 
reporting some irritable symptoms at some point over the course of development 
(Carlson et al., 2016; Copeland, Brotman, & Costello, 2015; Wakschlag et al., 2012); 
temper tantrums also appear to be the most common symptom of irritability in 
community samples (Copeland et al., 2013, 2015; Dougherty et al., 2014). This almost 
universal experience of irritability in the general population is not surprising as 
irritability, in particular anger, could also be an adaptive behaviour; anger is 
considered to be an approach behaviour, thus it helps maintaining the motivational 
focus on a goal, increasing the effort to achieve that goal (Carver & Harmon-Jones, 
2009; Leibenluft & Stoddard, 2013). Therefore, it is important to identify pathological 
parameters of irritability to identify a more clinically relevant phenotype and avoid 
pathologizing a normative reaction, especially in children and adolescents. This has 
been done with SMD/DMDD which require features of severity, pervasiveness and 
chronicity; in fact, among other criteria, irritable symptoms need to be present almost 
every day, in different life settings and be enduring for a period of at least one year 
(American Psychiatric Association, 2013; Leibenluft, 2011). Applying these clinical 
cut-offs reduces the prevalence, as chronic and severe irritability, in the form of 
SMD/DMDD, affects 0.1% to 8.2% of children and adolescents in community samples 
(Althoff et al., 2016; Brotman et al., 2006; Dougherty et al., 2014, 2016). In clinical 
samples SMD/DMDD is more common with prevalence rates ranging from 16% to 
31% of children and adolescents (Axelson et al., 2012; Freeman, Youngstrom, 
Youngstrom, & Findling, 2016; Margulies et al., 2012).  
Empirical evidence for the stability of irritability, conceptualised either as symptoms 
or within diagnostic labels, is mixed. Irritable symptoms tend to decrease with age and 
both their prevalence and trajectories do not seem to vary based on sex (Copeland et 
al., 2015; Mayes et al., 2015; Wakschlag et al., 2012; Wiggins, Mitchell, Stringaris, & 
Leibenluft, 2014). This decreasing trend is also observed for diagnostic rates in the 
general population as DMDD seems to be more prevalent in late childhood as 
Chapter 1 | page 8 
  
opposed to young adulthood (Althoff et al., 2016; Copeland et al., 2013). In clinical 
samples however, SMD/DMDD seems to be more stable with a consistent proportion 
of individuals with a persistent diagnosis at different time points across childhood and 
adolescence; there is also an even a greater proportion of individuals with 
subthreshold SMD/DMDD who still show severe and impairing irritable symptoms in 
at least one functional domain (Axelson et al., 2012; Deveney et al., 2015). Overall 
the stability of DMDD is, nevertheless lower compared to other psychiatric disorders 
(e.g., ADHD) (Axelson et al., 2012; Mayes et al., 2015). It should however be noted 
that the interest in chronic and severe irritability is recent, and specific measures to 
assess this phenotype are scarce. In these previous studies, SMD/DMDD diagnosis 
was assigned post hoc, extracting items from the different clinical interviews 
administered in the samples analysed. Similarly, irritable symptoms were assessed 
using different questionnaires and interviews. Additionally, the use of different raters 
(e.g., parents vs. clinicians), as well as different clinical cut-offs, have been shown to 
affect the prevalence estimates of both irritable symptoms and SMD/DMDD diagnosis 
(Eyre et al., 2017; Margulies et al., 2012; Mayes et al., 2015, 2016). Finally, even 
among clinicians there are inconsistences in diagnostic agreement for SMD/DMDD 
(Regier et al., 2013). All these factors may explain the variability in prevalence 
estimates, and the questionable stability of chronic and severe irritability diagnosis 
over time. 
 
1.1.4 Clinical correlates and outcomes of childhood irritability 
Severe irritability is associated with a wide range of internalising and externalising 
conditions, both within time and longitudinally, and is associated with persisting 
impairments. 
Cross-sectionally, the most common psychiatric conditions associated with severe 
irritability are disruptive behaviours, mostly ADHD, where severe irritability is found to 
co-occur in 65-86% of individuals and ODD, where a 78-96% co-occurrence rate has 
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been reported (Axelson et al., 2012; Deveney et al., 2015; Freeman et al., 2016; 
Leibenluft, 2011; Margulies et al., 2012; Mayes et al., 2015, 2016). Depressive 
disorders (e.g., MDD and Dysthymia) and anxiety disorders (e.g., separation, social 
and generalised anxiety disorder) are also frequently comorbid with severe irritability 
with rates ranging from 20%-37.3% and 20%-58.2%, respectively (Axelson et al., 
2012; Deveney et al., 2015; Freeman et al., 2016; Leibenluft, 2011; Margulies et al., 
2012; Mayes et al., 2015, 2016). These within time associations of severe irritability 
with both internalising and externalising disorders are consistent both in clinical (e.g., 
Cornacchio, Crum, Coxe, Pincus, & Comer, 2016; Eyre et al., 2017) and community 
samples (Mayes et al., 2015, 2016). 
Longitudinal associations between severe irritability and a wide variety of psychiatric 
conditions have also been observed across the life span, from early childhood to 
adulthood. Severe irritability in the general population predicts several internalising 
conditions, most commonly depressive disorders (e.g., MDD and Dysthymia) and 
anxiety disorders (e.g., generalised and social anxiety disorders) over and above 
psychiatric symptoms and conditions at baseline (Brotman et al., 2006; Copeland, 
Shanahan, Egger, Angold, & Costello, 2014; Dougherty et al., 2015; Stringaris, 
Cohen, Pine, & Leibenluft, 2009; Vidal-Ribas et al., 2016). Severe irritability has also 
been shown to be a significant predictor of externalising conditions, especially ODD 
(Dougherty et al., 2015; Stringaris et al., 2009; Vidal-Ribas et al., 2016), whereas its 
longitudinal association with ADHD and Substance Use Disorder (SUD) is less 
consistent (Leibenluft, Cohen, Gorrindo, Brook, & Pine, 2006; Vidal-Ribas et al., 
2016). Research on clinical outcomes of severe irritability in clinical cohorts is scarce. 
The research to date seems to confirm that severe irritability predicts both depressive 
and anxiety disorders in clinical samples with a number of different disorders 
(Deveney et al., 2015; Eyre et al., 2019). Clinical outcomes linked to severe irritability 
in youths with ADHD are particularly relevant for this thesis and they are discussed in 
detail in the second section of this general introduction (section 1.2, paragraph 1.2.3). 
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In children and adolescents from the general population, severe irritability is also 
associated with negative outcomes in multiple areas of functioning, such as impaired 
relationships with peers and adults, school impairments with high rates of school 
suspensions and low academic achievement and substance abuse (Althoff et al., 
2016; Copeland et al., 2013; Dougherty et al., 2014, 2015). These irritable youths also 
show greater health and school service use, they are more likely to come from 
disadvantaged backgrounds and are twice as likely to have learning disability 
compared to those with mental health conditions without irritability (Althoff et al., 2016; 
Copeland et al., 2013). Finally, adults with a history of childhood irritability also have 
poorer health outcomes, increased rates of antisocial behaviours and poor financial 
functioning compared to both healthy controls and those with other psychiatric 
conditions (Copeland et al., 2014; Stringaris et al., 2009). In terms of social 
relationships those with severe irritability are more likely to have strained and violent 
relationships and fewer friends compared to healthy controls (Copeland et al., 2014). 
Another important outcome associated with severe irritability is suicidality, which 
comprises both suicidal ideations, plans and attempts. Adolescents with DMDD have 
up to a fourfold risk of suicidality compared to those with other psychiatric disorders 
without DMDD (Althoff et al., 2016);  co-occurring symptoms of severe irritability have 
also been linked to suicidal ideation in adolescents and adults (Conner, Meldrum, 
Wieczorek, Duberstein, & Welte, 2004; Pickles et al., 2010). Overall, these clinical 
and functional impairments, including suicidality, seem to be independent of other 
comorbid symptoms and conditions (Althoff et al., 2016; Conner et al., 2004; 
Copeland et al., 2013; Dougherty et al., 2014; Eyre et al., 2019; Stringaris et al., 2009).  
A number of conclusions can be drawn from these findings. First, these results 
suggest that despite the variable and debated clinical validity and stability of chronic 
and severe irritability, severe irritability is consistently associated with both clinical and 
functional impairments over and above the effect of comorbidity. This supports the 
clinical and public health relevance of this phenotype and addressing severe irritability 
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in future research and interventions might thus be useful to prevent the broad range 
of impairments specifically associated with it. Second, the associations of severe 
irritability with both internalising and externalising conditions further support the 
difficulty of studying irritability as a separate diagnostic entity, as it might be differently 
characterised across psychiatric conditions. Third, although under-researched, 
results on clinical outcomes of severe irritability in clinical cohorts offer preliminary 
evidence of this phenotype as a possible source of heterogeneity, leading to different 
psychiatric conditions and comorbidities. However, it should be considered that in this 
section the term “severe irritability” is used to indicate both chronic and severe 
irritability, as per SMD/DMDD diagnoses, and severe irritable symptoms, measured 
with different assessment instruments across studies. More studies are therefore 
needed to explore these cross-sectional and longitudinal associations with a more 
stringent and clinically relevant phenotype of chronic and severe irritability, especially 
in clinical samples.  
 
1.1.5 Risk factors 
The aetiology of irritability is yet to be understood and studies investigating genetic 
and environmental contributions to the construct are scarce. The few twin studies 
show both genetic and environmental influences in the aetiology of irritability 
(Coccaro, Bergeman, Kavoussi, & Seroczynski, 1997; Roberson-Nay et al., 2015; 
Stringaris, Zavos, Leibenluft, Maughan, & Eley, 2012). In particular, genetic factors 
seem to play a consistent role in irritability with a heritability (i.e., the proportion of 
phenotypic variance explained by genes) around 37% in adult twins (Coccaro et al., 
1997) and 31% in adolescents (Stringaris, Zavos, et al., 2012). Whether these genetic 
influences are additive or non-additive in nature is yet to be understood, whilst some 
studies observe dominance effects, other studies provide evidence for additive 
genetic effects only (Coccaro et al., 1997; Roberson-Nay et al., 2015). There is also 
a significant contribution of unique environment that explains 63% and 69% of 
Chapter 1 | page 12 
  
irritability phenotypic variance in twin adults and adolescents, respectively; counter to 
this, the role of shared environment appears to be negligible (Coccaro et al., 1997; 
Stringaris, Zavos, et al., 2012). Notably, “unique” and “shared” environment refer 
respectively to the environment experienced by each individual separately, which 
contributes to individual differences (e.g., individual experiences) and to the one 
shared by twin pairs (e.g., family setting), contributing to individual similarities instead. 
Recent work looked at genetic and environmental influences on irritability over time, 
showing an opposite trend in males and females (Roberson-Nay et al., 2015); the 
heritability of irritability in males is robust, increasing from 36% up to 89% from 
childhood to young adulthood with stable genetic influences over time; however, new 
sets of genes also emerged during adolescence with an influence in late adolescence 
and young adulthood (Roberson-Nay et al., 2015). Counter to this, in females, genetic 
liability declines over the course of development from 66% to 46%; similarly to males, 
both stable and new genetic factors in early adolescence contribute to heritability 
estimates of irritability in females (Roberson-Nay et al., 2015). Shared environment 
seems to play a negligible part for both males and females as opposed to a consistent 
contribution of unique environment in both sexes, characterised by both stable and 
new factors emerging over time with a decreasing longitudinal contribution 
(Roberson-Nay et al., 2015). The role of environmental influences are also observed 
in intervention studies where parent training is shown to effectively reduce severe 
irritability especially in children (Brotman, Kircanski, Stringaris, et al., 2017; Leibenluft, 
2017b). Furthermore, preliminary findings seem to suggest a gene-environment 
correlation by which genetically driven aggressive behaviours in youths evoke 
parental negative reactions (O’Connor, Deater-Deckard, Fulker, Rutter, & Plomin, 
1998), although more research is needed to identify environmental risk factors and 
their possible interplay with genetic liability.  
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Additionally, in the attempt to identify specific genes associated with this phenotype, 
several Genome-Wide Association Studies (GWAS) have been conducted. GWAS 
approach aims to identify Single-Nucleotide Polymorphism (SNP); SNPs are common 
genetic variants present with a frequency of 5% or more in the general population 
across the entire genome that are involved in the genesis of the clinical phenotype 
considered. No GWAS study to date has investigated common genetic variants 
associated specifically with chronic and severe irritability. Most of the empirical 
evidence comes from previous GWASs investigating related traits and constructs to 
irritability, such as Emotional Lability, Emotional Dysregulation and antisocial 
behaviours (including aggression). As shown in section 1.1.1, these terminologies do 
not specifically identify severe irritability, therefore it is not entirely possible to 
generalise findings obtained with such operationalisations. A recent GWAS identified 
several loci across the genome associated with Emotional Lability with SNPs 
explaining 9% of phenotypic variance (Ward et al., 2019). These common genetic 
variants were expressed in the brain tissue and enriched in genes involved in brain 
development and neuron differentiation (Ward et al., 2019). Additionally, they were 
associated with different psychiatric traits such as MDD, anxiety, Post Traumatic 
Stress Disorder, schizophrenia and BD (Ward et al., 2019). Previous work on 
Emotional Dysregulation obtained more modest results, revealing only one SNP (i.e., 
common genetic variant) associated with this phenotype, and in males as opposed to 
females; this SNP was located on a gene regulating inflammatory responses (Powers 
et al., 2016). However, this study was underpowered, mostly due to the small sample 
size used to conduct a GWAS analysis, which might also explain the identification of 
only one SNP. Additionally, this study was conducted on an adult sample, largely 
females and with small income, making it difficult to generalise these findings to 
different populations, such as children and adolescents (Powers et al., 2016). 
Previous work was also conducted on antisocial behaviours, although it failed to 
identify genome-wide significant genetic variants (Tielbeek et al., 2017). Promising 
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SNPs with p-values close to significance were identified, and they showed sex-
specific differences as males and females had different enriched loci on different 
chromosomes across the genome; the proportion of phenotypic variance explained 
was however negligible (Tielbeek et al., 2017). Common genetic contributions to 
irritability have also been investigated in the context of other psychiatric disorders, 
such as Bipolar Disorder. GWAS results on irritable temperament in a sample of 
individuals with BD provide evidence for two common genetic variants located in 
genes on chromosome 1. These genes seem to be involved in DNA damage control 
and replication, and in RNA processing and transcription (Greenwood, Akiskal, 
Akiskal, & Kelsoe, 2012). Finally, GWAS findings in a sample of adults with BD 
identified promising loci on chromosome 13 uniquely associated with irritable mood 
in BD as opposed to elated mania BD or controls (Greenwood et al., 2013). The peak 
of common genetic variants identified in this region does not seem to be within any 
known gene, although neighbouring genes associated to neurite outgrowth may 
influence its genetic expression (Greenwood et al., 2013). These promising results 
failed however to be replicated in a clinically diverse sample of individuals with BP 
(Greenwood et al., 2013). Taken together these findings suggest that irritability is a 
heritable trait and that both genetic and environmental factors play a role across 
development; however, more research is needed to identify specific genetic variants, 
especially those associated with a narrower and more clinically relevant definition of 
chronic and severe irritability as opposed to irritability-related constructs and facets 
(e.g., Emotion Dysregulation/Lability, temperament, antisocial behaviours, or episodic 
irritable mood). 
 
1.1.6 Treatments and interventions for chronic and severe irritability 
As the heightened interest in chronic and severe irritability is relatively recent, 
interventions studies are limited; the findings gathered so far suggest promising 
effects for pharmacological, cognitive and psychosocial treatments (Stringaris et al., 
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2018). It should however be noted that intervention studies have been conducted on 
facets of irritability (e.g., aggression) or related constructs, such as ODD; these 
represent the vast majority of empirical evidence on treatments related to this 
phenotype. In particular, in clinically diverse youths, pharmacological treatments 
based on antidepressant drugs seem to be associated with a reduction of aggression 
and disruptive behaviours (Kim & Boylan, 2016). Similarly, behavioural interventions 
developed to help parents reinforce adaptive, instead of maladaptive, behaviours in 
youths also yield significant improvements in antisocial and disruptive behaviours, 
emotion dysregulation, and aggression (Brotman, Kircanski, & Leibenluft, 2017). 
There are, however, few studies looking at severe irritability in the form of SMD and 
only one addressing chronic and severe irritability diagnosis (i.e., DMDD). In 
particular, only two pharmacological studies have been conducted in severely irritable 
youths (i.e., individuals with SMD) (Dickstein et al., 2009; Krieger et al., 2011). One 
study found a significant improvement of irritable symptoms, comorbid psychiatric 
symptoms (i.e., ADHD, anxiety and depression) and associated impairments using 
antipsychotic medications; these benefits seemed to persist over time with an 
adequate degree of drug tolerability (Krieger et al., 2011). It should however be noted 
that this study did not include any placebo, thus results might be biased. The only 
other published study was a Randomised Control Trial (Dickstein et al., 2009) and 
was the first well-controlled study to date that investigated the efficacy of 
pharmacological treatment in those with SMD. The aim was to look at the efficacy of 
lithium treatment in reducing symptoms of irritability and associated functional and 
clinical outcomes, and overall it yielded non-significant results (Dickstein et al., 2009). 
A pilot study of cognitive training targeting hostile interpretation bias was also 
conducted in those with chronic and severe irritability (i.e., DMDD) in the attempt to 
reduce these impairing symptoms (Stoddard et al., 2016). This study had promising 
findings associated with a reduction of severe irritability manifestation and related 
impairment which was persistent over time; although more research is needed to 
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understand the role of comorbid conditions and relevant psychiatric symptoms 
(Stoddard et al., 2016). There is also preliminary anecdotal evidence from clinical 
cases on the effectiveness of Cognitive-Behavioural Therapy targeting symptoms 
related to DMDD such as irritability and aggression (Tudor, Ibrahim, Bertschinger, 
Piasecka, & Sukhodolsky, 2016), although well-controlled research on 
psychotherapeutic interventions on chronic and severe irritability is lacking.  
Taken together these findings suggest that there is a paucity of interventions studies 
targeting chronic and severe irritability specifically. However, it should be considered 
that pharmacological, therapeutic, cognitive or behavioural interventions should be 
developed in accordance with robust knowledge of aetiological and neurocognitive 
underpinnings, and with the nature of chronic and severe irritability, that are currently 
lacking. Additionally, due to the different terminologies associated with this severe 
phenotype and their interchangeable use, evidence obtained focusing on aspects of 
severe irritability cannot be generalised to the phenotype as currently conceptualised. 
 
In conclusion, chronic and severe irritability has become increasingly prominent for 
research, clinical practice, children with ADHD and their families, especially with the 
introduction of DMDD in the DSM-5. The clinical usefulness of this diagnostic label is 
however questioned due to the high comorbidity rates and mixed evidence on its 
prevalence and longitudinal stability, possibly suggesting that a dimensional 
conceptualisation of this phenotype might be more promising. Nonetheless, the 
clinical importance of severe irritability is well documented, being associated with a 
wide range of internalising and externalising disorders and being a predictor of 
consistent functional and clinical impairments. Thus, this phenotype is worth 
investigating further, as a potential source of comorbidity and in the public health 
interest, especially since the empirical knowledge gathered so far has proven to be 
insufficient due to the interchangeable use of different terms. Digging into the wide 
knowledge gaps related to chronic and severe irritability, priority should be given to 
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clarify the nature, cognitive markers and aetiological factors specifically associated 
with this phenotype, as recommended by the 2014 workshop of the NIMH (Leibenluft 
& Avenevoli, 2014). Indeed, further knowledge of these aspects can inform the 
development of better tailored interventions targeting specifically chronic and severe 
irritability. 
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1.2 Attention Deficit Hyperactivity Disorder  
Attention Deficit Hyperactivity Disorder is a neurodevelopmental disorder 
characterised by impairing symptoms in the dimensions of inattention, hyperactivity 
and impulsivity (Cortese & Coghill, 2018). ADHD is a very heterogeneous condition; 
this heterogeneity affects core symptom presentation, developmental trajectories, co-
occurring conditions, functional impairments, neurocognitive functioning and relevant 
risk factors (Thapar & Cooper, 2016). This great variability ultimately represents a 
barrier to both clinical practice and research, as it impacts upon the possibility of 
identifying well-established aetiological pathways, pathophysiological mechanisms, 
and developing effective treatments (Agid et al., 2013; Feczko et al., 2019; Hayman, 
2007; Sonuga-Barke & Coghill, 2014; Sonuga-Barke & Halperin, 2010). This section 
of the introduction aims to explain the clinical relevance of ADHD, stressing the 
importance of addressing its great heterogeneity to both gain a deeper understanding 
of its pathological underpinnings and improve clinical practice. The important role of 
irritability in achieving this aim is also illustrated. 
 
1.2.1 ADHD diagnostic criteria 
ADHD diagnosis formulation is informed by national practice guidelines that find 
consensus across different countries, to ensure diagnostic reliability and improve 
evidence-based clinical practice (Seixas, Weiss, & Müller, 2012). A diagnosis of 
ADHD in children is ascertained by asking adult informants, most commonly parents 
and teachers, about children’s behaviours in the domains of inattention and 
hyperactivity-impulsivity, often using standardised clinical interviews. These 
measures are normally designed based on two complementary diagnostic systems: 
The Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric 
Association, 2013) or the International Classification of Diseases (World Health 
Organization, 2018). Prior to the third version of the DSM, intense emotionality, 
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characterised in particular by anger, was considered a pivotal feature of ADHD and 
included in the diagnostic criteria for the disorder. However, after the publication of 
the DSM-III these symptoms were removed and considered as marginal, focusing the 
diagnosis of ADHD mostly on inattentive and hyperactive-impulsive symptoms 
(Faraone et al., 2019). According to the fifth and most recent version of the DSM 
(2013), a diagnosis of ADHD is given to children endorsing six or more inattentive 
and/or hyperactive-impulsive symptoms, such as “often does not seem to listen when 
spoken directly”, “often runs about” and “often has difficulty waiting his/her turn”; for 
individuals aged 17 or older endorsing five symptoms of either domains suffice 
(American Psychiatric Association, 2013). To be diagnosed with ADHD, these 
symptoms must be present prior to the age of 12 and be significantly impairing in 
multiple everyday life settings, such as in an academic/occupational or social setting 
(American Psychiatric Association, 2013). The DSM-5 accounts for the heterogeneity 
of ADHD core symptom presentation by using diagnostic descriptors based on the 
predominant symptoms endorsed; thus an individual with ADHD could have a 
predominantly inattentive, hyperactive-impulsive or combined presentation of core 
symptoms, where a combined ADHD presentation includes symptoms of both 
inattentive and hyperactive-impulsive domains (American Psychiatric Association, 
2013). It should be noted that this thesis includes measures that investigate ADHD 
clinical symptoms and diagnosis using the fourth edition of the DSM criteria (American 
Psychiatric Association, 2000), as data was collected prior to the publication of DSM-
5. The DSM-IV and DSM-5 criteria for ADHD however did not differ dramatically; there 
are only three main changes in the DSM-5: 1) the age of onset for ADHD increased 
from 7 to 12 years of age, to facilitate the formulation of ADHD diagnosis in adults 
(Cortese & Coghill, 2018); 2) total symptoms required to diagnose ADHD in those 
aged 17 or older decreased from six to five, to acknowledge the persistence of ADHD 
symptoms whilst accounting for developmental decreases overtime (Cortese & 
Coghill, 2018); 3) ADHD “subtypes” have been replaced by ADHD “presentation”, to 
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account for the heterotypic continuity of ADHD symptoms within the core domains; 
“subtype” is in fact a more static concept (American Psychiatric Association, 2000, 
2013; Cortese & Coghill, 2018). The International Classification of Diseases is 
developed by the World Health Organization (WHO) that has recently published the 
eleventh edition of the ICD (World Health Organization, 2018). The ICD diagnostic 
criteria for ADHD greatly overlap with those included in the DSM (American 
Psychiatric Association, 2013; World Health Organization, 2018). ICD-11 however 
seems to identify a more severe form of ADHD diagnosis, symptoms from all three 
domain of inattention, impulsivity and hyperactivity need to be endorsed which is akin 
to the combined symptom presentation in the DSM-5. Similarly to the DSM, the ICD 
accounts for the heterogeneous presentation of ADHD using diagnostic descriptors 
to describe the most prevalent symptoms endorsed by those with this condition (World 
Health Organization, 2018). 
Both DSM and ICD diagnostic systems follow a categorical approach to diseases, 
thus the ADHD diagnosis is reliant on arbitrary clinical cut-offs. ADHD symptoms are 
however normally distributed in the population, with those in the extreme end of the 
distribution having a greater severity of symptoms and being more likely to receive a 
diagnosis (Larsson, Anckarsater, Råstam, Chang, & Lichtenstein, 2012). A 
dimensional approach is noted to be difficult to utilise in clinical practice and 
categorical approaches are considered to be the best option to decide on access to 
treatment and resource allocation, in the absence of more objective, biologically-
based and robust parameters (Thapar & Cooper, 2016). It should finally be noted that 
in this thesis ADHD as conceptualised by the most recent versions of the DSM (DSM-
IV and DSM-5) would be considered. This is due to the worldwide use of the DSM 
diagnostic system, especially in research practice, although ICD is in fact more 
commonly used in clinical practice and mostly in European countries (Thapar & 
Cooper, 2016). 
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1.2.2 Prevalence of ADHD 
The diagnostic prevalence of ADHD had been a matter of debate in some circles for 
many years, mainly due to the variability in prevalence estimates across studies and 
across countries, and to the increase in diagnostic prevalence over time (Cortese & 
Coghill, 2018). Findings from the most comprehensive meta-analyses address this 
great variability showing that it mainly reflects methodological differences related to 
the inclusion of an impairment requirement to formulate a diagnosis, to different 
diagnostic system used (DSM vs. ICD) and to clinical information gathered using 
different informants (parents and/or teachers) (Polanczyk, De Lima, Horta, 
Biederman, & Rohde, 2007; Polanczyk, Willcutt, Salum, Kieling, & Rohde, 2014; 
Willcutt, 2012). Once these methodological differences are accounted for, prevalence 
estimates are similar worldwide and ADHD appears to be the most common 
neurodevelopmental disorder with a worldwide pooled prevalence around 5.3% 
(95%CI= 5.01 - 5.56) in children and adolescents up to 18 years of age (Polanczyk et 
al., 2007, 2014; Willcutt, 2012). 
ADHD seems to affect predominantly males with a ratio of 4:1 compared to females 
in the general population that reaches 7-8:1 in clinical samples (Thapar & Cooper, 
2016), although these differences seem to disappear in adulthood (Matte et al., 2015). 
Previous work suggested that these discrepancies could be due to referral bias of 
females with ADHD as, compared to males, they display fewer problematic 
externalising behaviours that are likely to drive clinical referrals (Abikoff et al., 2002; 
Biederman et al., 2002; Gershon, 2002). This is also supported by the comparable 
levels of social, educational and psychological impairments across males and females 
with ADHD (Biederman et al., 2005), suggesting that ADHD might be simply 
underdiagnosed in females. This referral bias in youths could also explain the near 
1:1 ratio of male and female adults diagnosed with ADHD as adults can self-refer 
themselves, thus reducing the referral bias (Faraone et al., 2000). Counter to this, it 
is also possible that females with ADHD show a greater burden of genetic risk for this 
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condition, compared to males, that could lead to the diagnosis of only the most severe 
female cases; this is consistent with the “female protective effect” model that seems 
to characterise neurodevelopmental disorders and according to which females require 
a greater exposure to risk factors to fully develop a clinically relevant condition, 
compared to males (Taylor et al., 2016). This model seems to be supported by 
behavioural findings as evidence from population based twin studies suggest that 
cotwins of females with ADHD had greater ADHD symptom severity than cotwin of 
males with ADHD (Taylor et al., 2016). Despite these possible insights on sex 
differences in ADHD, evidence is mixed  and more research is needed to explore the 
nature and underpinnings of female ADHD (Biederman et al., 2005; Greven, 
Richards, & Buitelaar, 2018; Martin et al., 2018). 
Finally, the prevalence ADHD diagnoses tends to decrease in adulthood and the 
overall prevalence of adults with this condition is 2.5% (95%CI= 2.1 - 3.1) (Simon, 
Czobor, Bálint, Mészáros, & Bitter, 2009). However, in line with the heterogeneous 
presentation of its core symptoms, ADHD trajectories show great variability. In fact, 
some evidence suggests that only ~10% of youths with ADHD fully grow out of this 
condition as adults, whereas ~15% keeps endorsing full diagnostic criteria; the 
majority of those with ADHD shows however a partial remission (~40-60%), they don’t 
meet all the diagnostic criteria but still show consistent impairments (Biederman, Mick, 
& Faraone, 2000; Faraone, Biederman, & Mick, 2006). Furthermore, this decline is 
particularly evident for hyperactive-impulsive symptoms, whereas inattentive 
symptoms tend to persist (Biederman, 2000).  
In conclusion, ADHD is a neurodevelopmental condition seen in around 5% of 
children, making it one of the most prevalent mental health disorders in childhood. 
Despite the natural decrease of its core symptoms and the variability of developmental 
trajectories, individuals with ADHD show consistent impairments over-time, which 
also highlight the lifelong clinical relevance of this condition.  
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1.2.3 Clinical correlates and functional outcomes of childhood ADHD 
 
Clinical correlates 
Large population studies show that the vast majority (67%-87%) of those with ADHD 
have at least one comorbid psychiatric condition, whereas 16%-67% of youths with 
ADHD are affected by more than one co-morbid disorder and 18%-33% have three 
or more co-morbid conditions (Kadesjo & Gillberg, 2001; Larson, Russ, Kahn, & 
Halfon, 2011). Similar rates of comorbidity are also observed in those with 
subthreshold ADHD (whereby individuals demonstrate some subthreshold symptoms 
and impairment, which do not meet diagnostic criteria) (Kadesjo & Gillberg, 2001). 
The great variability of these estimates is striking, although it could mainly be due to 
the methodological differences across studies, such as the time frame considered to 
define comorbidity, the diagnostic criteria used and variability across informants 
(Jensen & Steinhausen, 2015; Jensen, Martin, & Cantwell, 1997). Even using more 
stringent parameters to define the comorbidity and to diagnose ADHD (i.e., ICD-10 
diagnosed disorders), estimates still suggest that 50% of youths with ADHD have at 
least one comorbid disorder, whilst 26% have two or more (Jensen & Steinhausen, 
2015). These rates of comorbidity seem to be consistent also in clinical samples of 
children with ADHD (Reale et al., 2017). More specifically, ADHD in children and 
adolescents shows a complex pattern of comorbidity encompassing both 
externalising and internalising disorders. The most prevalent comorbidities within the 
externalising domain are Oppositional Defiant Disorder and Conduct Disorder 
(Biederman et al., 2002; Jensen & Steinhausen, 2015; Kadesjo & Gillberg, 2001; 
Larson et al., 2011; Reale et al., 2017). These behavioural disorders can affect up to 
66% and 21% of male youths with ADHD in clinical samples, respectively (Biederman 
et al., 2002). ADHD is also comorbid with internalising disorders, for example, studies 
have shown that 18% of youths with ADHD endorse an anxiety disorder and 14% 
have depression in large population cohorts (Larson et al., 2011). 
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Neurodevelopmental disorders also co-occur frequently with ADHD, especially autism 
(12.4%) and learning disability (46.1%) (Jensen & Steinhausen, 2015; Larson et al., 
2011). Finally, ADHD is also comorbid with disorders such as tics, epilepsy and 
Tourette syndrome, although to a lesser extent than both internalising and 
externalising disorders (Larson et al., 2011). Notably, ADHD comorbidity with 
internalising and externalising conditions is observed both within and across time 
(Chronis-Tuscano et al., 2010; Franke et al., 2018; Langley et al., 2010). This great 
variability is problematic for both clinical and research practice. The comorbid 
heterogeneity of ADHD represents a barrier to psychiatric care as this great overlap 
of psychiatric conditions is an obstacle to the diagnostic process. In particular, 
symptoms overlap across different psychiatric diagnoses, leading to a lack of clear 
criteria to define the presence of absence of a diagnosis, especially in the presence 
of co-occurring disorders (Feczko et al., 2019); for instance, lack of concentration and 
restlessness pertain both to ADHD and anxiety disorders (American Psychiatric 
Association, 2013). Similarly, the wide heterogeneity of ADHD clinical correlates 
impacts upon the possibility to identify reliable and robust pathophysiological markers 
specifically associated with this neurodevelopmental disorder (Agid et al., 2013; 
Feczko et al., 2019; Hayman, 2007; Uddin, Dajani, Voorhies, Bednarz, & Kana, 2017). 
More precisely, a pathophysiological marker leading to ADHD might also contribute 
to the presence of either internalising or externalising conditions, being possibly 
relevant only for a proportion of individuals with this neurodevelopmental disorder 
(Feczko et al., 2019). Addressing this heterogeneity by identifying sources of 
comorbidity is therefore important to possibly provide a comprehensive 
characterisation of ADHD, especially in terms of pathophysiological markers. This 
might then lead to the development of personalised interventions, based on different 
clinical profiles (Agid et al., 2013; Feczko et al., 2019; Hayman, 2007; Sonuga-Barke 
& Coghill, 2014; Sonuga-Barke & Halperin, 2010). 
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Functional Outcomes  
ADHD is associated with poor outcomes in multiple everyday-life settings (e.g., at 
school, at home) representing a burden to the individuals with the condition as well 
as to their families. Poor academic performance is frequently observed in children and 
adolescents with ADHD and it is a common reason for which children with ADHD 
receive clinical attention (Loe & Feldman, 2007). This poor performance can be 
observed in various ways; youths with ADHD show poorer reading and maths skills 
(Frazier, Youngstrom, Glutting, & Watkins, 2007; Kadesjo & Gillberg, 2001; Scheffler 
et al., 2009), more adverse school experiences (e.g., low grades, frequent school 
drop-out, low attendance and school suspension/expulsion) (Bussing et al., 2010; 
Kent et al., 2011; Klein et al., 2012; Loe & Feldman, 2007), and they make greater 
use of special education services (Barkley, Fischer, Smallish, & Fletcher, 2006; Loe 
& Feldman, 2007; Murray et al., 2014), compared to typically developing controls. 
This impaired academic functioning seems to affect also individuals with subthreshold 
ADHD (Kadesjo & Gillberg, 2001; Loe & Feldman, 2007). Additionally, youths with 
ADHD show poor social functioning with both peers and family members. Family 
relationships seem often characterised by greater levels of conflict and hostility, 
ultimately being more stressful than relationships of control families (Klassen, Miller, 
& Fine, 2004; Nijmeijer et al., 2008; Wehmeier, Schacht, & Barkley, 2010). Similarly, 
peer relationships could be problematic due to difficulties of those with ADHD in 
establishing and maintaining social relationships, often leading to peer rejection. 
These strained relationships seem characterised by inability to take turns in 
conversations, oppositionality, intrusiveness and negative and intense emotionality 
(Gardner & Gerdes, 2015; Nijmeijer et al., 2008; Wehmeier et al., 2010). Educational 
and social impairments negatively affect self-esteem and quality of life of youth with 
ADHD and their families in comparison to typically developing controls (Klassen et al., 
2004; Varni & Burwinkle, 2006; Wehmeier et al., 2010). These impairments are 
enduring and persists into adulthood, (Barkley et al., 2006; Bussing et al., 2010; 
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Galéra, Melchior, Chastang, Bouvard, & Fombonne, 2009; Klein et al., 2012) even in 
those who no longer meet criteria for a full ADHD diagnosis (Kadesjo & Gillberg, 2001; 
Klein et al., 2012). In particular, adults with childhood ADHD show poorer occupational 
outcomes, resulting in a lower socio-economic status (Barkley et al., 2006; Hechtman 
et al., 2016; Klein et al., 2012), and less stable relationships leading to greater number 
of divorces compared to controls (Barkley et al., 2006; Klein et al., 2012; Rokeach & 
Wiener, 2018). Those with ADHD as children also have greater occurrence of legal 
problems in adulthood, as they seem to have a greater history of incarceration than 
peers without this neurodevelopmental condition (Klein et al., 2012; Lichtenstein et 
al., 2012; Young, Moss, Sedgwick, Fridman, & Hodgkins, 2015). Finally, adult life of 
those with childhood ADHD also appears to be characterised by greater mortality 
rates, mainly related to unnatural accidents; in particular they have twice the risk of 
premature death compared to those without this condition as children (Dalsgaard, 
Ostergaard, Leckman, Mortensen, & Pedersen, 2015; Sun et al., 2019). This empirical 
evidence draws a concerning picture for individuals with ADHD and it should be noted 
that the risk of such negative outcomes increases in those with comorbid conditions. 
Coexisting psychiatric symptoms and diagnoses in individuals with ADHD are 
associated with greater school problems, such as poorer performance on academic 
standardised tests compared to individuals with ADHD alone (Larson et al., 2011; Loe 
& Feldman, 2007). The co-occurrence of ADHD and comorbid conditions also has a 
negative impact on perceived quality of life (Klassen et al., 2004). Additionally, those 
with ADHD and other psychiatric disorders show poorer family and social 
relationships than those with ADHD alone (Hurtig et al., 2007; Larson et al., 2011; 
Wehmeier et al., 2010). The risk of these impairments seems to be greater as the 
number of comorbid conditions increases (Larson et al., 2011), and especially in the 
presence of comorbid ODD/CD (Wehmeier et al., 2010). Similarly, the presence of 
ODD/CD negatively impacts on health and social outcomes, as individuals with ADHD 
and comorbid disruptive disorders (i.e., ODD/CD) are more likely to show substance 
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abuse (especially alcohol and cigarettes) and criminal behaviours, such as stealing 
and use of violence (Langley et al., 2010). Early antisocial behaviours in ADHD are 
also potential predictors of criminal behaviours as observed in incarcerated 
populations (Jensen & Steinhausen, 2015). Additionally, the presence of both 
ODD/CD and SUD is associated with greater mortality rates (Dalsgaard et al., 2015). 
Even the presence of internalising comorbidity is associated with a worse prognosis; 
previous work has shown that children and adolescents with ADHD and comorbid 
anxiety disorders are at increased risk for strained family relationships and more 
school and peer problems compared to those with ADHD alone (Bowen, Chavira, 
Bailey, Stein, & Stein, 2008). Taken together these findings suggest that although 
ADHD functional outcomes are heterogeneous, for some cases an ADHD diagnosis 
increases the risk of negative functional impairments over the course of development. 
The presence of comorbid psychiatric symptoms and conditions is associated with a 
worse prognosis, which remarks the need of addressing the clinical heterogeneity of 
ADHD in the attempt to prevent such broad impairments that are matter of public 
health concern. 
 
Severe irritability in those with ADHD 
Severe irritability is common in individuals with ADHD. More precisely, although 
irritability is not uniquely associated with ADHD, 25% to 50% of children with this 
condition show irritability when comprised in the broader phenotype of Emotional 
Dysregulation (Faraone et al., 2019; Shaw et al., 2014). As briefly noted in section 
1.1.4 of this chapter, ADHD is also the most common condition associated to chronic 
and severe irritability in the form of SMD and DMDD with rates up to 86% (Leibenluft, 
2011). Additionally, a previous study using the same clinical ADHD sample as the one 
considered in this PhD found that 92% of children with ADHD endorsed irritable 
symptoms, especially losing temper and temper tantrums (Eyre et al., 2017). Severe 
irritability is also associated with poor clinical and functional outcomes in those with 
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ADHD. More precisely, the presence of severe irritability in this clinical group is linked 
to the high cross-sectional and longitudinal prevalence of comorbid internalising and 
externalising conditions, such as ODD/CD, Substance Abuse Disorder, and mood 
disorders (Biederman, Petty, et al., 2012; Biederman, Spencer, et al., 2012; Eyre et 
al., 2017, 2019; Sobanski et al., 2010). Further evidence has shown that severe 
irritability could predispose children and adolescents with ADHD to this wide range of 
psychiatric conditions. More specifically, compared to controls, in this clinical 
population severe irritability seems to increase and mediate risk for both internalising 
(Anastopoulos et al., 2011; Karalunas et al., 2014; Seymour et al., 2012; Seymour, 
Chronis-Tuscano, Iwamoto, Kurdziel, & MacPherson, 2014) and externalising 
conditions (Anastopoulos et al., 2011; Karalunas et al., 2014; Rosen, Walerius, 
Fogleman, & Factor, 2015). This predisposition seems to be independent of comorbid 
psychiatric disorders (Karalunas et al., 2014; Seymour et al., 2012, 2014). In terms of 
functional outcomes severe irritability in those with ADHD seems associated with 
ADHD symptom severity, behavioural, emotional, school and social problems 
(Biederman, Petty, et al., 2012; Biederman, Spencer, et al., 2012; Bunford, Evans, & 
Langberg, 2014; Mulraney, Zendarski, Mensah, Hiscock, & Sciberras, 2017; Sobanski 
et al., 2010). Similar functional impairments linked to severe irritability in those with 
ADHD are shown across time from childhood to adolescence and they are observed 
both when comparing individuals with ADHD and severe irritability against typically 
developing controls and most importantly, against those with ADHD alone 
(Biederman, Petty, et al., 2012; Biederman, Spencer, et al., 2012). Additionally in 
youths with ADHD, severe irritability shows associations with sleep problems (e.g., 
reduced sleep duration), high rates of hospitalisation, and poor parental mental health 
(Biederman, Petty, et al., 2012; Graziano, McNamara, Geffken, & Reid, 2011; 
Mulraney et al., 2017; Nixon et al., 2008). Finally, severe irritability in children with 
ADHD is also associated with self-perceived low self-esteem especially in terms of 
poor quality of social relationship with peers and parents, poor well-being and less 
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confidence in physical appearance (Ek, Westerlund, Holmberg, & Fernell, 2008). 
Symptoms of irritability are also common in adults with ADHD (44%-73%) or those 
with a past history of childhood ADHD (~36%), and they contribute significantly to 
impairments in social, familial and romantic relationships, as well as to poor 
financial/occupational outcome, quality of life, unsafe driving and criminal behaviours 
(Barkley & Fischer, 2010; Barkley, Murphy, & Epstein, 2010; Skirrow & Asherson, 
2013; Surman et al., 2013). It should be noted that the influence of additional comorbid 
conditions in explaining poorer functional outcomes associated with severe irritability 
in those with ADHD is yet to be understood. Despite being under-researched in 
children and adolescents with ADHD, preliminary evidence seems to suggest that the 
association between severe irritability and functional impairments is independent of 
the presence of comorbid symptoms and conditions (Bunford et al., 2014; Skirrow & 
Asherson, 2013; Sobanski et al., 2010; Surman et al., 2013), although there are some 
findings to the contrary (Bunford et al., 2014; Mick, Spencer, Wozniak, & Biederman, 
2005) and the different operationalisations of severe irritability used, such as defining 
irritability within Emotion Dysregulation/Lability, limit the conclusions that can be 
drawn. 
Overall, these findings suggest that the negative clinical and functional impact of 
severe irritability in youths with ADHD does not seem to be a mere epiphenomenon 
of other comorbid psychiatric conditions. Most importantly, this severe phenotype 
appears to be a source of variation, which may be related to the broad patterns of 
comorbidity of ADHD with both internalising and externalising clinical correlates. 
Understanding the pathological mechanisms of severe irritability in those with ADHD 
by might therefore contribute to explain the problematic heterogeneity associated with 
this neurodevelopmental disorder, enabling a better understanding of ADHD and the 
development of tailored interventions that might possibly reduce the broad functional 
impairments too.  
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1.2.4 Risk factors for ADHD: genes and environment 
Considering the wide phenotypic heterogeneity of ADHD, it is not surprising that there 
is not a single cause of the disorder. The aetiology of ADHD has a complex 
architecture involving both genetic and environmental risk factors. ADHD risk is 
shown to be continuously distributed across the population, thus the same genetic 
and environmental risk factors are involved in ADHD and differences between 
affected and non-affected individuals are quantitative rather than qualitative (Chen et 
al., 2008; Demontis et al., 2018; Larsson et al., 2012). According to this dimensional 
model of disease, ADHD is just the extreme end of this distribution of risk that 
operates across the inattentive and hyperactive-impulsive symptoms (Chen et al., 
2008; Larsson et al., 2012). A very large twin study has confirmed this dimensional 
nature of ADHD in both males and females (Larsson et al., 2012). 
 
Genetic Risk Factors 
ADHD is known to run in families; the estimated heritability ranges from 60% to 80% 
with a 5 to 9-fold increased risk in proband’s siblings of developing the condition 
(Biederman et al., 1992; Biederman, Faraone, Keenan, Knee, & Tsuang, 1990; Chen 
et al., 2008; Faraone & Larsson, 2018); these high heritability estimates seem to 
persist across the life span (Larsson, Chang, D’Onofrio, & Lichtenstein, 2014). 
Different genetic study designs have tried to investigate more specifically the genetic 
architecture of ADHD to identify underlying aetiological and pathophysiological 
pathways leading to this condition. Initially, within molecular genetic research, 
candidate gene studies dominated this field, looking at specific genes in the aetiology 
of ADHD. These candidate genes, thought to be involved in ADHD, were selected 
aprioristically and their choice was mostly informed by pharmacological treatments 
that flagged the importance of monoamine neurotransmitter systems, namely 
dopamine, serotonin and noradrenaline (Banaschewski, Becker, Scherag, Franke, & 
Coghill, 2010; Gizer, Ficks, & Waldman, 2009; Hawi et al., 2015). Other promising 
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genetic candidates possibly involved in ADHD affect neuronal transmission, 
outgrowth and plasticity; however overall these polymorphisms only accounted for a 
negligible proportion of ADHD heritability (Cortese & Coghill, 2018; Gizer et al., 2009; 
Hawi et al., 2015). Technological advances enabled a paradigm shift moving from 
candidate genes to more promising and powerful hypothesis-free design: The GWAS, 
aiming to identify Single-Nucleotide Polymorphisms across the entire genome. A 
recent population-wide GWAS has identified 12 regions (i.e., loci) involved in the 
aetiology of ADHD (Demontis et al., 2018). SNPs on these loci encompass genes 
involved in neurodevelopmental processes, such as synapse formation, neuronal 
development and plasticity; they explained overall 22% of ADHD heritability and each 
individually has a modest odds ratios (OR= 1.08 to 1.98) (Demontis et al., 2018). 
Interestingly, the genes identified do not overlap with previous candidate genes of 
molecular genetic studies (Demontis et al., 2018; Hawi et al., 2015). Evidence from 
the study of common genetic variants also shows a consistent genetic risk overlap 
between ADHD and comorbid psychiatric symptoms and diagnosis, in particular 
depression, Bipolar Disorder, autism spectrum disorder, schizophrenia and anxiety 
(Anttila et al., 2018; Demontis et al., 2018; Du Rietz et al., 2018; Hamshere, 
Stergiakouli, et al., 2013; Schork et al., 2019). This suggests a pleiotropic effect of 
these common genetic variants that could also act through shared intermediate 
phenotype, such as cognitive functioning; this might be particularly relevant especially 
considering the negative correlation between ADHD and cognitive ability, also shared 
by other psychiatric conditions (e.g., schizophrenia) (Anttila et al., 2018; Du Rietz et 
al., 2018). Finally, common genetic risk also links ADHD with increased risk-taking 
behaviours that have negative health outcomes, such as smoking, obesity, alcohol 
use and substance abuse (Anttila et al., 2018; Demontis et al., 2018; Du Rietz et al., 
2018). Recent evidence suggests that these common genetic variants shared across 
psychiatric conditions could affect genes involved in foetal neurodevelopment of the 
brain (Schork et al., 2019). Common genetic variants specifically associated with 
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ADHD also seem to contribute to the persistence of ADHD over time, as well as to 
the ADHD diagnostic status and symptom severity; notably, persistent trajectories of 
ADHD symptoms were linked to a greater burden of ADHD common genetic variants 
(Riglin et al., 2016; Stergiakouli et al., 2015). Additionally, this common genetic risk 
obtained from clinical samples contributes to subclinical level of ADHD symptoms in 
the general population (Martin, Hamshere, Stergiakouli, O’Donovan, & Thapar, 2014) 
and viceversa, ADHD common genetic variants obtainted in population samples is 
also associated with ADHD diagnostic status and symptom severity in ADHD clinical 
samples (Stergiakouli et al., 2015). This further confirms the pivotal role of genetic 
risk factors in the pathophysiology of ADHD (Martin, Hamshere, Stergiakouli, 
O’Donovan, & Thapar, 2014). 
Genetic research on ADHD has also focused on rare mutations that affect less than 
1% of individuals in the general population; these are called Copy Number Variants 
(CNVs) and consist of duplications or deletions of sections of the genome (e.g. 
>100kb in length) (Faraone & Larsson, 2018). Previous research has shown that 
CNVs are consistently present in ADHD, with a prevalence around 15% compared to 
the 7% of controls,  representing a 2.09 increased risk of having a large, rare CNVs 
(Williams et al., 2010). These estimates increase dramatically in those with ADHD 
and comorbid learning disability, where CNVs have been found in 42% of individuals 
(Williams et al., 2010). These CNVs seem to be linked to genes involved in learning, 
central nervous system development and in neuronal signalling (Elia et al., 2010). 
Similarly to common genetic variants, CNVs have also been found to be enriched in 
loci reported to be involved in schizophrenia and autism, further supporting the genetic 
overlap across psychiatric conditions (Elia et al., 2010; Thapar et al., 2016; Williams 
et al., 2010). However CNVs only explain 0.2% of ADHD heritability (Cortese & 
Coghill, 2018) and as they are rare, genetic studies investigating CNVs require a very 
large sample. Taken together this evidence suggests that ADHD has a strong genetic 
component with a complex architecture, composed of common and rare genetic 
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variants, with some specific genes involved identified, but many more to be 
discovered. Investigating both common and rare genetic risk is therefore needed, and 
this is further supported by both additive and multiplicative effects of these types of 
genetic variants found to contribute to ADHD disease risk (Martin, O’Donovan, 
Thapar, Langley, & Williams, 2015).  However, common genetic risk explains only the 
22% of the large ADHD heritability; this low estimate might be due to the relationships 
between genetic risk factors and environmental risk factors, possibly leading to 
ADHD. 
 
Environmental Risk Factors 
Twin studies show a negligible contribution of shared environment as opposed to a 
greater importance of unique environment in the aetiology of ADHD (Nikolas & Burt, 
2010). Environmental factors potentially conveying risk for ADHD have been identified 
both prenatally and postnatally; some environmental risks are represented by early 
exposure to maternal smoking, alcohol, and toxic chemicals (e.g., organophosphate 
pesticides), as well as low birth weight and premature birth (Cortese & Coghill, 2018; 
Faraone et al., 2015). The association of these environmental risks with ADHD is 
however weak and further investigations revealed that the increased risk for ADHD 
associated with some of these environmental factors might be due to the confounding 
effect of genetic factors (Cortese & Coghill, 2018; Langley, Heron, Smith, & Thapar, 
2012). Preterm birth and severe deprivation are risk factors that do not seem to be 
accounted for by genetic factors, however these risks are not specific to ADHD but 
rather are risk factors for a broad range of psychiatric conditions (Cortese & Coghill, 
2018; Faraone et al., 2015). Severe maternal deprivation is also more specifically 
associated with ADHD-like symptoms rather than ADHD diagnosis (Stevens et al., 
2008). Additionally, a mechanism that can account for the difference between high 
heritability estimates and the small variance explained by the common and rare 
genetic risk variants identified is the interplay between genes and environment. 
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Investigation into gene-environment interactions are therefore worth exploring, 
although overall so far it yielded inconclusive results; possibly this is due to the low 
power of previous studies to detect an effect as very big samples are needed to 
address this matter properly (Faraone et al., 2015). Nonetheless, despite the most 
studies being underpowered and the complexity of studying environmental risk factors 
and gene-environment interaction, studies in this area revealed a modest and non-
specific role of the environment in the aetiology of ADHD. 
In conclusion, the genetic, environmental, and gene-environment risk factors 
identified so far do not account for the whole ADHD heritability and its high estimates 
reported by twin studies. This suggests that more research in this area is needed to 
identify more robust factors involved in the aetiology of this condition. An alternative 
explanation considers the role played by heterogeneous clinical correlates of ADHD. 
As mentioned previously, ADHD is comorbid with a variety of psychiatric symptoms 
and diagnosis which is also observed at genetic risk level. Genes involved in the 
aetiology of ADHD overlap with genetic risk for a variety of psychiatric conditions; in 
other words, the same risk factors increase the risk for several psychiatric conditions, 
being therefore a-specifically associated with ADHD. In GWAS, this heterogeneity is 
found to reduce both the power to find significant genetic associations and the effect 
sizes associated with the common genetic variants contributing to disease risk 
(Manchia et al., 2013). Additionally, this variability suggests that the genetic risk 
variants identified might be relevant for distinct subgroups of individuals with ADHD 
with specific clinical profiles, and thus underly different aetiological pathways leading 
to this condition (Agid et al., 2013; Hayman, 2007). The high degree of comorbidity 
with ADHD might therefore be problematic for the identification of robust risk factors 
with big effect sizes, ultimately preventing both a deeper understanding of the 
aetiology of ADHD, and the possibility to delineate preventing strategies, effective and 
relevant for all cases of ADHD.  
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1.2.5 Neuro-functioning 
ADHD is also associated with consistent structural and functional brain abnormalities. 
In terms of structure, recent mega-analyses reveal that the ADHD brain is 
characterised by a smaller volume in many regions, such as the frontal, temporal and 
cingulate areas, although strongest effect sizes are found for the total brain volume 
(Greven et al., 2015; Hoogman et al., 2017, 2019). Some regions in the brain of those 
with ADHD also differ from those of controls based on cortical thickness as individuals 
with ADHD show thinner temporal and fusiform gyrus areas (Hoogman et al., 2019). 
These results seem to be independent of the effect of sex, IQ (Intelligence Quotient) 
and comorbidity although there is an effect of age; differences in cortical volume and 
thickness are seen in children but not in adolescents and adults with ADHD (Hoogman 
et al., 2019). This seems to support the idea that those with ADHD are characterised 
by a cortical maturation delay compared to typically developing controls (Shaw et al., 
2007). Similar volume abnormalities have been found also in relatives of probands 
confirming the familiarity of ADHD (Greven et al., 2015; Hoogman et al., 2019); a set 
of these areas with different volume also correlate with attention symptoms in the 
general population, providing further evidence in favour of a dimensional distribution 
of ADHD traits and risk in the general population (Hoogman et al., 2019). Meta-
analytic findings from the field of functional neuroscience found both hypo- and hyper-
activation of several brain networks, such as the frontoparietal and the attention 
networks involved respectively in goal-directed activities and decision-making, and 
attention orientation to relevant stimuli (Cortese et al., 2012). Abnormal functioning of 
the sensorimotor network has also been detected, possibly underpinning motor 
hyperactivity (Cortese et al., 2012). Finally, the default network, involved in lower 
cognitive processes and suppressed during cognitive performance, is characterised 
by hyperactivity in those with ADHD compared to controls, possibly suggesting 
interference in goal-directed activities (Cortese et al., 2012). Other findings show 
consistent hypoactivation of the ventral striatum, an area important for reward 
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processing and connected with the limbic system, highly involved in emotion 
processing (Plichta & Scheres, 2014). It should be noted that these functional and 
structural brain abnormalities are associated with small effect sizes and, despite the 
robustness of these findings, there are studies that fail to show brain differences 
comparing those with ADHD to controls (e.g., emotional and motivational network 
differences in Cortese et al., 2012). Once again, the heterogeneity of ADHD might 
play a role in these inconsistencies and small effect sizes, as the great degree of 
comorbidity in those with ADHD is shown to possibly mask the identification of brain 
differences comparing cases to controls (Adisetiyo et al., 2014). 
It might also be worth considering that these differences in the activity and structure 
of the brain between youths with ADHD and controls might reflect ADHD impairments 
at the cognitive level. These impaired brain areas are indeed implicated in cognitive, 
motivational and emotional functioning, such as memory and response inhibition, 
reward processing, and emotion processing and regulation (Greven et al., 2015; 
Hoogman et al., 2017, 2019). Thus, these structural and functional differences in the 
brain could lead to ADHD symptoms by affecting cognitive functioning. 
It should however be noted that ADHD is heterogeneous also in terms of cognitive 
functioning impairments (for more discussion see section 1.3.4 of this chapter). 
In conclusion, there are several functional and structural differences in brain regions 
comparing ADHD to typically developing controls, although the role of the 
heterogeneity in terms of ADHD clinical correlates needs to be understood as possibly 
linked to the small effect sizes and inconsistencies found across studies. This appears 
to be highly relevant for the discovery of brain-related underpinnings of ADHD.  
 
1.2.6 Treatment of ADHD 
Pharmacological, behavioural, cognitive or, more often, combined interventions could 
all be used for those with ADHD. These are all recommended by the UK National 
Institute for Health and Care Excellence (NICE) guidelines (National Institute for 
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Health and Care Excellence, 2018) that indicate first-line treatments for ADHD, based 
on age and severity of this condition. 
Pharmacological treatment is recommended for adults with ADHD and for school 
children or young persons with severe and consistently impairing ADHD symptoms 
who did not respond to non-pharmacological treatments (National Institute for Health 
and Care Excellence, 2018). The most common pharmacological treatments are 
psychostimulants, in particular methylphenidate and amphetamines, especially 
lisdexamfetamine and dexamfetamine, that are associated with a significant reduction 
of ADHD core symptoms as endorsed by multiple raters (Cortese et al., 2018; 
Faraone et al., 2015; National Institute for Health and Care Excellence, 2018). 
Methylphenidate is mostly used in children as proven to be effective as well as well 
tolerated and accepted by those with ADHD and their family (Cortese et al., 2018). 
Similarly, amphetamines are the preferential choice for the treatment of ADHD in 
adults achieving good standards in terms of effectiveness, tolerability and 
acceptability (Cortese et al., 2018). The efficacy of these treatments in reducing 
inattentive and hyperactive-impulsive symptoms seems independent of comorbidities, 
IQ and dose used (Cortese et al., 2018). It should be noted however that medications 
are a short-term option for the treatment of ADHD, as long-term effectiveness over a 
number of years is less well understood and there seem to be an adaptation to 
psychostimulants over-time (Rutter & Pickles, 2016). Furthermore, despite the 
efficacy of psychostimulants in reducing core symptoms of ADHD and comorbid 
disruptive behaviours (e.g., ODD and CD), impairing symptoms, such as Emotional 
Dysregulation, still persist (Shaw et al., 2014). This suggests that severe irritability 
and related constructs might still represent an adverse outcome, warranting tailored 
interventions; although one previous study seems to show promising effects 
combining stimulants and psychosocial treatment in reducing symptoms of severe 
irritability in this population (Blader et al., 2016). 
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According to NICE, pharmacological treatments are however not recommended for 
preschool children, school aged children and young people with mild ADHD. In this 
case, behavioural interventions, often addressed to parents but can involve children 
and adolescents as well, are recommended, such as parent-training, educational 
programmes and Cognitive-Behavioural Therapy (National Institute for Health and 
Care Excellence, 2018). Meta-analyses show evidence of behavioural treatments in 
reducing comorbid symptoms of ADHD (e.g., ODD/CD), as well as improving 
parenting skills, family functioning, and social and academic skills, with however only 
limited support in reducing ADHD core symptoms (Daley et al., 2014; Rimestad, 
Lambek, Zacher Christiansen, & Hougaard, 2019; Sonuga-Barke et al., 2013). It 
should be noted that the results are discrepant considering unblinded or blinded 
assessments, with the latter producing less empirical evidence on the efficacy of 
behavioural interventions (Daley et al., 2014; Rimestad et al., 2019; Sonuga-Barke et 
al., 2013).  
Finally, other non-pharmacological treatments have been developed in the attempt to 
reduce ADHD core and comorbid symptoms and improve impairment, although these 
are not included in NICE. For instance, cognitive interventions and neurofeedback are 
also available and stem from the idea that neurocognitive impairments seen in ADHD 
mediate the pathophysiology and phenotypic expression of this condition (Cortese et 
al., 2015, 2016). Whilst cognitive training targets mostly working memory, inhibition 
and attention; neurofeedback aims to restore the aberrant pattern of brain activity 
seen in ADHD (Cortese et al., 2015, 2016). In meta-analyses, both cognitive training 
and neurofeedback yielded similar results of those obtained with behavioural 
interventions whereby when considering only well-controlled interventions with 
blinded raters, significant improvements were not robustly observed in either ADHD 
core symptoms or in cognitive impairments (Cortese et al., 2015, 2016; Sonuga-Barke 
et al., 2013; Van Doren et al., 2019). However, conclusions on the effectiveness of 
neurofeedback and cognitive training interventions should be made with caution due 
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to the recent development of these interventions, warranting further investigation. 
Additionally, systematic meta-analyses have been conducted only on EEG 
neurofeedback (Cortese et al., 2016; Sonuga-Barke et al., 2013; Van Doren et al., 
2019), whereas neurofeedback can also rely on other techniques (e.g., Functional 
Magnetic Resonance Imaging) (Alegria et al., 2017; Marx et al., 2015), possibly 
yielding different results, but those have not been robustly investigated yet. 
Considering the high heterogeneity in clinical correlates, neurocognitive and biological 
underpinnings of ADHD, inconsistent results on ADHD treatment is not surprising 
(Feczko et al., 2019; Franke et al., 2018). Addressing the high variability of this 
neurodevelopmental condition is therefore a priority to develop more effective 
pharmacological, behavioural, and neurocognitive interventions.  
 
To conclude, ADHD is the most common psychiatric condition in children and 
adolescence (Cortese & Coghill, 2018; Polanczyk et al., 2007). Despite the decrease 
in some symptoms and remittance for some over time, the associated impairments 
are very broad and enduring. ADHD however is very heterogeneous, especially in its 
clinical correlates, which makes it difficult to gain a complete understanding of risk 
factors, biological underpinnings and neurocognitive markers of this condition; this 
also has a negative impact on the development of preventative strategies and on the 
efficacy of treatments. Future research should therefore aim to understand this 
variability, considering in particular the public health relevance of this 
neurodevelopmental condition. In this section the potential role of irritability in 
explaining the clinical heterogeneity of ADHD is also illustrated, being a cross-
diagnostic symptom and a possible source of heterogeneity. 
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1.3 Executive functions 
This section covers a main aspect of this thesis that is cognitive functioning, 
describing its operationalisation in terms of Executive Functions (EFs) and showing 
its relevance for both irritability and ADHD. 
 
1.3.1 Origin and definition 
The term “Executive Functions” describe a variety of high order and top-down 
cognitive processes involved in goal directed activities and supported by the frontal 
lobes (Zelazo & Carlson, 2012). Historically, the conceptualisation of EFs developed 
from clinical studies investigating the variety of cognitive deficits displayed by patients 
with damages in the Prefrontal Cortex (PFC), a brain region anterior to the premotor 
and motor areas (Zelazo & Carlson, 2012; Zelazo & Muller, 2002). Based on these 
clinical observations, several cognitive processes have been identified that are 
grouped into Cool and Hot Executive Functions (Zelazo & Muller, 2002). Cool EFs 
refer to cognitive processes that take place during abstract and decontextualized 
scenarios, such as perception, attention, and memory. Counter to this, Hot EFs are 
involved in motivational and emotional contexts and are thought to require different 
cognitive processes than Cool EFs, such as reward-related and emotion regulation 
strategies (Zelazo & Carlson, 2012; Zelazo & Muller, 2002).  
Cool and Hot EFs have been found to be independent in many aspects and using 
different methodological approaches. More precisely, individuals with brain lesions 
can show impairments in Hot but not Cool EFs and vice-versa (Zelazo & Carlson, 
2012); this distinction is also supported at the brain level. In particular, Cool EFs are 
underpinned by the Dorsolateral Prefrontal Cortex (DL-PFC) whereas Hot EFs are 
associated with the activity of the Orbitofrontal Cortex (OFC) whose impairments often 
produce non-adaptive social and emotional behaviours. These brain regions show 
connections with distinct parts of the brain as well; the DL-PFC is associated with the 
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thalamus, part of the basal ganglia, the hippocampus and primary and secondary 
association areas that altogether enable the integration of both sensory and 
mnemonic information, and they also regulate the intellectual functions and actions 
(Zelazo & Muller, 2002). OFC shows connections with brain areas in the limbic 
system, such as the amygdala and it is important for the regulation of motivation, 
reward and emotion (Zelazo & Carlson, 2012; Zelazo & Muller, 2002). Finally, studies 
looking at overarching factors of different EFs have consistently shown a distinction 
between Hot and Cool EFs, as tasks measuring motivation and emotion tend to group 
together, and Cool tasks appear to load on separate factors to Hot EFs in factor 
analysis (Brock, Rimm-Kaufman, Nathanson, & Grimm, 2009; Kim, Nordling, Yoon, 
Boldt, & Kochanska, 2013; Willoughby, Kupersmidt, Voegler-Lee, & Bryant, 2011). 
This distinction between Cool and Hot EFs is also confirmed by factor analyses in 
clinical samples, especially in those with ADHD (Coghill, Seth, & Matthews, 2014; 
Nigg, Willcutt, Doyle, & Sonuga-Barke, 2005; Sonuga-Barke, Bitsakou, & Thompson, 
2010; Sonuga-Barke, Dalen, & Remington, 2003). It is also important to note that, 
although Cool and Hot EFs are overall distinct at the phenotypical and 
neuroanatomical level, there are also shared neural connections and brain regions 
between DL-PFC and OFC (Zelazo & Carlson, 2012). This is also reflected by the 
functional overlap between Cool and Hot EFs as goal-directed activities normally take 
place in emotional or motivational settings but they also require Cool cognitive 
processes, such as information processing and planning, to be accomplished; 
nonetheless Cool and Hot EFs put emphasis of distinct processes underpinned by 
largely distinct brain regions (Zelazo & Carlson, 2012). 
There are several Cool and Hot EFs, although the most relevant for this thesis are: 
behavioural inhibition and cognitive flexibility for Cool EFs, and temporal discounting, 
decision-making and reward processing for Hot EFs. Behavioural inhibition is a 
component of inhibitory control which is the ability to control cognitive processes, such 
as attention and behaviour, against an intense predisposition to respond to internal or 
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external circumstances (Diamond, 2013; Jurado & Rosselli, 2007). Behavioural 
inhibition refers specifically to the ability to successfully suppress preponderant motor 
responses to maintain goal-directed activities (Diamond, 2013). Cognitive flexibility, 
also known as set-shifting, is the ability to flexibly adjust one’s behaviours to ever-
changing environmental circumstances and demands to adaptively respond to them 
(Diamond, 2013; Jurado & Rosselli, 2007). Considering Hot EFs, temporal 
discounting is the tendency to devalue a reward as a function of time, the more the 
delay the lesser the value (Richards, Zhang, Mitchell, & de Wit, 1999). Similarly, 
decision-making is a complex cognitive function that enables individuals to make 
optimal decisions in emotional circumstances (i.e., those that involve rewards or 
losses) (Kerr & Zelazo, 2004). Finally, reward processing refers to several cognitive 
processes that enables to learn, predict, and respond to environmental contingencies, 
to achieve a goal (i.e., reward) (Brotman, Kircanski, & Leibenluft, 2017). 
 
1.3.2 Developmental trajectories and impairments in EFs 
EFs emerge early in life, around the end of the first year, when young children seem 
to use these skills as a reaction to environmental demands (e.g., avoid touching an 
attractive toy in response to a parental request); as they get older, they learn how to 
effectively process environmental stimuli, planning a more adaptive response (e.g., I 
should stop watching tv now, so I can watch more later) (Diamond, 2013; Garon, 
Bryson, & Smith, 2008; Jurado & Rosselli, 2007; Zelazo & Muller, 2002). EF skills 
seem to decrease in late adulthood as older adults tend to meet environmental 
demands with a decreased planning ability. Thus EFs developmental trajectories 
seem to follow a U-shape over the course of development (Diamond, 2013; Jurado & 
Rosselli, 2007; Zelazo & Muller, 2002). However, Cool and Hot EFs seem to follow 
slightly different developmental trends across childhood; they both develop at the end 
of the first year, but while Cool EFs seem to improve rapidly with age, to the point that 
12-year olds perform as well as adults on many tasks (e.g., Wisconsin Card Sorting 
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Test – a measure of cognitive flexibility) (Zelazo & Muller, 2002), Hot EFs seem to 
develop at a slower rate (Zelazo & Carlson, 2012). These developmental differences 
seems to be present also at the anatomical level (Jurado & Rosselli, 2007; Zelazo & 
Carlson, 2012; Zelazo & Muller, 2002), suggesting a maturational delay of the OFC 
as opposed to the DL-PFC. A typical development of EFs is particularly important as 
it enables an individual to properly respond and to adapt to environmental demands. 
In fact, EF skills show associations with intellectual functioning (Brock et al., 2009; 
Hongwanishkul, Happaney, Lee, & Zelazo, 2005), academic functioning and 
achievement (Allan, Hume, Allan, Farrington, & Lonigan, 2014; Brock et al., 2009; 
Willoughby et al., 2011), suggesting that they are particularly relevant for school 
success. Additionally, EF skills seem to be important for physical health (Riggs, 
Spruijt-Metz, Sakuma, Chou, & Pentz, 2010) and they are also associated with a 
better quality of life (Davis, Marra, Najafzadeh, & Liu-Ambrose, 2010) in youths and 
adults. Counter to this, impaired cognitive functioning is associated with a variety of 
psychiatric symptoms and conditions (Diamond, 2013; Jurado & Rosselli, 2007), 
especially within the externalising domain (Granvald & Marciszko, 2016; Schoemaker, 
Mulder, Deković, & Matthys, 2013; Woltering, Lishak, Hodgson, Granic, & Zelazo, 
2016). Taken together these findings suggest that Cool and Hot EFs appear to be 
distinct even in their developmental trajectories, and that both are important for a 
range of functional outcomes across development. This is further supported by the 
frequently observed EF impairments in clinical populations; this thesis focuses in 
particular on cognitive impairments in chronic and severe irritability and ADHD, 
outlined in the sections below.  
 
1.3.3 Executive Functions and chronic and severe irritability  
Executive Functions are relevant to research on severe irritability and this phenotype 
is particularly intertwined with the concept of reward, included in the Hot EF domain. 
The neuroscientific paradigm of irritability relies on the concept of “Frustrative Non-
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Reward” (FNR), proposed by the NIMH and included within the Research Domain 
Criteria (RDoC) framework (Brotman, Kircanski, & Leibenluft, 2017; Lilienfeld, 2014). 
The RDoC is an alternative dimensional approach to mental illness developed by the 
NIMH that stems from dissatisfaction with the current diagnostic nosology (Lilienfeld, 
2014). It is complementary to the DSM, which has been considered too reductionist 
and unable to capture the neurobiological underpinnings leading to the development 
and maintenance of psychiatric conditions (Garvey, Avenevoli, & Anderson, 2016). 
Within the RDoC, FNR is defined as an emotional state, characterised mostly by 
anger, induced by frustrating circumstances, for example in scenarios where the 
attainment of a previously available reward is blocked (e.g., a child who must stop 
playing a videogame to do other duties) (Leibenluft, Blair, et al., 2003). This 
conceptualisation of irritability seems to have biological foundations as previous work 
using animal models showed that mice react with aggressive behaviours and 
increased activity when facing frustrating circumstances (Amsel, 1958; Burokas, 
Gutiérrez-Cuesta, Martín-García, & Maldonado, 2012); similar behaviours have been 
observed in primates (Davenport & Thompson, 1965) as well as children (Deveney et 
al., 2013; Perlman, Luna, Hein, & Huppert, 2014; Ryan & Watson, 1968). As 
mentioned previously (Chapter 1, section 1.1.3), the discomforting emotion of anger 
that follows frustration is a normative and possibly adaptive reaction, however 
compared to typically developing peers, severely irritable youths seem to respond 
differently to this FNR paradigm. In particular, they seem to display both a lower 
tolerance of frustration, and a more intense and dramatic emotional response, with a 
greater duration (Deveney et al., 2013; Leibenluft, Blair, et al., 2003; Perlman et al., 
2015; Rich et al., 2011, 2007). In other words, severely irritable individuals react with 
dramatic and intense emotions to frustrating circumstances to which typically 
developing individuals react only mildly; this emotional response is also more 
enduring compared to peers. 
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Irritability from a cognitive perspective is also associated with other important Hot EFs 
related to reward processing. Frustrating circumstances are often precipitants of 
irritability as modelled by the FNR paradigm, however the increased efforts to achieve 
the withheld reward can induce Instrumental Learning (IL), that is the ability to learn 
and adjust to reward and punishment contingencies (Brotman, Kircanski, Stringaris, 
et al., 2017). Optimal IL is essential to adapt to the environment, as it would increase 
the chance of gaining a reward and avoid punishment in a variety of contexts 
(Brotman, Kircanski, Stringaris, et al., 2017). This is done by retaining behaviours that 
lead to reward and dropping those that lead to punishment, thus Instrumental 
Learning could reduce the probability of an individual incurring in frustrating 
circumstances. IL is a complex ability that contributes to more basic reward 
processing skills, such as the ability to value a reward, the ability to predict the 
instances when a reward is given, as well as the ability to learn from reward 
contingencies (Brotman, Kircanski, Stringaris, et al., 2017). Conversely, individuals 
with chronic and severe irritability seem to be characterised by impaired IL and related 
reward processing. In particular, impairments in this population are observed in 
reward prediction, reward learning and reward sensitivity (Brotman, Kircanski, & 
Leibenluft, 2017; Brotman, Kircanski, Stringaris, et al., 2017; Leibenluft, 2017b). 
Expected value representation, meaning the anticipated value attributed to a reward, 
is also impaired in those with severe irritability both at the neural and behavioural 
level, leading to suboptimal decision-making choices and failure to learn from 
environmental contingencies (White et al., 2014, 2013, 2016). Similar cognitive 
impairments are likely to increase the probability of individuals with chronic and severe 
irritability encountering frustrating circumstances, as they would struggle to value, 
learn, predict, and respond to reward contingencies, failing to attain the desired 
reward. This would in turn elicit the aberrant and enduring emotional response 
observed during FNR paradigms, compared to peers (Brotman, Kircanski, & 
Leibenluft, 2017). Empirical evidence on reward processing impairments in youths 
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with chronic and severe irritability is covered more in detail in Chapter 4. At this point 
in this thesis, it should however be remembered that the current conceptualisation of 
chronic and severe irritability is a recent construct and research on neurocognitive 
markers of this phenotypes is at its early stages, therefore more empirical evidence 
is necessary to validate reward processing as neurocognitive markers of irritability. 
This would be beneficial to both gain a deeper understanding of underpinnings of 
chronic and severe irritability as well as develop tailored interventions. 
 
1.3.4 Executive Functions in ADHD 
As mentioned previously, ADHD is a heterogeneous condition, and its heterogeneity 
also lies in neuropsychological impairments (Thapar & Cooper, 2016). 
Neuropsychological deficits in ADHD may overlap in an individual but there is no 
specific cognitive profile that identifies children with this neurodevelopmental disorder 
(Castellanos, Sonuga-Barke, Milham, & Tannock, 2006; Thapar & Cooper, 2016). 
Consistent with the heterogeneous nature of ADHD, different neuropsychological 
models have been developed in the attempt to understand the origin and the extent 
of cognitive impairments in ADHD, possibly identifying pathways leading to this 
neurodevelopmental condition. For instance, the default-mode network model has 
acquired a great importance in the ADHD literature as failure to regulate this network 
seems to lead to lapses of attention, performance variability and impulsive behaviour. 
All these impairments are frequently observed in individuals with ADHD and they also 
interfere with goal directed activities (Sonuga-Barke & Castellanos, 2007). Counter to 
this, according to the state-regulation model, those with ADHD have consistent 
problems in regulating effort, arousal and activation, which refers to the physiological 
readiness to respond (Sergeant, 2000, 2005; Wahlstedt, Thorell, & Bohlin, 2009). 
These regulatory impairments are thought to disrupt cognitive processes and 
underpin the Reaction Time (RT) variability frequently observed in this condition 
(Sergeant, 2005; Wahlstedt et al., 2009). However, over the past decades the 
Chapter 1 | page 47 
  
dominant and more extensively studied model conceived ADHD as having impaired 
Executive Functions. The EF model (Barkley, 1997; Castellanos et al., 2006; Sonuga-
Barke, 2002; Zelazo & Muller, 2002) also has a biological foundation as the PFC (the 
anatomical underpinning of EFs) is strictly intertwined with the dopamine system, the 
main target of ADHD pharmacological treatment (Fusar-Poli, Rubia, Rossi, Sartori, & 
Balottin, 2012). Additionally, ADHD core symptoms and executive functioning seem 
to be normally distributed in the general population, and these symptom severity and 
cognitive performance seem to be associated with one another (Petrovic & 
Castellanos, 2016). Historically, ADHD was thought to be characterised by a core 
inhibitory control deficit, disrupting Cool EFs in a cascade effect (Barkley, 1997), 
although this paradigm failed to explain the totality of ADHD cases. This failure to 
account for all ADHD cases determined a shift in the study of cognitive impairments 
in ADHD, suggesting that there are multiple aberrant pathways leading to this 
condition; the idea being that the heterogeneity of ADHD would be better accounted 
for by multiple deficits, as opposed to a single deficit in inhibitory control. In particular, 
empirical work stresses the importance of studying motivational and emotional 
aspects in ADHD. Impairments in Hot EFs are in fact shown to be robust in this clinical 
population, although less thoroughly studied compared to Cool EFs (Castellanos et 
al., 2006). Thus, ADHD is now more comprehensively conceptualised as having both 
Cool and Hot Executive Function impairments, which is also supported by 
neuroanatomical findings (Petrovic & Castellanos, 2016). More precisely, the most 
consistent Cool deficits in youths with ADHD appear to be poor inhibitory control, 
attention, working memory and vigilance. Working memory refers to withholding and 
updating task-relevant information for either further processing or for recall, within a 
span of a few seconds (Castellanos & Tannock, 2002; Diamond, 2013); whereas 
vigilance (i.e. sustained attention) is the ability to maintain a conscious focus and to 
keep processing stimuli with repetitive and dull features (McAvinue et al., 2015; 
Thapar & Cooper, 2016). Considering Hot EFs, meta-analyses show consistent 
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impairment in reward processing and decision-making, characterised by impulsivity 
and poor evaluation of consequences in individuals with ADHD, compared to typically 
developing controls (Dekkers, Popma, Agelink van Rentergem, Bexkens, & Huizenga, 
2016; Jackson & MacKillop, 2016; Mowinckel, Pedersen, Eilertsen, & Biele, 2015; 
Willcutt, Doyle, Nigg, Faraone, & Pennington, 2005). Despite this established model, 
ADHD still shows a consistent amount of heterogeneity related to EF impairments. 
There is in fact a substantial proportion (7% to 29%) of those with ADHD who do not 
have any cognitive impairment, and among those who do show similar deficits, youths 
with ADHD can display impairments in Cool EFs (working memory, behavioural 
inhibition, set-shifting) and/or Hot EFs (e.g., delay aversion - the preference for 
smaller-immediate over larger-delayed rewards - and emotion processing) (Sjöwall, 
Roth, Lindqvist, & Thorell, 2013; Sjöwall & Thorell, 2018). Additionally, those with 
ADHD can fail multiple tasks tapping EFs, although generally individuals show 
impairments in one or two tasks more commonly than they fail multiple tasks (Nigg et 
al., 2005; Sjöwall et al., 2013; Sjöwall & Thorell, 2018). This seems to be consistent 
even when Cool and Hot EFs were rearranged into overarching factors, as empirical 
evidence reports cognitive impairment variability to a similar extent (Coghill et al., 
2014; Nigg et al., 2005; Sonuga-Barke et al., 2010; Sonuga-Barke et al., 2003). 
Overall, these findings show the relevance as well as the wide heterogeneity of 
executive functioning impairments in ADHD that neither looking at “single” EFs nor 
using factor solutions is able to reduce. This also suggests that these deficits are not 
required nor sufficient to formulate a diagnosis, nonetheless they appear to be 
relevant pathophysiological mechanisms at least for a subset of individuals with 
ADHD. More research is therefore needed in order to account for this cognitive 
heterogeneity, looking at possible sources of variability that can explain some of these 
cognitive impairments in ADHD. Considering the cognitive overlap in Hot EF deficits 
between chronic and severe irritability and ADHD, this phenotype might be a good 
candidate to serve this purpose. 
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In conclusion of this general introduction, chronic and severe irritability appears to be 
understudied, despite being a clinically relevant phenotype (see section 1.1). In 
particular, the NIMH task force highlighted the investigation of the nature, 
pathophysiological markers and aetiological factors of this phenotype as research 
priorities (Leibenluft & Avenevoli, 2014). Addressing these priorities in youths with 
ADHD might be particularly beneficial. This is due to chronic and severe irritability 
being highly prevalent in this population and associated with worse clinical and 
functional outcomes than ADHD alone (see section 1.2.3). The investigation of this 
phenotype in ADHD might additionally be beneficial in helping to understand the 
heterogeneity of ADHD, observed at the clinical, cognitive and aetiological levels, that 
ultimately impacts on clinical practice (see section 1.2.3). Considering that chronic 
and severe irritability is associated with a wide range of internalising and externalising 
conditions, and its Hot cognitive impairments overlap with those observed in ADHD, 
this phenotype appears to be a possible source of heterogeneity in this population. 
However, no study to date has investigated chronic and severe irritability as a source 
of heterogeneity in a sample of youths with ADHD. Thus, addressing the nature, 
pathophysiological markers, and aetiological factors of chronic and severe irritability 
in those with ADHD might enhance the understanding of both this phenotype, 
increasingly important to research and clinical practice, and the heterogeneity of 
ADHD. This would ultimately enable the development of tailored and more effective 
interventions. This thesis addresses these knowledge gaps and research priorities as 
follows. 
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1.3.5 Thesis Aims 
The main aim of this thesis is to explore the characterisation of chronic and severe 
irritability in a sample of children with ADHD and it is split into three specific aims, 
covered in Chapter 3, Chapter 4, Chapter 5. 
1) The first aim, addressed in Chapter 3, is to investigate the nature of chronic 
and severe irritability. In particular, the validity of a bi-dimensional construct of 
this phenotype, exploring patterns of co-occurrent associations with clinical 
correlates of ADHD and further validate these, looking at longitudinal clinical 
associations and maternal psychopathology. This will inform how irritability will 
be conceptualised in subsequent chapters. 
2) The second aim, addressed in Chapter 4, looks at Hot EFs (as opposed to 
Cool EFs) as a possible pathophysiological marker of chronic and severe 
irritability, using both a variable-driven and a data-driven approach. More 
precisely, this is a longitudinal study where chronic and severe irritability is 
measured in childhood and EFs in adolescence. This will inform of chronic and 
severe irritability as a possible source of cognitive heterogeneity and its impact 
on cognitive functioning in adolescents with ADHD. 
3) The third aim, addressed in Chapter 5, explores the common genetic risk 
associated with childhood chronic and severe irritability and investigate 
possible associations with cognitive performance. This will inform of the 
genetic underpinnings of chronic and severe irritability that could be useful to 
understand biological mechanisms that impact on adolescents with ADHD.  
Taken together these investigations will increase the understanding of chronic and 
severe irritability in terms of its nature, pathophysiological markers, and risk factors, 
ultimately answering to the research priorities in this field as outlined by the 2014 
workshop (Leibenluft & Avenevoli, 2014). Additionally, considering the relevance of 
this phenotype in ADHD, addressing these aims could help identifying and eventually 
explain the heterogeneity of ADHD at the behavioural, cognitive, and genetic level. 
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The following chapter (Chapter 2) describes the methods used across all the studies 
that are part of this thesis; whereas Chapter 6 discusses the overall findings from the 
three main aims of this thesis, especially in terms of clinical implication, strengths and 
limitations, and future directions.
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Methods 
 
 
Chapter description 
In this thesis a clinical sample of children with ADHD was used across the different 
studies. Longitudinal data was also collected on a subsample of these children. In 
particular, Chapter 3 uses both the baseline data from this clinical ADHD sample, as 
well as follow-up data from those available, whereas Chapter 4 and Chapter 5 only 
focus on participants for whom follow-up data was available. This chapter describes 
the recruitment, assessment procedures and methods related to this sample within 
and across time. 
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2.1 Sample 
 
2.1.1 Baseline 
This clinical ADHD sample is composed of children who participated in the SAGE 
study at Cardiff University. The study took place between 2007 and 2011. Participants 
were recruited from child psychiatry and paediatric clinics across the UK, where 
clinicians asked families of children aged 6-18 years, and with either a suspected or 
ascertained ADHD diagnosis, if they would be interested in taking part in research. 
Contact details of families who assented were then passed on to the research team 
who contacted them by phone, conducting a brief screening interview. This interview 
aimed to check the inclusion and exclusion criteria to determine the eligibility and 
willingness of the family to participate in the study. Children were considered eligible 
if they had a clinical diagnosis of ADHD or if they were going through diagnostic 
assessment for ADHD when they were first contacted. Only British Caucasian children 
were taken forward in the study, as relevant for the genetic analyses. Finally, children 
had to be living with at least one biological parent. Exclusion criteria related to the 
child having a common neurological, neuropsychiatric, or genetic disorder, namely 
fragile X syndrome, tuberous sclerosis, epilepsy, and psychosis. Children with any 
Tourette syndrome, autism, or pervasive developmental disorder, as specified by the 
DMS-IV and ICD-10 guidelines, were also excluded. Notably, a low IQ (conventionally 
< 70) was not considered an exclusion criterion to account for the heterogeneity of 
clinical samples commonly seen in psychiatric clinics. Once children were screened, 
the research team scheduled home visits with eligible participants to proceed with the 
assessment protocol. An invitation letter was also sent out to family homes, together 
with details of the study, consent forms, questionnaires to complete ahead of the visit, 
and a reminder of the date and time of the appointment. Research visits were 
conducted by a pair of trained psychologists, one conducting the parent assessment 
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and the other the child assessment. For the purpose of genetic analyses, a venous 
blood or saliva sample was also collected from the child and both parents, where 
possible. Following the home assessment that was overall 2-3 hours long, a research 
report summarising the main clinical and neuropsychological findings was written for 
all participants and sent to the referring clinician. Finally, a £15 voucher was given to 
the families to thank them for their participation in the study, whilst regular newsletters 
were sent to keep these families updated on relevant aspects of the study, such as 
the results. 
Before taking part in the study, parents had to sign a consent form as did those 
participants aged 16 years or older. For participants 15 years of age or younger, a 
written assent form was collected. Ethical approval was obtained from the Wales 
Multicentre Research Ethics Committee (reference number: 06/MRE08/75). This 
study was funded by the Wellcome Trust (Grant No: 079711). 
 
2.1.2 Follow-up 
Families who took part in the SAGE study, and who consented to be contacted for 
future research, were asked if they were interested in taking part in a follow-up study 
that ran at Cardiff University from 2011 until 2016. Initially, only boys aged 10-17 years 
and with an IQ > 70 were considered eligible, and they were followed up two to five 
years after their original participation (two and a half years later, on average). These 
inclusion criteria were then broadened to be inclusive of females and younger children 
with a broader range of IQ. Families who agreed to take part were sent clinical 
questionnaires through post and then invited to Cardiff University for further 
assessment. Diagnostic interviews, clinical questionnaires, and questionnaires about 
the young person were administered to parents, whilst adolescents completed 
research diagnostic interviews and neuropsychological tasks. The research protocol 
was delivered by two trained psychologists. 
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The assessment took approximately 4-5 hours, after which families received £25 as 
a thank you for their participation, in addition to their food and travel expenses. 
The UK Medical Research Council fund this research (grant number: G1000632) and 
ethical approval was obtained from the Wales Multicentre Research Ethics Committee 
(reference number: 11/WA/0050). Parents (and adolescents over the age of 16) gave 
written informed consent, whilst children gave written informed assent. 
 
2.2 Assessment Measures 
This section describes the assessment measures used to collect both baseline and 
follow-up data, a summary of these methods are shown in Figure 2.1. It should be 
noted that both the baseline and follow-up data collection preceded the publication of 
DSM-5, released in 2013 (American Psychiatric Association, 2013) and/or used 
clinical measures based on previous versions of the DSM. Therefore, ADHD research 
diagnosis was formulated following DSM-IV or DSM-III-R criteria (American 
Psychiatric Association, 1987, 2000). Following the publication of DSM-5 and 
considering the changes to ADHD diagnostic criteria, data for all participants was 
reassessed for DSM-5 ADHD diagnosis by two child and adolescent psychiatrists.  
 
 
Figure 2.1 Summary of the different baseline and follow-up assessment measures  
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CAPA = Child and Adolescent Psychiatric Assessment; ADHD = Attention Deficit Hyperactivity Disorder; 
ODD = Oppositional Defiant Disorder; CD = Conduct Disorder; MDD= Major Depressive Disorder; ASQ 
= Autism Screening Questionnaire; ICU = Inventory of Callous-Unemotional Traits; HADS = Hospital 
Anxiety and Depression Scale; SES = Social Economic Status; DAWBA = Development and Well-Being 
Assessment; SDQ = Strengths and Difficulties Questionnaire; EFs = Executive Functions; WCST = 
Wisconsin Card Sorting Test; GnG = Go no Go; CPT = Card Playing Task; TDT = Temporal Discounting 
Task; CxR = Choice per Risk Task; UG = Ultimatum Game. 
 
2.2.1 Baseline Measures 
 
Child Psychopathology 
Child psychopathology was assessed using the parent version of the Child and 
Adolescent Psychiatric Assessment (CAPA), a semi-structured psychiatric interview 
covering the presentation of a wide range of clinical symptomatology within the 
preceding 3-months (Angold & Costello, 2000). The CAPA was specifically used to 
make research diagnoses and to collect symptoms related to ADHD, Oppositional 
Defiant Disorder / Conduct Disorder, Separation Anxiety Disorder, Generalised 
Anxiety Disorder, Social Anxiety Disorder and Major Depressive Disorder. Where 
psychiatric symptoms were endorsed, impairment was also assessed, including for 
ADHD. In particular, for each area where symptoms were present, parents had to rate 
their child’s impairment in different areas of functioning: home, social interactions, 
community activities, school, sports / clubs, learning to take care of oneself, play / 
leisure activities and handling of daily chores / responsibilities. Impairment was rated 
on a 4-point Likert scale where 0 is ‘never’, 1 is rarely’, 2 is ‘sometimes’ and 3 ‘often’, 
with scores of 2 and 3 considered indicative of impairment in the relevant area of 
functioning. Thus it was possible to derive a continuous score of ADHD burden, 
summing up the impairment rated in different settings, with scores ranging from 0 to 
8 consistent with previous research (Agha, Zammit, Thapar, & Langley, 2013). In 
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addition to impairment, the pervasiveness of symptoms across settings is required to 
formulate an ADHD diagnosis. This criterion was confirmed by teachers using the 
Child ADHD Teacher Telephone Interview (ChATTI) (Holmes et al., 2004), a 
telephone interview investigating ADHD core symptoms and school impairment. 
Whenever the research team struggled to get in contact with teachers to assess the 
ADHD impairment, they sent out to schools the Conner's Teacher Rating Scale 
(Conners, Sitarenios, Parker, & Epstein, 1998) and the DuPaul teacher rating scales 
(DuPaul, 1991) for teachers to complete. For each measure, the pervasiveness 
criterion was met if teachers endorsed at least one symptom for each ADHD core 
domain, plus impairment. 
All interviewers undertook comprehensive training and had weekly supervisions with 
an experienced child and adolescent psychiatrist. They also maintained a high level 
of inter-rater reliability; the kappa for ADHD diagnosis was 1.00 and parent-rated CD 
symptoms also showed a very good inter-rater reliability with intra-class correlation of 
.98. 
 
Parent-rated autistic symptoms were collected using the Autism Screening 
Questionnaire (ASQ), a 40-item measure assessing symptoms in the domain of social 
interaction, language and communication, and repetitive and stereotyped behaviours 
(Berument, Rutter, Lord, Pickles, & Bailey, 1999). ASQ items are scored 0 or 1 to 
indicate the absence and presence of autistic symptoms, respectively. A 0 to 39 total 
score is computed summing individual items, except for the first item investigating 
current language level which is not included in the total score. 
 
The parent-rated version of the Inventory of Callous-Unemotional Traits (ICU) was 
also included in the clinical assessment. This measure aimed to assess callous and 
unemotional traits in children and adolescents, as indexed by three subscales: 
callous, unemotional and uncaring (Kimonis et al., 2008; Moore et al., 2017; 
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Willoughby, Mills-Koonce, Waschbusch, & Gottfredson, 2015). The ICU is composed 
of 24 items; responses on each item were made on a scale from 0 to 3, ranging from 
“not at all true” to “definitely true”. ICU total score was computed summing items, with 
a maximum obtainable score of 72. 
 
Chronic and Severe Irritability 
A measure of chronic a severe irritability was obtained post hoc, extracting items from 
the ODD and Depression sections of the CAPA (Angold & Costello, 2000), consistent 
with previous works (Copeland et al., 2015; Eyre et al., 2017). In particular, from the 
ODD section the items “Losing Temper” and “Temper Tantrums” were considered, 
whereas from the Depression section the items selected were “Touchy or Easily 
Annoyed”, “Angry or Resentful” and “Irritability”. Losing Temper refers to discrete 
episodes of shouting or name calling, whereas Temper Tantrums are similar discrete 
episodes but also characterised by violent behaviours against people or property. 
Irritable symptoms from the depression section are respectively manifested with the 
child being sulky (“Touchy or Easily Annoyed”), prone to resentment and anger under 
a minor provocation (“Angry or Resentful”), and with irritable mood characterised by 
enduring feelings of anger that persist between outbursts (“Irritability”). 
To identify a more clinically relevant phenotype of irritability and thus, to operationalise 
irritability in its severity and chronicity, cut-offs based on frequency, pervasiveness 
and duration were applied. These cut-offs determined the presence and absence of 
each one of these five symptoms of irritability and they were chosen based on DSM-
5 DMDD criteria, consistent with previous research on this sample (Eyre et al., 2017). 
More specifically, a symptom was considered as present if it was endorsed frequently 
within a week, for a period longer than 12 months and in more than one setting, details 
of these thresholds are reported in Table 2.1. 
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CAPA ITEMS DESCRIPTION 
“LOSING TEMPER” AND 
“TEMPER TANTRUMS” 
Items extracted from the ODD section of the 
CAPA. CAPA considers the inconsistency 
with development. 
FREQUENCY ≥ 36 (3 TIMES 
PER WEEK OVER 3 MONTHS) 
Items must have a frequency of ≥36, 
consistent with the average of 3x per week 
over the 3-month period assessed by the 
CAPA, to be endorsed. 
DURATION >12 MONTHS 
Items must be present for more than 12 
months at the expected frequency to be 
endorsed. 
PERVASIVENESS IN AT LEAST 
TWO SETTINGS 
 Items must be present in at least two settings 
at the expected frequency to be endorsed. 
“TOUCHY/EASILYANNOYED”; 
“ANGRY/RESENTFUL”; 
“IRRITABILITY” 
These items are extracted from the 
Depression section of the CAPA. 
FREQUENCY >45 (PER WEEK 
OVER 3MTHS) 
To be endorsed, these symptoms must have 
a frequency greater than 45, therefore being 
present more days than not, over the 3-month 
period of time assessed by the CAPA. 
DURATION >12 MONTHS 
These symptoms are endorsed if they are 
present for more than 12 months at the 
expected frequency. 
PERVASIVENESS ACROSS AT 
LEAST TWO SETTINGS 
Implicitly asked in question concerning 
irritable mood (i.e., “irritability” item). 
Table 2.1 Criteria used to assess Chronic and Severe irritability with frequency/severity cut offs 
 
Maternal Psychopathology 
Maternal psychopathology was assessed using self-report questionnaires, 
investigating ADHD, Conduct Disorder, and Anxiety and Depression symptoms.  
Current maternal DSM-IV/5 ADHD symptoms were collected using a DSM-based 18 
item check-list, assessing the presence of ADHD symptoms in the last 6 months 
(American Psychiatric Association, 2000, 2013). Symptoms were considered as 
present if items had a score of at least 2 on a 4-point Likert-scale (0 “not at all”, 1 “just 
a little”, 2 “pretty much” and 3 “very much”). A 0 to 18 total score for ADHD current 
symptoms was generated summing individual items. Additionally, Cronbach’s alpha 
for ADHD measures showed adequate reliability ranging from .91 to .94. 
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Similarly, mothers completed a self-rated DSM-IV/5 Conduct Disorder symptom 
checklist, assessing the presence of maternal CD symptoms in childhood, when 
mothers were 7 to 11 years of age. This checklist was composed of 15 items on scale 
from 0 to 3, where 0 is “never”, 1 is “rarely”, 2 is “sometimes” and 3 is “often”; 
symptoms were rated as “present” if mothers scored at least “sometimes”. Maternal 
childhood CD symptoms total score was computed, ranging from 0 to 15. Finally, it 
should be noted that ODD symptoms were excluded from this checklist. 
 
Self-rated maternal anxiety and depression symptoms in the past week were collected 
using the Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983). 
Anxiety and Depression subscales were composed of seven items each, focusing 
mostly on cognitive expression of anxiety (e.g., “worry a lot”) and anhedonia (i.e., 
pleasure no longer gained from previously enjoyable activities), respectively. 
Symptom severity was measured on a 4-point Likert scale, from “not at all” to “most 
of the time” and total scores were generated separately for the depression and anxiety 
scale, ranging from 0 to 21 each. The anxiety and depression symptoms were 
considered separately in this thesis. Cronbach’s alpha for the HADS depression scale 
in this study is .83. 
 
Sociodemographic Measures 
Demographic information on child sex, age, Social Economic Status (SES) and IQ 
were also gathered. In particular, SES was determined based on the occupation of 
the family member who earned the highest, following the guidelines of the UK 
Standard Occupation Classification (Office for National Statistics, 2000); this is also 
consistent with previous work (e.g., Agha, Zammit, Thapar, & Langley, 2017b). A 
dichotomous score of SES (i.e., low or not low) was then computed classifying families 
as having a low SES, if the main earner was in unskilled employment or unemployed 
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(Agha et al., 2017b). A full-scale measure of IQ was collected using the Wechsler 
Intelligence Scale for Children (WISC-IV) and used dimensionally (Wechsler, 2003). 
This full-scale is composed of 10 subtests measuring four main abilities: Verbal 
Comprehension, Perceptual Reasoning, Working Memory and Processing Speed. 
Finally, parents were also asked to provide information on any current ADHD 
medication used by the child. 
 
2.2.2 Follow-up Measures 
 
Youth Psychopathology 
Adolescent psychopathology was measured at follow-up using the parent-rated 
version of the Development and Well-Being Assessment (DAWBA), a structured 
clinical interview investigating common emotional and behavioural DSM-IV disorders 
in the present and recent past (Goodman, Ford, Richards, Gatward, & Meltzer, 2000). 
Of relevance to this study, at this follow-up, parents were administered the ADHD and 
CD sections of the DAWBA from which continuous measures of symptom severity for 
both conditions were generated. Additionally, diagnoses of CD and ADHD were also 
derived following the DSM-5 diagnostic criteria as the DAWBA provides information 
on symptoms duration (where required), their burden on adolescent’s life and their 
pervasiveness in family life, learning, social relations and leisure activities. It should 
however be noted that at this follow-up assessment, teacher-rated symptoms were 
not assessed, thus pervasiveness across settings was only endorsed by parents. The 
shorter DAWBA was administered instead of the previously used CAPA to reduce the 
duration of the assessment families were committed to.  
 
The Strengths and Difficulties Questionnaire (SDQ), including the impact section, was 
also used to investigate psychological adjustments of youths as rated by parents 
(Goodman, 1999). In particular, the SDQ is composed of 25 items grouped into five 
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subscales, representing emotional, conduct, hyperactivity-inattention, peer problems 
and prosocial behaviours. Each item is rated on a 3-point Likert scale where 0 is "not 
true", 1 is "somewhat true" and 2 is "certainly true" and subscale scores are generated 
summing the relevant items (Goodman, 1997). Subscale scores for emotional, 
conduct, hyperactivity-inattention, and peer problems (excluding the prosocial 
subscale), are then added together to derive an adolescent’s total difficulties score. 
In addition to these 25 items, the utilised version of the SDQ also investigates the 
impact of these adjustment problems. More precisely, parents are asked whether they 
think their children have a problem and if so, to rate how long this problem is lasting, 
and to what extent this represents a burden to either the parent or the family as a 
whole. Additionally, parents rate the distress these symptoms cause to their children 
and in terms of their impact on family life, friendship, learning and leisure. Scores on 
these items are then combined into a total impact score ranging from 0 to 10.  
 
Finally, it should be noted that all measures were administrated by trained 
psychologists who undertook weekly supervision meetings with a child psychiatrist 
and a psychologist. 
 
Cognitive Measures 
In this section it is important to note that the cognitive measures described below are 
taken from a more comprehensive cognitive battery, originally selected as its tasks 
are widely validated and used in ADHD populations. The Cool and Hot tasks 
described below are the ones most relevant to this project, as being able to capture 
cognitive makers associated with chronic and severe irritability (more details are 
provided in Chapter 4). Cognitive tasks were administered by trained psychologists 
and participants were asked to suspend their ADHD medication 24h prior the 
assessment to prevent this affecting their performance on the cognitive battery.  
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Cool EF tasks 
  
The “Wisconsin Card Sorting Test” (WCST) (Figure 2.2) is a measure of set-shifting 
behaviour, the ability to flexibly adapt one’s response to changes in positive feedback 
contingencies. The WCST is considered an indicator of prefrontal cortical functioning 
and it is designed for both children and adults, being sensitive to developmental 
changes (Chelune & Baer, 1986). During this task, participants need to discern 
matching criteria to sort a set of cards (Greve, 2001). These matching criteria rely on 
stimulus features such as colour, form or number and the criteria vary after 10 
consecutive and correct trials. Based on received feedback, participants need to 
detect changes in the matching criteria and flexibly adapt their response to keep 
sorting the cards properly. The 64-card computerised version was used in this thesis 
(Greve, 2001). To detect impairments in set-shifting, total number of errors and 
perseverative errors were considered. 
 
 
 
The “Go no Go” task (GnG) (Figure 2.3) is a measure of motor inhibition widely 
validated and extensively used in ADHD research (Hart, Radua, Nakao, Mataix-Cols, 
& Rubia, 2013; Rubia, Smith, & Taylor, 2007; Wahlstedt et al., 2009); its test-retest 
reliability is adequate, and it is used successfully to discriminate those with ADHD 
from typically developing controls (Wahlstedt et al., 2009). In this study the GnG task 
Figure 2.2 WCST task design 
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is divided into two subtests of two minutes and 32 seconds each, each subtest 
measuring right and left-hand responses one at the time. Stimuli are presented in the 
middle of the screen for 300ms, with a 1.3 seconds blank screen in between. This 
task is administered in a block of 150 trials and the total duration was five minutes 
and four seconds. Participants are asked to either respond or inhibit a preponderant 
motor response according to the go or no-go stimuli showed on the computer screen. 
Specifically, participants need to press the appropriate arrow button (pointing left or 
right respective on the hand tested) as quickly as possible in the presence of a 
spaceship (“go” signal) and withhold their response in the presence of a green planet 
(“no go” signal). The spaceship is present in 73% of trials to induce a preponderant 
motor response, whereas the green planet is shown in only 27% of trials. Measures 
considered were Reaction Time to go signals and probability of inhibition, which is the 
percentage of responses to no-go signals (i.e. participant’s response to the green 
planet) successfully inhibited. As complete data for both right and left hands was not 
available for all participants, only the dominant hand performance was considered. 
 
 
Hot EF tasks 
 
The “Card Playing Task” (CPT) (Figure 2.4) is a measure of response perseveration 
when facing increasing loss, that indicates an individual’s reward and punishment 
sensitivity (Newman, Patterson, & Kosson, 1987). To play, participants just need to 
click on the deck, and they are shown either a red (hearts or diamonds) or a black 
Figure 2.3 Go no Go task design 
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(clubs or spades) card. If black, participants win £0.10 and they receive a feedback 
on the screen which says: “YOU WIN!”; if red, participants lose £0.10 and are shown 
a “YOU LOSE!” feedback on the screen. Participants start with no money and, on 
every trial, they are asked if they are willing to keep on playing the next card or to quit 
the game. The task involves a deck of 110 cards, divided in blocks of 10. The initial 
block has 100% probability of winning money but the probability of losing increases 
by 10% with each consecutive block, such that by the end of the task, punishment 
completely outweighs reward (Newman et al., 1987). More precisely, when the sum 
of £3.10 is reached, the deck of cards starts consistently to lose and ideally that is 
when participants should stop. The dependent variable was the total number of cards 
played before quitting as a measure of reward and punishment sensitivity. 
 
 
 
The “Temporal Discounting Task” (TDT) (Figure 2.5) measures the degree to which 
a reward is devalued in relation to its temporal delay, an index of impulsivity (Richards 
et al., 1999; Rubia, Halari, Christakou, & Taylor, 2009). In the TDT, participants 
choose, by pressing the relevant button, between a small and immediate monetary 
reward (ranging from £0 to £100) and a large reward (always £100) that is delayed by 
a week, a month, one year or two years. The TDT is composed of 20 trials for each 
type of delay and it lasts for 12 minutes; the rewards to choose from are randomly 
displayed for 4s on the right and left side of a computer screen, and each trial is 
Figure 2.4 CPT Task Design 
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separated by an 8s blank screen. An algorithm is used to ensure equal number of 
immediate and delayed reward options are presented across the task, and it adjusts 
the immediate reward based on participant’s previous choices to each of the four 
different delays. This adjustment determines the “indifference point”, that is when the 
choice between the immediate and delayed reward is considered equivalent by the 
participant (Richards et al., 1999; Rubia et al., 2009). Typically reward discounting 
follows a hyperbolic function that depends on the amount, delay and k, a free 
impulsivity parameter calculated by fitting the hyperbolic function to the indifference 
point for each delay. Large values of k reflect a greater reward discounting (i.e., more 
impulsivity) (Richards et al., 1999). The dependent variables for this task were the 
difference in RT between delayed and immediate reward choice, and the Area Under 
the Curve (AUC) as a measure of impulsivity. The k parameter is normally the main 
impulsivity factor, however due to its hyperbolic function, it is associated with some 
measurement problems (e.g. very skewed distribution). The Area Under the Curve 
(AUC) is instead a good and a widely used alternative to measure temporal 
discounting (Myerson, Green, & Warusawitharana, 2006), whose values range from 
0 to 1; larger AUC values represent less delay discounting (i.e. less impulsivity) 
(Myerson et al., 2006). 
 
 
 
The “Choice per Risk Task” (CxR) is a measure of risk-taking behaviour and how it is 
affected by reward and punishment (Syngelaki, Moore, Savage, Fairchild, & van 
Figure 2.5 TDT task design 
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Goozen, 2009). The aim of the CxR is to win as many points as possible by choosing 
between two wheels of fortune, an experimental wheel and a control wheel, displayed 
randomly on the right and left side of a computer screen. Each wheel has eight 
segments, each segment can make participants win or lose two different amounts of 
points (two or eight points for the experimental wheel and one point for the control 
wheel) at different probability (Figure 2.6). More precisely, the control wheel always 
has a 50% probability of winning or losing one point; thus, it has an equivalent number 
of segments (i.e., four segments) awarding or forfeiting one point (Figure 2.6). 
Contrarily, there are eight different types of experimental wheels that give a chance 
of winning or losing either two or eight points at a probability of 25% or 75%, 
depending on the wheel; some wheels are therefore riskier than others. Two 
additional positive and negative framing trial wheels are included to measure risk 
aversion and risk seeking, for a total of ten different types of experimental wheels. 
The negative framing trial (Figure 2.7) is characterised by a control wheel with a 
guaranteed possibility of gaining four points and an experimental wheel with 50% 
chance of winning either eight or zero points; whereas the positive framing trial has 
wheels with the same probability of losing the same amount of points on both the 
experimental and control wheels (Fairchild et al., 2009; Sully, Sonuga-Barke, Savage, 
& Fairchild, 2016; Syngelaki et al., 2009). 
These wheels also differ on their relative Expected Value (∆EV), that is the difference 
between the control and experimental wheel that the participant is presented with, 
providing information on how beneficial it is to choose the experimental wheel over 
the control one or vice versa. During each trial, participants with good decision-making 
skills and a reduced propensity to gamble are expected to choose the most favourable 
wheel based on the ∆EV, as that gives them the best chance of winning. For example, 
the control wheel has always an EV of 0, mathematically represented by the formula: 
(0.5 × 1) + (0.5 × -1), where 0.5 is the probability of winning or losing, multiplied by 
the points the participant could gain or not. Whereas, an experimental wheel with 25% 
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chance of losing eight points and 75% probability of winning two points would have 
an EV of -0.5 ((0.25 × - 8) + (0.75 × 2)). Therefore, in this example, it is safer to gamble 
on the control wheel than the experimental one, as their ∆EV is -0.5 relative to the 
experimental wheel. 
The CxR task is composed of 4 blocks of 20 trials each (i.e. 80 trials in total); in each 
block the 10 different types of experimental wheels are presented twice, in a pseudo-
randomised order. Participants choose a wheel by clicking with the mouse on the 
preferred wheel, which results in that wheel spinning and stopping on a particular 
segment awarding or forfaiting points. Each participant starts with 100 points at the 
beginning of each block and they are both given feedback on their choice and 
provided with the revised score for 2 seconds before the next trial. Several dependent 
measures were taken into account from this rich dataset. First, the overall propensity 
to gamble, measured as the percentage of times the experimental wheel was chosen 
as opposed to the control wheel. Second, participants’ performance on six different 
types of experimental wheels, as a measure of risky decision-making. This measure 
is indexed by the number of times the experimental wheel was chosen for trial type 
zero and three which had value ±8 and ∓2 with a probability of .25 or .75 of winning, 
respectively; for trial type four and six which had value +8/+2 and -8/-2 with a 
probability of .25 of winning, respectively; for trial eight which had values of 0 and -8 
with a probability of .5 of winning and vice-versa (0; +8) for trial nine (positive and 
negative framing trials). Finally, participants’ choice of the experimental over the 
control wheel after winning or losing small/big amounts (expressed as a percentage) 
was investigated, as an index of the impact of reward and punishment on risk-taking 
behaviour.  
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Figure 2.7 Negative framing trial design 
 
The “Ultimatum Game” (UG) (Figure 2.8) is an economic decision-making computer 
game, often used as a measure of emotion regulation as it assesses decision-making 
performance in emotionally charged scenarios (Koenigs & Tranel, 2007; Northover, 
Thapar, Langley, & van Goozen, 2015a). The UG is composed of 22 trials; in each 
trial, participants are presented with a photograph of a fictional peer (the proposer), 
offering a way to split a sum of money. Participants (or responders) need to decide 
whether to accept or refuse the offer made by the proposer; across trials, this 
proposed split can either be more or less favourable to responders, ranging from 
being very fair (5/5 split) or moderately unfair (6/4, 7/3 split) to very unfair (8/2, 9/1 
split). Participants are told that if they accept the proposer’s offer, both of them are 
Figure 2.6 CxR task design, trial type six which had the experimental wheel 
with values of +2 and -2, with a probability of .25 of winning the + value. 
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paid accordingly; if they refuse it, neither the responder nor the proposer gains money. 
To make it more believable, participants are told that these offers come from previous 
participants in the same study and at the end of the task, responders are asked to 
make their own offers to be stored in the database for future participants. The 
frequency of the offers is standardised by having two 5/5, two 6/4, six 7/3, six 8/2 and 
six 9/1 offers. Receipt of unfair offers is often associated with feelings of anger and 
other negative emotions which lead the responder to refuse them. This is considered 
an irrational emotionally driven decision (Koenigs & Tranel, 2007; Northover et al., 
2015a), as the responder loses the possibility of making a utilitarian choice and 
gaining money, albeit less than the proposer. Optimal, emotion regulation strategies 
are therefore important to reduce the emotional arousal and make utilitarian decisions 
(Koenigs & Tranel, 2007; Northover et al., 2015a). The dependent variable considered 
was the percentage of moderately unfair (6/4; 7/3 split) offers accepted whose 
acceptance or refusal rate is more variable compared to those of truly fair (5/5 split) 
and very unfair (8/2; 9/3 split) offers, which almost all participants accept or reject, 
respectively. 
 
 
 
Sociodemographic Measures 
Participants age and IQ were re-assessed at follow-up. IQ was measured using the 
Wechsler Abbreviated Scale of Intelligence (WASI) (Wechsler, 1999) and was based 
Figure 2.8 Graphic representation of the UG Moderately Unfair offers 
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only on vocabulary and matrix reasoning tests, measures of verbal comprehension 
and perceptual reasoning respectively. Previous studies also used the WASI to 
measure IQ (Northover, Thapar, Langley, Fairchild, & van Goozen, 2016; Northover 
et al., 2015a; Northover, Thapar, Langley, & van Goozen, 2015b; van Goozen et al., 
2016). 
 
2.3 Recruitment numbers 
This section describes the number of participants recruited both at baseline and 
follow-up, providing the final sample sizes at these different time points. A flowchart 
of this recruitment procedure is shown in Figure 2.9. 
 
2.3.1 Baseline 
A final sample of 697 participants had data available for analysis; 17% were females 
(n= 116) and 83% were males (n= 581). Of these participants, only those with a DSM-
IV ADHD diagnosis were selected (n= 592) and among these, 585 had irritable data 
available. To reduce the confounding effect of relatedness, 24 siblings were removed 
from this sample leading to a final sample size of 561 children with ADHD and 
irritability information. Notably, all participants met DSM-5 criteria for ADHD at 
baseline. 
 
Additionally, information on maternal psychopathology was available for 467 mothers 
whose child took part in the baseline data collection. 
 
2.3.2 Follow-up 
Between 2013 and 2016, 483 families who participated to the SAGE study and agreed 
to be re-contacted for future research were considered eligible for this follow-up (i.e., 
had a male child aged 10-17 with an IQ within the normal range). 226 of these families 
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were traced and agreed to participate (47%), whereas 257 were either not found to 
be contacted or refused to take part in this follow-up (53%). An additional 46 
participants, who expressed an interest in the SAGE study but were not seen at 
baseline, were recruited as they all had a clinical diagnosis of ADHD and had some 
overlapping information with the current baseline data, collected as part of previous 
research studies they participated in. The final sample size at follow-up changes 
across the individual studies included in this thesis and information about these 
changes is provided in the following chapters. Notably, all of the extra participants 
with a DSM-IV ADHD diagnosis also met the DSM-5 criteria at baseline. 
 
 
Figure 2.9 Flowchart of the recruitment procedure both at baseline and follow-up.  
Further details regarding participant numbers, attrition and representativeness can 
be seen in Chapter 4, 5 and 6 alongside the relevant analyses. 
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Chapter 3  
Investigating the Concept of Phasic and 
Tonic Irritability in Childhood ADHD 
 
Chapter description  
This chapter addresses the first aim of this thesis, which is to investigate the validity 
of a bi-dimensional construct of chronic and severe irritability in children with ADHD. 
This study is important as it also sets the way chronic and severe irritability is 
operationalised in the following studies of this thesis, either as a unitary construct or 
split into the two proposed components. Both the baseline and the follow-up data from 
this clinical ADHD sample is used in this chapter which focuses on clinical measures 
only. A brief overview of the samples and methods used is provided, with these 
elements described in more detail in Chapter 2. 
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3.1 Introduction 
As discussed in Chapter 1, irritability has been defined as proneness to react with 
anger disproportionate to the situation and is subject to individual differences. This 
angry reaction can be displayed as temper tantrums and aggressive behaviours 
and/or as sullen, grumpy mood (Copeland et al., 2015; Leibenluft, 2017a; Vidal-Ribas 
et al., 2016). Irritability is also a cross-diagnostic symptom present in both internalizing 
and externalizing disorders (Stringaris, 2011); however, it has assumed unique 
diagnostic validity with the introduction of Disruptive Mood Dysregulation Disorder in 
the DSM-5 (American Psychiatric Association, 2013). Since the creation of the DMDD 
diagnostic label, chronic and severe irritability has acquired a greater importance. This 
interest is justified by the impairments across multiple areas of functioning associated 
with severe irritability both in childhood and in adulthood, even when adjusting for 
baseline psychopathology (Brotman, Kircanski, & Leibenluft, 2017; Vidal-Ribas et al., 
2016) (see Chapter 1, section 1.1.4 for more details). Additionally, the clinical 
importance of irritability has been widely ascertained, as it is one of the most common 
reasons children are referred to mental health services, especially when 
conceptualised within aggressive and disruptive behaviours (Peterson, Zhang, Santa 
Lucia, King, & Lewis, 1996). 
 
As suggested by the definition of irritability, this phenotype can include behavioural 
symptoms (i.e., temper tantrums) and/or persistent mood symptoms (e.g., grumpy 
mood). Both these behavioural and mood manifestations of irritability are core 
symptoms of DMDD, which is included in the Mood Disorder section of the DSM-5 
(American Psychiatric Association, 2013). However, irritability, both as symptom and 
in the form of DMDD, is more commonly and highly associated with disruptive 
behaviours, especially ADHD and ODD (Brotman, Kircanski, & Leibenluft, 2017; 
Evans et al., 2017). It is therefore unclear whether chronic and severe irritability is 
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mainly a behavioural or a mood symptom and the homogeneity of this construct is 
questioned. In the 2014 NIMH workshop, which collected current knowledge on 
chronic and severe irritability, these mood and behavioural aspects were suggested 
to be different components of this phenotype (Leibenluft & Avenevoli, 2014). More 
precisely, group members defined two components of chronic and severe irritability: 
phasic and tonic irritability. The phasic dimension comprises episodic angry outbursts, 
which are intense and inconsistent with the developmental level; and the tonic 
dimension is conceived as chronic grumpy, grouchy, and angry mood that occur alone 
or in between temper outbursts (Brotman, Kircanski, & Leibenluft, 2017; Copeland et 
al., 2015; Leibenluft & Avenevoli, 2014; Vidal-Ribas et al., 2016). These distinct 
components of irritability are suggested to identify different subgroups of individuals, 
those who are euthymic and who display disruptive behaviours under minor 
provocation, and those with a constant negative mood (Blader et al., 2016). The 
distinction of phasic and tonic dimensions could also provide a possible explanation 
for the longitudinal associations of chronic and severe irritability with both internalising 
and externalising conditions (Eyre et al., 2019; Vidal-Ribas et al., 2016) (refer to 
Chapter 1, section 1.1.4 for more details). This is further suggested by a recent study 
that showed heterogeneity in developmental trajectories of severe irritability, with 
childhood onset and adolescent onset of irritability also linked to genetic liability for 
externalising (i.e., ADHD) and internalising (i.e., MDD) disorders, respectively (Riglin 
et al., 2019). This distinction suggests the existence of separate neurodevelopmental 
and mood types of severe irritability which fits well with the definition of phasic and 
tonic irritability. Whilst this theoretical definition has been proposed, whether phasic 
and tonic components are distinct in terms of defining characteristics and in their 
transition into externalising and internalising disorders over childhood has not been 
explored (Kessel et al., 2016; Leibenluft & Avenevoli, 2014; Vidal-Ribas et al., 2016). 
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As outlined in Chapter 1, ADHD is a common heterogeneous childhood condition 
leading to impairment in multiple settings (Cortese & Coghill, 2018; Thapar & Cooper, 
2016). The core symptoms concern the dimensions of inattention and hyperactivity-
impulsivity, however irritable symptoms are frequently observed in this population 
(Shaw et al., 2014) and prior to the DSM-III they were considered as diagnostic 
features of ADHD (Faraone et al., 2019). As shown in the general introduction, severe 
irritability is highly prevalent in youths with ADHD, that is also the most common 
condition associated with chronic and severe irritability in the form of SMD and DMDD 
(Faraone et al., 2019; Shaw et al., 2014); this is also confirmed at baseline in the 
same clinical ADHD sample used in this chapter (Eyre et al., 2017) (see Chapter 1, 
sections 1.1.4 and 1.2.3). The presence of severe irritability is also associated with 
poor functional outcomes in this clinical population. Preliminary evidence also 
suggests that irritability might be a source of clinical heterogeneity in ADHD, 
predisposing to both internalising and externalising conditions independently of 
comorbid conditions (see Chapter 1, section 1.2.3 for more details). Considering the 
clinical relevance and the high prevalence of severe irritability, children with ADHD 
seems to be an ideal sample to study chronic and severe irritability as currently 
conceptualised. This would also be beneficial to understand the heterogeneity of 
ADHD clinical correlates, which is problematic for several aspects of the research into 
this neurodevelopmental disorder (see Chapter 1, section 1.2 for details).  
 
The phasic and tonic components of irritability have been previously explored together 
as symptoms included within the DMDD diagnosis, in both epidemiological and 
clinical samples (Axelson et al., 2012; Dougherty et al., 2014; Eyre et al., 2017; 
Mulraney et al., 2016). However, to the best of my knowledge, no study has 
specifically compared phasic and tonic irritability in a sample of children with ADHD. 
Copeland and colleagues (2015) were the first to directly compare these components 
but focused on an epidemiological sample. In an attempt to explore the validity of the 
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bi-dimensional structure of irritability, they assessed the prevalence, interplay, overlap 
and normative levels of phasic and tonic irritability in 1420 children derived from the 
Great Smoky Mountain Study (GSMS) and followed from 9 to 16 years of age. Across 
the eight waves of assessments, this study showed that both phasic and tonic 
irritability over childhood and adolescence were highly prevalent, in 51.4% and 28.3% 
respectively, with a high overlap between the two (22.8% of individuals endorsed 
both). Both phasic and tonic dimensions appeared to be equally accurate at identifying 
children with impaired functioning, or who were at risk for psychopathology (Copeland 
et al., 2015), perhaps indicating that the distinction between these dimensions was 
not clinically informative. The consistent overlap between phasic and tonic irritability 
has also been observed both in general psychiatric and epidemiological samples, in 
a study using dimensions of phasic and tonic irritability similarly operationalised as in 
Copeland’s (2015) (Carlson et al., 2016; Copeland et al., 2015). Another recent study 
also explored tonic and phasic irritability, in a population twin study, showing that there 
are distinct genetic and unique environmental factors influencing tonic and phasic 
irritability (Moore et al., 2019). More specifically, tonic irritability seems to be 
influenced by genetic and unique environmental influences that are independent to 
risk factors associated with losing temper and temper tantrums, characteristics of 
phasic irritability (Moore et al., 2019). This suggests a difference between these two 
phenotypes at the aetiological level. 
Whilst these findings are a first step in the study of phasic and tonic irritability, further 
investigation in clinical samples, including investigating the association with external 
validators, such as family history and developmental clinical outcomes (Copeland et 
al., 2015; Moore et al., 2019; Vidal-Ribas et al., 2016), are needed to ascertain the 
validity of their distinction. 
 
In summary, little is known about the validity of phasic and tonic irritability in clinical 
samples such as in those with ADHD. This sample is ideal to research the taxonomy 
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of phasic and tonic irritability, especially in terms of different patterns of comorbidity 
and external validators of family history and long-term outcomes. This is due to the 
high prevalence of severe irritability, the functional and clinical outcomes associated 
with severe irritability in this clinical population and the need for information to help 
explaining the heterogeneity of ADHD. Thus, this is the first study investigating the 
cross-sectional prevalence of phasic and tonic irritability and exploring their 
associations with ADHD clinical correlates and maternal psychopathology. The 
longitudinal associations between phasic and tonic irritability with a range of clinical 
correlates were also explored. The aim was to ascertain the validity of the bi-
dimensional structure of irritability in a sample of children with ADHD and additionally 
investigate whether one dimension was a stronger predictor of clinical correlates than 
the other. This then informed the conceptualisation of irritability for future subchapters. 
 
3.2 Methods 
 
3.2.1 Sample 
In this study the baseline data from 561 children (details of the study are fully 
described in Chapter 2) was used. These children all had a diagnosis of ADHD, 
available irritability data and were aged 6-18 years (mean age 10.73, s.d. 2.98) at 
baseline. Data on current and childhood parental psychopathology was available for 
467 mothers and for only 233 of fathers; thus, only maternal psychopathology was 
considered in this study. To investigate longitudinal elements of these research 
questions, follow-up data from a subset of 191 children aged 10-18 years (mean age 
13.84, s.d. 1.83) was considered; these participants were previously assessed at 
baseline and had longitudinal clinical data available. 
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3.2.2 Irritability Measure 
Phasic and tonic irritability presence was computed by extracting items from the ODD 
and Depression scales of the CAPA, consistent with the previous work of Copeland 
and colleagues (2015). Within the ODD section of the CAPA, the items related either 
to “Losing Temper” or “Temper Tantrums” were taken as symptoms of phasic 
irritability, whilst the tonic component was composed of symptoms of “Touchy or 
Easily Annoyed”, “Angry or Resentful”, and “Irritability”, taken from the CAPA 
Depression section. 
The criteria utilised to assess the presence of these irritability dimensions were more 
stringent than those used by Copeland and colleagues (2015). Copeland and 
colleagues focused on a general population sample, allowing the use of broader 
criteria to assess the different dimensions of irritability. The present study however 
focused on a clinical population of children with ADHD therefore, in line with previous 
work (Eyre et al., 2017), more stringent criteria were necessary to avoid a too broad 
inclusion of cases and to identify more clinically relevant irritability. As described in 
Chapter 2, if either “Losing Temper” or “Temper Outburst” was present at the required 
frequency, for a period longer than 12 months and in more than one setting, phasic 
irritability was considered endorsed. Similarly, if “Touchy or Easily Annoyed”, “Angry 
or Resentful” or “Irritable Mood” was endorsed at the required frequency, duration and 
pervasiveness cut-offs, tonic irritability criteria were met (see Chapter 2, Table 2.1). 
 
3.2.3 Psychopathology Measures 
As previously described, child psychopathology was measured cross-sectionally 
using the CAPA, rated by parents (Angold & Costello, 2000). In particular, from the 
CAPA measures of ADHD, ODD, CD and Depressive symptom severity were 
generated by summing the relevant endorsed symptoms together. Notably, for this 
investigation, ODD and depression symptom scores excluded the irritability items to 
account for the overlap with the measure of chronic and severe irritability. Considering 
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that few individuals endorsed depressive symptoms, this measure was binary coded 
where 0 indicated the absence of symptoms and 1 indicating one or more symptom. 
The CAPA was also used to derive a research diagnosis of DSM-IV/5 ADHD and any 
anxiety disorder. It is important to consider that “any anxiety diagnosis” was a 
dichotomous variable, created combining the presence of Separation Anxiety 
Diagnosis, Generalised Anxiety Diagnosis or Social Anxiety Diagnosis to deal with 
the few cases per diagnostic category. A measure of ADHD impairment generated as 
described in Chapter 2 was also used. Parent-rated autistic symptoms and self-report 
psychopathic traits were collected from the ASQ (Berument et al., 1999) and the ICU 
(Andershed, Kerr, Stattin, & Levander, 2002) (see Chapter 2 for further details). 
 
As detailed in Chapter 2, maternal psychopathology was assessed using self-report 
questionnaire and in particular, measures of current ADHD symptoms and childhood 
CD symptoms were considered. Additionally, maternal depression and anxiety 
symptoms were collected using the HADS (Zigmond & Snaith, 1983). 
 
At follow-up, the parent version of the DAWBA structured interview (Goodman et al., 
2000) was used to ascertain clinical symptoms of CD and ADHD. Symptom scores 
for CD and ADHD diagnoses were calculated according to the DSM-5 criteria 
(American Psychiatric Association, 2013). The parent-rated emotional, conduct, 
hyperactivity and impact subscales of the SDQ (Goodman, 1999) were also used. 
 
3.2.4 Sociodemographic Measures 
At baseline, demographic information related to child sex, age, full scale IQ and Social 
Economic Status were also collected and derived as detailed in Chapter 2. 
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3.3 Statistical Analyses 
All analyses were conducted using SPSS version 23 (Corp, 2015) and STATA version 
14 (StataCorp, 2015). First the prevalence of phasic and tonic irritability was assessed 
and their association with demographic factors such as sex, age, IQ and SES were 
considered. 
Multiple linear and logistic regressions were performed to test whether the presence 
of either phasic and/or tonic irritability was associated with clinical correlates and 
maternal psychopathology at baseline and clinical outcomes at follow-up. Unadjusted 
analyses were followed by analyses including both types of irritability, demographic 
characteristics, ADHD symptom severity and baseline symptom measurement as 
covariates, where relevant. 
A z-test was performed to determine whether phasic or tonic irritability was a stronger 
predictor of the clinical variables. To control for the effect of multiple testing when 
investigating the impact of both dimensions of irritability on clinical correlates, 
maternal psychopathology and clinical outcomes, Bonferroni correction was 
performed considering p-value thresholds of .006 (number of tests: 8); .01 (number of 
tests: 4) and .008 (number of tests: 6), respectively. 
To assess how representative the follow-up characteristics of this clinical ADHD 
sample were of the baseline ones, Chi-square and t-test analyses were run across 
these two waves on the rates of phasic and tonic irritability, demographic 
characteristics and clinical variables assessed cross-sectionally. 
Considering the size of these samples, the distribution of the variables of interest is 
not likely to be problematic as per the Central Limit Theorem (Field, 2013), however 
robust adjusted regressions were also used to check whether the results were 
different for those variables that violated the normality assumption (i.e., baseline 
children’s CD symptoms, maternal CD symptoms in childhood, and SDQ 
hyperactivity). 
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3.4 Results 
 
3.4.1 Prevalence of phasic and tonic irritability 
At baseline, 83.1% of participants were males, with a mean IQ of 81.79 (s.d. 13.40). 
approximately half of the sample came from a family with low SES (54.6%). The mean 
symptom severity and disorder prevalence can be seen in Table 3.1. 
The presence of any irritability symptoms was common in this clinical ADHD sample, 
92.3% of parents endorsed at least one symptom of phasic irritability, while 81% 
reported at least one symptom of tonic irritability (Table 3.2). The application of 
frequency, duration and pervasiveness criteria qualified reduced this prevalence 
(Table 3.2). Using these criteria, severe and frequent phasic irritability was present in 
the 19.3% of children, whereas tonic irritability was present in 51.3%. There was much 
overlap between the two with 15.8% of the sample having both phasic and tonic 
irritability (Table 3.2). 
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 N (%) MEAN (S.D.) 
BASELINE CHARACTERISTICS 
CD DIAGNOSIS 119 (21.2%)  
ANY ANXIETY DIAGNOSIS 35 (6.4%)  
DEPRESSIVE SYMPTOMS 211 (38.3%)  
ADHD SYMPTOMS  15.36 (2.35) 
ODD SYMPTOMS  2.29 (1.47) 
CD SYMPTOMS  1.27 (1.65) 
AUTISM SYMPTOMS  11.94 (6.62) 
PSYCHOPATHY  35.04 (13.2) 
MATERNAL PSYCHOPATHOLOGY 
CURRENT ADHD SYMPTOMS  5.48 (5.4) 
CHILDHOOD CD SYMPTOMS  1.10 (1.75) 
DEPRESSIVE SYMPTOMS  6.88 (4.24) 
ANXIETY SYMPTOMS  9.84 (4.94) 
FOLLOW-UP CHARACTERISTICS  
SDQ EMOTIONAL SCORE  5.34 (2.53) 
SDQ CONDUCT  5.38 (2.42) 
SDQ HYPERACTIVITY  9.05 (1.42) 
SDQ IMPACT  5.45 (2.82) 
ANY ADHD DIAGNOSIS 158 (83.2%)  
CD DIAGNOSIS 70 (36.8%)  
 
Table 3.1 Descriptive characteristics of the clinical ADHD sample at baseline, follow-up, and maternal 
psychopathology 
SDQ = Strengths and Difficulties Questionnaire, S.D.= Standard Deviation. 
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 PHASIC  
N (%) 
TONIC  
N (%) 
DIMENSIONS 
N (%) 
IRRITABILITY SYMPTOMS 
PRESENT 
518 (92%) 451 (81%)  
FREQUENCY ≥ 3X/WEEK 315 (56%) 317 (57%)  
TIME LAPSE >12 MONTHS* 295 (53%) 286 (51%)  
SYMPTOMS PRESENT IN AT 
LEAST 2 SETTINGS* 
111 (20%) /  
FULL CRITERIA PREVALENCE 108 (19.3%) 286 (51.3%)  
ONLY ONE DIMENSION 
PRESENT 
19 (3.4%) 198 (35.6%)  
NEITHER DIMENSION PRESENT   252 (45.2%) 
BOTH DIMENSIONS PRESENT   88 (15.8%) 
EITHER ONE DIMENSION 
PRESENT 
  217 (39%) 
 
Table 3.2  Prevalence of phasic and tonic irritability and criteria 
* at the required symptoms frequency. 
 
3.4.2 Phasic and tonic irritability associations with clinical correlates at 
baseline 
Cross-sectional analyses revealed that irritability and demographic factors did not 
seem to be inter-related, except for the association between phasic irritability and low 
SES (OR= 2.39, 95%CI= 1.3/4.3, p= .003). In this sample of children with ADHD, the 
presence of phasic irritability was associated with a three-fold increase in the 
likelihood of being diagnosed with CD (OR= 2.95, 95%CI= 1.6/5.4, p< .001), whilst 
those with tonic irritability had a greater than two-fold increase in the chance of 
displaying CD diagnosis (OR= 2.53, 95%CI= 1.4/4.5, p= .002). Tonic irritability was 
also associated with a three-fold increased risk of being diagnosed with anxiety 
disorders (OR= 3.3, 95%CI= 1.3/8.3, p= .01) (Table 3.3). Robust multiple regressions 
produced similar estimates for CD symptoms, which was independently predicted by 
both phasic and tonic irritability (unstandardized B= 1.06, p= .001; unstandardized B= 
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.54, p= .002, respectively). Z-tests revealed that there was no significant difference in 
the strength of association of phasic and tonic irritability for any of the clinical 
correlates considered (Table 3.3). 
 
3.4.3 Phasic and tonic irritability associations with maternal 
psychopathology  
 
Table 3.1 shows the means and standard deviations of the maternal psychopathology 
variables considered, whilst their association with phasic and tonic irritability are 
reported in Table 3.3. Phasic irritability seemed not to be significantly associated with 
any of the measures of maternal psychopathology. However, tonic irritability alone 
showed a significant association with maternal mood and anxiety symptoms. 
Bootstrapped estimates for maternal CD consistently show a non-significant 
association between phasic or tonic irritability with maternal CD symptoms 
(respectively: unstandardized B= .14, p= .54; unstandardized B= .26, p= .14). As 
shown by the z-tests, phasic irritability was not more strongly associated than tonic 
irritability with any of the maternal psychopathology variables considered (Table 3.3). 
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 MODEL BETA/OR (95% CI) ADJ- MODEL BETA/OR (95% CI) Z- TEST 
BASELINE DATA 
ADHD SYMPTOMS 
Phasic B= 1.06 (.52, 1.61)*** Phasic B= .59 (.02, 1.16)* 
n.s. 
Tonic B= 1.02 (.59, 1.44)*** Tonic B= .78 (.34, 1.23)*** 
ODD SYMPTOMS 
Phasic B= 1.20 (.87, 1.53)*** Phasic B= .63 (.32, .95)*** 
n.s. 
Tonic B= 1.18 (.93, 1.43)*** Tonic B= .83 (.58, 1.08)*** 
CD SYMPTOMS 
Phasic B= 1.31 (.94, 1.68)*** Phasic B= .85 (.49, 1.21)*** 
n.s. 
Tonic B= 1.05 (.75, 1.34)*** Tonic B= .68 (.39, .96)*** 
AUTISM SYMPTOMS 
Phasic B= 2.30 (.75, 3.85)** Phasic B= .87 (-.73, 2.47) 
n.s. 
Tonic B= 2.84 (1.64, 4.05)*** Tonic B= 2.13 (.87, 3.39)*** 
PSYCHOPATHY 
SYMPTOMS 
Phasic B= 8.23 (5.21,11.3)*** Phasic B= 4.37 (1.37, 7.37)** 
n.s. 
Tonic B= 8.91 (6.6, 11.2)*** Tonic B= 6.68 (4.31, 9.05)*** 
CD DIAGNOSIS 
Phasic OR= 4.23 (2.51, 7.2)*** Phasic OR= 2.95 (1.63, 5.37)*** 
n.s. 
Tonic OR= 3.73 (2.22, 6.26)*** Tonic OR= 2.53 (1.41, 4.51)** 
ANY ANXIETY 
DIAGNOSIS 
Phasic OR= 1.14 (.45, 2.91) Phasic OR= .74 (.27, 1.98) 
n.s. 
Tonic OR= 3.4 (1.42, 8.14)** Tonic OR= 3.27 (1.29, 8.26)** 
DEPRESSIVE 
SYMPTOMS 
Phasic OR= 2.03 (1.25, 3.3)** Phasic OR= 1.51 (.89, 2.57) 
n.s. 
Tonic OR= 1.88 (1.27, 2.78)** Tonic OR= 1.44 (.94, 2.22) 
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MATERNAL PSYCHOPATHOLOGY 
CURRENT ADHD 
SYMPTOMS  
Phasic B= .07 (-1.17, 1.30) Phasic B= -.08 (-1.38, 1.22) 
n.s. 
Tonic B= .36 (-.64, 1.35) Tonic B= .38 (-.67, 1.42) 
CHILDHOOD CD 
SYMPTOMS 
Phasic B= .25 (-.15, .65) Phasic B= .15 (-.28, .57) 
n.s. 
Tonic B= .30 (-.03, .62) Tonic B= .26 (-.08, .60) 
DEPRESSIVE 
SYMPTOMS 
Phasic B= 1.04 (.07, 2.01)* Phasic B= .55 (-.48, 1.55) 
n.s. 
Tonic B= 1.43 (.65, 2.20)*** Tonic B= 1.29 (.48, 2.1)** 
ANXIETY SYMPTOMS 
Phasic B= 1.53 (.40, 2.66)** Phasic B= .75 (-.42, 1.92) 
n.s. 
Tonic B= 2.17 (1.28, 3.06)*** Tonic B= 1.97 (1.04, 2.9)*** 
 
Table 3.3  Univariate and multivariate logistic and linear regressions on clinical variables and maternal psychopathology. 
The adjusted models (ADJ) were controlled for all the demographic factors, ADHD symptoms and the respective dimension of irritability, with the exception of ADHD symptoms 
controlled for IQ, SES, age and sex, only. Whereas maternal psychopathology adjusted models have been controlled only for the relevant type of irritability. p< .05*; p≤.01**, 
p≤.001*** 
After Bonferroni: within-time phasic - ADHD symptoms and tonic - any anxiety diagnosis associations failed to reach significant threshold. No changes were observed for maternal 
psychopathology.  
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3.4.4 Phasic and tonic irritability associations with longitudinal clinical 
correlates 
As a consequence of the initial inclusion criteria, demographic characteristics of this 
clinical ADHD sample significantly differed at baseline and follow-up (Table 3.4) (see 
Chapter 2 for more details on inclusion and exclusion criteria across the two waves). 
The clinical variables considered remained consistent across these two waves, 
although children with higher rates of tonic and phasic irritability were more likely to 
be included at follow-up (Table 3.4). 
Overall, phasic and tonic irritability showed different patterns of association. Phasic 
irritability predicted ADHD diagnosis persistence, CD diagnosis in adolescence, 
whereas tonic irritability was a predictor of mood and anxiety symptoms, as rated by 
the emotional subscale of the SDQ, and a great impact at follow-up (Table 3.5). Tonic 
irritability was also the only significant predictor of SDQ hyperactivity symptom 
severity, which was also confirmed by the bootstrapped estimates of the robust 
multiple regression (unstandardized B= .50, p= .031) For all these clinical correlates, 
the z-tests revealed non-significant differences in the strength of association between 
phasic and tonic irritability across all variables (Table 3.5). 
 
Following the application of the Bonferroni correction, many of the within-time 
associations between either phasic or tonic irritability with ADHD clinical correlates 
remained significant, the exceptions to this were associations between phasic 
irritability and ADHD symptoms and the associations between tonic irritability and any 
anxiety diagnosis (Table 3.3). Bonferroni correction did not impact on the pattern of 
associations observed for maternal psychopathology, where significant associations 
still reached the statistical threshold after correcting for multiple testing (Table 3.3). 
Counter to this, most longitudinal associations were no longer significant after 
applying the Bonferroni correction, apart for phasic irritability still predicting CD 
diagnosis (Table 3.5). 
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 BASELINE FOLLOW-UP T-TEST/Χ2   
P-VALUE 
SEX (MALE) 289 (78.1%) 177 (92.7%) p< .001 
SES (LOW) 184 (58%) 81 (48.2%) p< .05 
IQ 80.15 (14.2) 85.04 (10.9) p< .001 
AGE 11.24 (3.15) 9.72 (2.31) p< .001 
ADHD SYMPTOMS 15.22 (2.44) 15.63 (2.15) n.s. 
ADHD IMPAIRMENT 6.75 (1.49) 6.93 (1.31) n.s. 
ODD SYMPTOMS 2.22 (1.43) 2.42 (1.54) n.s. 
CD SYMPTOMS 1.25 (1.63) 1.30 (1.68) n.s. 
ASQ SYMPTOMS 11.59 (6.32) 12.58 (7.11) n.s. 
TOTAL PSYCHOPATHY 35.03 (13.1) 35.06 (13.4) n.s. 
CD DIAGNOSIS 78 (21.1%) 41 (21.5%) n.s. 
ANY ANXIETY 
DIAGNOSIS 
23 (6.4%) 12 (6.5%) n.s. 
DEPRESSIVE 
SYMPTOMS 
137 (37.7%) 74 (39.4%) n.s. 
PHASIC IRRITABILITY 62 (16.8%) 46 (24.1%) p< .05 
TONIC IRRITABILITY 174 (47.4%) 112 (58.9%) p< .05 
Table 3.4 Prevalence rates, means and standard deviations of irritability dimensions, demographic and 
clinical variables considered at baseline. The results of the comparison of these estimates is also 
reported. 
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 MODEL BETA/OR (95% CI) ADJ- MODEL BETA/OR (95% CI) Z- TEST 
SDQ: EMOTIONAL 
Phasic B= .59 (-.25, 1.43) Phasic B= .33 (-.53; 1.20) 
n.s. 
Tonic B= .90 (.17, 1.62)* Tonic B= .82 (.06; 1.57)* 
SDQ: CONDUCT 
Phasic B= 1.59 (.82, 2.37)*** Phasic B= .65 (-.17, 1.47) 
n.s. 
Tonic B= 1.31 (.63, 1.99)*** Tonic B= .63 (-.05, 1.32) 
SDQ: 
HYPERACTIVITY 
Phasic B= .20 (-.28, .67) Phasic B= -.12 (-.61, .37) 
n.s. 
Tonic B= .64 (.23, 1.04)** Tonic B= .51 (.08, .94)* 
SDQ: IMPACT 
Phasic B= .41 (-.54, 1.35) Phasic B= .11 (-.86, 1.08) 
n.s. 
Tonic B= .97 (.16, 1.78)* Tonic B= .95 (.10, 1.79)* 
ANY ADHD 
DIAGNOSIS 
Phasic OR= 5.66 (1.30, 24.7)* Phasic OR= 4.86 (1.09, 21.7)* 
n.s. 
Tonic OR= 2.08 (.96, 4.49) Tonic OR= 1.64 (.74, 3.61) 
CD DIAGNOSIS 
Phasic OR= 3.11 (1.56, 6.20)*** Phasic OR= 2.75 (1.35, 5.61)** 
n.s. 
Tonic OR= 1.94 (1.04, 3.61)* Tonic OR= 1.55 (.81, 2.96) 
Table 3.5 Regressions and logistic regressions with clinical correlates at follow-up.  
SDQ = Strengths and Difficulties Questionnaire. The adjusted models (ADJ) have been controlled for the relevant type of irritability. Additionally, SDQ Hyperactivity and SDQ 
Conduct have also been controlled for the relevant baseline symptoms. p< .05*; p≤ .01**, p< .001**  
After Bonferroni: only the longitudinal association between phasic irritability and CD diagnosis remained significant.  
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3.5 Discussion 
The findings suggest that phasic and tonic irritability are highly prevalent in children 
with ADHD and are associated cross-sectionally with most of the clinical correlates 
tested, to an equal extent. Analyses of associations with external validators showed 
a different picture; phasic irritability was a consistent predictor of CD diagnosis in 
adolescents, whilst tonic was significantly associated with maternal internalising 
psychopathology. However, overall, phasic and tonic irritability did not significantly 
differ in the strength their associations and many of the longitudinal associations did 
not survive the Bonferroni correction. 
 
In the present sample, the prevalence of tonic irritability was 51.3%, whilst phasic was 
19.3%. 15.8% of children with ADHD showed both phasic and tonic symptoms. Tonic 
irritability was therefore the most frequent phenotype, whereas the phasic phenotype 
rarely appeared alone (in only 3.4% of cases). These prevalence rates differ from 
findings of Copeland and colleagues (2015), where phasic irritability alone was found 
to be more common than tonic: 51.4% and 28.3% respectively, with 22.8% reporting 
both. However, more stringent criteria than Copeland’s (Copeland et al., 2015) were 
used in this clinical sample of youths with ADHD, and this was in line with previous 
work (Eyre et al., 2017). The application of less stringent criteria solely based on the 
presence or absence of irritability symptoms, as those used by Copeland and 
colleagues (2015), led to very similar results. Phasic irritability was more common 
than tonic irritability (92% and 81% respectively, see Table 3.2) but mostly these 
components greatly overlapped (78%, see Table 3.2). Thus, in addition to differences 
in the study population, the more stringent criteria used to assess phasic and tonic 
irritability in this study may account for these prevalence differences. This is further 
confirmed in a recent twin study showing higher rates of tonic irritability than phasic 
irritability when the frequency criteria was applied (Moore et al., 2019). Notably, tonic 
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and phasic irritability in Moore and colleagues’ study (2019) were operationalised 
more similarly with this current study than Copeland’s, as irritability cut offs based on 
frequency were applied (Copeland et al., 2015). As mentioned in the introduction of 
this chapter, the application of different cut-offs was considered important to 
operationalise phasic and tonic irritability in their chronic and severe facets, as well 
as to avoid over-diagnosing children with either dimension of irritability whose relevant 
symptoms were endorsed by the vast majority (see Table 3.2). Additionally, in the 
study of Mayes and colleagues (2015) tonic irritability was also found to be more 
common than phasic irritability in both children (17.3% vs. 13.4% on average) and 
adolescents (14.2% vs. 8.1% on average). However, it should be noted the aim of 
Mayes and colleagues’ study (2015) was not to compare phasic and tonic irritability, 
which were also operationalised using different measures and items compared to both 
this current and Copeland’s study (2015). Thus, taken together, the current findings 
find corroboration in several studies using both lenient and stringent cut-offs. 
 
Cross-sectionally, the multivariate regression analyses show a similar pattern of 
associations for both phasic and tonic irritability to the clinical correlates considered, 
questioning the usefulness of their distinction. The absence of significant cross-
sectional associations between either of irritability dimensions and depressive 
symptom presence and anxiety diagnosis is somewhat surprising. The comorbidity 
between ADHD and symptoms of depression and anxiety is consistent within the 
scientific literature (Schatz & Rostain, 2006; Spencer, Biederman, & Wilens, 1999), 
as well as the comorbidity between irritability and depression and anxiety symptoms 
and disorders (Brotman, Kircanski, & Leibenluft, 2017). Previous findings have also 
shown that DMDD, as a proxy for severe irritability, is significantly associated with 
anxiety symptoms and diagnosis (Eyre et al., 2017, 2019; Mulraney et al., 2016) and 
with depressive symptoms in children with ADHD (Eyre et al., 2017, 2019). Similar 
patterns of association were also observed in this sample of pre-pubertal children with 
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ADHD (Eyre et al., 2017, 2019). However, this is the first study to investigate 
associations with phasic and tonic components of irritability separately. Furthermore, 
depression is relatively uncommon in childhood and the risk of which increases over 
adolescence, with a greater prevalence found especially after puberty (Thapar, 
Collishaw, Pine, & Thapar, 2012). With a mean age of 10.73 (s.d. 2.98), the majority 
of the current sample had not yet reached the typical age of onset for depression 
(Eyre et al., 2017). This is also supported by the very few depressive symptoms 
endorsed by individuals in this sample. Similarly, any anxiety diagnosis was only 
present in the 6.4% of the current sample which also showed a greater male 
preponderance. Overall, sex differences are not shown in pre-pubertal children with 
anxiety disorder, except for separation anxiety that does appear to be more common 
in female than males in childhood (Hayward & Sanborn, 2002; Pine & Fox, 2015). 
Separation anxiety was amongst the disorders added into the “any anxiety disorder 
variable” used in this study that might have contributed to reduce the power to find a 
significant association. 
 
Additionally, findings associated with external validators (i.e. maternal 
psychopathology and longitudinal associations), used to further and more robustly 
explore the distinction between dimensions of irritability over and above cross-
sectional associations, do not seem to consistently support the distinction between 
tonic and phasic irritability. Considering only those associations that survive 
Bonferroni correction, maternal psychopathology analyses revealed that mothers with 
symptoms of depression and anxiety are more likely to have children with tonic 
irritability, consistent with the theoretical conceptualisation of tonic irritability as a 
persistent negative mood symptom. However, tonic irritability does not seem to be 
associated with emotional symptoms longitudinally. Phasic irritability seems to be 
linked to disruptive behaviours predicting CD diagnosis at follow-up, but it does not 
seem to be associated with disruptive symptoms when considering maternal 
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psychopathology or at follow-up. Thus, the independent contribution of phasic and 
tonic irritability seems very limited considering these external validators, whilst 
furthermore the longitudinal associations between phasic and tonic irritability and 
clinical correlates do not seem to be independent of the effect of comorbid symptoms 
at baseline as evidenced in Table 3.5. Floor effects might have driven some of these 
non-significant findings; for instance, only few mothers endorsed CD symptoms in 
childhood which is not surprising considering that disruptive behaviours are more 
commonly observed in males and that CD symptoms were investigated 
retrospectively (Carlson, Tamm, & Gaub, 1997; Newman et al., 1996; Nock, Kazdin, 
Hiripi, & Kessler, 2006). Additionally, this clinical sample was smaller at follow-up than 
it was at baseline which might account for the non-survival of the longitudinal 
associations. These inconsistencies in terms of pattern of associations of phasic and 
tonic irritability both within and across time thus limit the possibility to draw stronger 
conclusions; more studies are needed to validate the bi-dimensional nature of chronic 
and severe irritability, especially those looking at longitudinal associations and using 
larger samples. 
 
There are several strengths to this study. In particular, the analyses run on irritability 
and outcome variables were independent of the influence of ADHD symptom severity. 
The same consideration applies to the measure of ODD and depressive symptoms, 
which were disentangled from irritability items. Another strength of this study is the 
validity of criteria used to assess the presence of phasic and tonic irritability. They 
partially replicate those used in the study by Copeland and colleagues (2015) and are 
also adapted to a sample of children with ADHD in line with previous studies (Eyre et 
al., 2017). This study also benefited from a large sample size and careful 
characterisation of clinical constructs using well validated assessment measures. 
Finally, external validators (i.e. maternal psychopathology and longitudinal data) have 
been used alongside the cross-sectional data to increase the consistency of the 
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present findings. There are also a number of limitations that should be considered. 
Phasic and tonic irritability were measured indirectly by using the CAPA interview. 
Although the criteria used are aligned to those in the original conceptualisation of tonic 
and phasic irritability (Leibenluft & Avenevoli, 2014) and previous studies (Copeland 
et al., 2015; Eyre et al., 2017), researchers have stressed the need of having 
measures specifically designed to capture each dimension (Leibenluft & Avenevoli, 
2014; Vidal-Ribas et al., 2016). ODD symptoms at follow-up were also excluded from 
the analysis due to different scoring systems, and baseline ODD CAPA diagnosis was 
also not looked at, as it was not feasible to disentangle the non-irritable symptoms 
due to high overlap with the current measure of irritability. The use of different 
assessment measures across time points may also have limited the robustness of 
these results. In the light of these limitations, further research is therefore necessary 
to corroborate these findings. 
 
This is the first study to compare phasic and tonic irritability in a clinical sample and 
specifically, in childhood ADHD. Cross-sectional analyses seem to suggest that at the 
clinical level, separating tonic and phasic irritability may not be useful due to their 
similar predictive power in term of strength and associations with clinical correlates. 
Similarly, analyses using external validators in the form of maternal psychopathology 
and longitudinal outcomes failed to provide strong conclusion about the theoretical 
distinction between these components of irritability. Taken together these results 
suggest that irritability might just be a marker of severity in ADHD. Therefore, within 
clinical practice, separating tonic and phasic irritability may not be useful in identifying 
children at future risk for internalising or externalising disorders. Although considering 
the pioneering nature of this study, more research is needed to validate these findings. 
Considering the purpose of this thesis, separating phasic and tonic irritability does not 
seem to be justified, thus chronic and severe irritability in the following chapters would 
be considered as a unitary construct.
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Chapter 4  
Investigating the cognitive markers of 
childhood chronic and severe irritability 
in a sample of adolescents with ADHD 
 
Chapter description  
This chapter addresses the second aim of this thesis which is to investigate the impact 
of childhood chronic and severe irritability on Hot, as opposed to Cool, Executive 
Functions in a sample of adolescents with ADHD. In this chapter only participants with 
available follow-up data are considered, which focuses on cognitive measures. A brief 
description of the clinical and demographic variables, and cognitive tasks is provided 
although these are described more comprehensively in Chapter 2. 
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4.1 Introduction  
The previous chapter looked at the proposed phasic and tonic dimensions of chronic 
and severe irritability and their associations with clinical correlates of ADHD, in 
childhood. Following these analyses, it does not seem to be justified to conceptualise 
irritability bi-dimensionally and so a single construct will be utilised. Nonetheless, the 
associations between chronic and severe irritability with a range of clinical correlates 
were observed, supporting the relevance of this construct in youths with ADHD. 
However, little is known about how irritability mediates risk for future psychiatric 
conditions and about its pathophysiology (Avenevoli, Blader, & Leibenluft, 2015). 
Research on pathophysiological mechanisms of irritability is a new frontier and great 
importance is given to the concept of “frustration” to which irritability is closely 
intertwined (Brotman, Kircanski, & Leibenluft, 2017; Leibenluft, 2017b). In fact as 
explained in the general introduction (Chapter 1, section 1.1.1), irritability can be 
conceptualised as a lower tolerance to react with anger often precipitated by 
frustrating circumstances; such as situations where a desired and expected reward is 
withheld (Brotman, Kircanski, & Leibenluft, 2017; Leibenluft, 2017b). Deficits in 
reward processing may in turn increase the exposure to frustration for youth with 
severe irritability as such impairments would hinder the attainment of the desired 
reward. This paradigm seems to be supported by previous findings that youth with 
severe irritability show impairments in reward learning, reward prediction error, 
expected value representation and aberrant sensitivity to rewards (Brotman, 
Kircanski, & Leibenluft, 2017; Leibenluft, 2017b; Vidal-Ribas et al., 2016). However, 
research in this area is far from clear and findings are mixed; impairments are often 
found at neurophysiological level but overall they are not supported by behavioural 
results (Adleman et al., 2011; Dickstein et al., 2007; Perlman et al., 2015; Rau et al., 
2008) and it is noted that some cognitive tasks used do not actually tap reward-related 
processes (Dickstein et al., 2007). More specifically, significant behavioural findings 
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are found for a-specific measures of cognitive performance, such as overall task 
accuracy, rather than for measures that are more strictly linked to reward processing 
impairments (e.g., change in reward contingencies) (Adleman et al., 2011; Dickstein 
et al., 2007). Furthermore, previous work comparing children with SMD, BD and 
typically controls found that cognitive performance of severely irritable youths seems 
to differ either from controls or from other clinical groups, without showing a unique 
characterisation associated with chronic and severe irritability (Dickstein et al., 2007). 
Additionally, some of the evidence claimed to support deficits in reward learning in 
this population were obtained using Cool EF tasks, thus cognitive processes that 
occur in unemotional contexts, such as the ID/ED task tapping cognitive flexibility 
(Brotman, Kircanski, & Leibenluft, 2017; Dickstein et al., 2007). Some previous 
research also focuses on emotional (i.e. anger) (Gagne & Goldsmith, 2011) and 
behavioural (i.e. disruptive/antisocial behaviours) correlates of irritability, rather than 
on irritability as currently conceptualised (Finger et al., 2011; White et al., 2014, 2013). 
Some studies also suggest that reward-related impairments in youth with severe 
irritability may also be mediated by deficits in cognitive control processes such as 
behavioural inhibition (Brotman, Kircanski, & Leibenluft, 2017; Brotman, Kircanski, 
Stringaris, et al., 2017; Leibenluft, 2017b). However, previous findings comparing 
severely irritable children, those with BD and healthy controls did not find any 
compelling differences in the behavioural performance of the different groups on a 
motor inhibition task, as well as when comparing children with high and low trait anger 
(Deveney et al., 2012; Liu et al., 2015). This ultimately suggests that it may be reward 
processing impairments that are more relevant for youths with severe irritability. 
An additional limitation of these previous findings is that overall their construct of 
irritability has often been based on Severe Mood Dysregulation, a proxy for chronic 
and severe irritability with a hyperarousal component that greatly overlaps with ADHD 
symptoms (Adleman et al., 2011; Deveney et al., 2012; Dickstein et al., 2007; Rich et 
al., 2007). Because of the convergence between ADHD and SMD, it is difficult to 
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partial out the contribution of ADHD to these results, something also indicated by the 
high prevalence of ADHD diagnosis in different samples of children with SMD studied, 
ranging between 77% to 85% (Adleman et al., 2011; Deveney et al., 2012; Dickstein 
et al., 2007; Rich et al., 2007). Further research is therefore needed to test the 
hypothesis that there is an association between decision-making and reward-related 
processes with severe irritability, and this may be especially relevant in those with 
ADHD. 
 
Neuropsychological impairments found in previous studies for those with irritability are 
also common in children with ADHD. As mentioned in Chapter 1, ADHD is a 
heterogeneous neurodevelopmental disorder that shows variability in core symptom 
presentation, co-occurring conditions and neuropsychological deficits (Thapar & 
Cooper, 2016; Wahlstedt et al., 2009). At the cognitive level, children with ADHD do 
not show a specific neuropsychological profile, rather they display a variety of 
impairments in Executive Functions (Castellanos et al., 2006; Thapar & Cooper, 
2016). As mentioned in the general introduction (Chapter 1, section 1.3.1), EFs are 
conceptualised as a top-down cognitive abilities that regulate goal directed activities 
and can be split into “Cool” and “Hot” components. Whilst Cool EFs are used when 
facing abstract and decontextualized problems, Hot EFs refer to emotionally engaging 
cognitive processes (Castellanos et al., 2006). To date, the literature on children with 
ADHD has mainly focused on the Cool EFs, whereas recent evidence also points to 
the important role played by motivational and reward-related processes (Hot EFs) 
(Dekkers et al., 2016; Mowinckel et al., 2015; Sjöwall & Thorell, 2018; Willcutt et al., 
2005). Children with ADHD, compared to typically developing controls, show the most 
robust deficits in Cool EF processes of inhibitory control, attention, working memory 
and vigilance, and Hot EF processes of decision-making and reward processing 
(Baroni & Castellanos, 2015; Thapar & Cooper, 2016). Notably, previous work found 
Hot EF deficits also in youths with disruptive behaviours (i.e., ODD/CD) (Alegria, 
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Radua, & Rubia, 2016; Fairchild et al., 2009; Sully et al., 2016), some of these studies 
used an identical task to the one considered in this current study, such as the Choice 
per Risk Task (Fairchild et al., 2009; Sully et al., 2016). The presence of disruptive 
behaviours seems associated with impaired Hot EFs also in those with ADHD 
(Northover et al., 2015a). More precisely, the presence of disruptive behaviours (i.e., 
ODD/CD) seems to worsen Hot cognitive functioning in those with ADHD compared 
to children with ADHD alone (Dekkers et al., 2016; Groen, Gaastra, Lewis-Evans, & 
Tucha, 2013). The study of neuropsychological impairments in ADHD is particularly 
important in order to try to understand possible sources of the heterogeneity of this 
condition and in turn identify underlying risk pathways. 
 
As noted previously, irritable symptoms are frequently observed in children with 
ADHD (Krieger, Leibenluft, Stringaris, & Polanczyk, 2013) with a prevalence ranging 
between 57% and 92% (Eyre et al., 2017). Irritability in those with childhood ADHD is 
also associated with greater impairment, poorer outcome and higher rates of co-
morbid conditions (Biederman, Spencer, et al., 2012; Eyre et al., 2017; Faraone et al., 
2019; Shaw et al., 2014). Studies aiming to understand the sources of comorbidity 
between irritability and ADHD which focus on neuropsychological mechanisms are 
however scarce and far from conclusive. 
A study by Sjöwall and colleagues (2013) looked at the overlap between Emotional 
Dysregulation and neuropsychological deficits showing that 44% of children with 
ADHD have both emotion regulation impairments and neuropsychological deficits. 
Emotion Dysregulation and impairments in emotion recognition significantly contribute 
to discriminate children with ADHD from controls. This contribution seems to be 
independent of neuropsychological deficits and the effect is consistent even when 
controlling for behavioural and emotional problems (Sjöwall et al., 2013). 
Banaschewski and colleagues (2012) showed that ADHD and Emotional Lability are 
associated with the same neuropsychological indicators, however the relationship 
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between neuropsychological functions and Emotional Lability was completely 
mediated by ADHD symptom severity. Both bottom-up emotional reactivity and top-
down regulatory mechanisms are also suggested as possible reasons for the overlap 
between ADHD and Emotional Dysregulation (Shaw et al., 2014). In terms of bottom-
up processes, individuals with ADHD show difficulties in both orienting attention to 
emotionally relevant stimuli and in the evaluation of rewards, as demonstrated by the 
aberrant neurophysiological activity and poor performance in delay aversion tasks 
(Shaw et al., 2014). This suggests an enhanced emotionality that could give rise to 
Emotional Dysregulation in ADHD (Shaw et al., 2014). Top-down mechanisms are 
also impaired in individuals with ADHD as supported by studies that showed their 
difficulties in engaging cognitive control strategies to downregulate emotional 
reactivity (Shaw et al., 2014). In fact, children with ADHD show both a poor 
parasympathetic response to emotional stimuli, as indexed by physiological indicator 
of emotion regulation, and impairments in allocating their attention to or away from 
emotional stimuli, which is important to regulate emotional arousal (Shaw et al., 2014). 
However, these bottom-up and top-down impairments provide only indirect evidence 
for the co-occurrence of Emotion Dysregulation in ADHD. Furthermore, all these 
studies have conceptualised irritability within broader phenotypes such as Emotional 
Lability and Emotional Dysregulation, where symptoms, such as hot temper, 
tearfulness and mood swings are included in addition to irritability symptoms 
(Banaschewski et al., 2012; Shaw et al., 2014; Sjöwall et al., 2013). Finally, tasks 
included in these previous studies were mainly within the Cool EF domain and for Hot 
EFs only delay aversion has been considered (Banaschewski et al., 2012; Sjöwall et 
al., 2013). As suggested by the previous paradigm of irritability, Hot EFs could be a 
more promising line of research to understand pathophysiological mechanisms of 
severe irritability. Further research is therefore needed to understand the source of 
co-occurrence between ADHD and severe irritability with a more circumscribed 
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operationalisation of this phenotypes and tasks that comprise a broader variety of Hot 
EF tasks. 
 
Based on these knowledge gaps, it appears important to disentangle 
neuropsychological markers specific to ADHD, those specific to severe irritability and 
to understand shared mechanisms explaining their co-occurrence. This was the broad 
aim of this study. To the best of my knowledge, this is the first study investigating 
neuropsychological markers of severe irritability in a sample of youths with ADHD. 
The aim was to see whether chronic and severe childhood irritability had a specific 
pattern of association with adolescents’ Cool and Hot EFs. Based on the paradigm of 
severe irritability (Brotman, Kircanski, Stringaris, et al., 2017; Leibenluft, 2017b), it 
was hypothesised that childhood severe irritable symptoms would be specifically 
associated with Hot EFs but not with Cool EFs in adolescence. I also wanted to 
examine if the significant associations between childhood chronic and severe 
irritability and adolescence Hot EF measures were present over and above childhood 
ADHD symptom severity. The importance of this study lies on the possibility to 
understand sources of heterogeneity within ADHD and neurocognitive markers 
specific to irritability, ultimately being able to investigate the impact that this phenotype 
has on ADHD at a cognitive level. 
 
4.2 Methods 
4.2.1 Sample 
The sample utilised in this chapter comprised of 219 adolescents with a clinical 
diagnosis of ADHD and with childhood irritability and cognitive data available. 
Participants were aged 10-18 years (mean age 14.04, s.d. 1.90), the majority of whom 
were taking medication for ADHD (78.8%), although they were asked to suspend it 
24h prior to testing. 205 of these participants were youths included in the SAGE study 
Chapter 4 | page 103 
 
who were followed up between two to five years later (mean 2.59; s.d. .91) (see 
Chapter 2 for further details), whereas the remaining 14 were extra participants 
included as having the same clinical and irritability baseline information, as CAPA was 
used as part of their original assessment. At follow-up, 14 SAGE participants with a 
baseline DSM-III-R ADHD diagnosis were also included; broadening the criteria of 
inclusion for this clinical ADHD sample was decided as using more stringent criteria 
(i.e., only baseline participants with a DSM-IV/5 diagnosis) led to an important drop in 
sample size, due to little availability of cognitive data. Finally, it is important to notice 
that 18.3% of this sample no longer met ADHD diagnostic criteria at follow-up, as 
opposed to 75.8% with persistent ADHD and 5.9% who did not have follow-up 
information available on ADHD diagnostic status. 
 
4.2.2 Clinical Measures 
As reported in Chapter 2, information on ADHD research diagnosis and symptoms 
was collected at baseline using the parent version of the CAPA (Angold & Costello, 
2000) and at follow-up using the parent version of the DAWBA (Goodman et al., 
2000). Similarly, parent rated CD symptoms were collected at follow-up using the 
DAWBA (Goodman et al., 2000). 
 
A composite score of chronic and severe irritability was extracted at baseline using 
five items from the ODD and the Depression section of the CAPA. These items were 
“Losing temper” and “Temper Tantrums” from the ODD section and “Touchy or Easily 
Annoyed”, “Angry or Resentful”, and “Irritability” from the Depression session. Cut-
offs based on frequency, pervasiveness and onset were applied to identify a more 
severe phenotype of irritability, consistent with previous work (Eyre et al., 2017) (refer 
to Chapter 2 for further details). The continuous score ranged from 0-4, as no 
participants endorsed the “Irritability” item. 
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4.2.3 Cognitive tasks 
The cognitive tasks used in this study and described below are illustrated in further 
details in Chapter 2. 
 
Cool EF tasks 
The “Wisconsin Card Sorting Test” is a measure of set-shifting where participant’s 
need to adapt their response to feedbacks on how to sort correctly a deck of cards 
(Greve, 2001). The outcome measures were total number of errors and number of 
perseverative errors. 
 
The “Go no Go” task measures behavioural inhibition and asks participants to either 
respond or withheld their preponderant motor response depending on the stimuli 
showed on the computer screen (Rubia et al., 2007). The outcome measures were 
RT to go signals and probability of inhibition in relation to performance using 
participants’ dominant hand. 
 
Hot EF tasks 
The “Card Playing Task” targets reward and punishment sensitivity (Newman et al., 
1987). Participants are asked to play with a deck of cards with a progressively 
decreasing probability of winning and decide when to stop. The outcome measure 
was the total number of cards played before quitting. 
 
The “Temporal Discounting Task” measures impulsivity expressed as reward 
devaluation as a function of its temporal delay (Richards et al., 1999; Rubia et al., 
2009). Participants are asked to choose between an immediate reward and a reward 
delayed over a week, a month, a year, or two years. The outcome measures were the 
RT difference in choosing between a delayed and an immediate reward and the Area 
Under the Curve as an index of impulsivity. AUC values range from 0 to 1; the larger 
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AUC values, the lesser the delay discounting (i.e. less impulsivity) (Myerson et al., 
2006). 
 
The “Choice per Risk Task” measures how reward and punishment impact on risk-
taking behaviours (Syngelaki et al., 2009). Participants need to win as many points 
as possibly by gambling on either one of two wheels of fortune that differ in their 
probability of winning and losing. The outcome measures were 1) the overall 
propensity to gamble; 2) participants’ risky decision-making on six different trials; 3) 
participants’ gambling behaviour after winning or losing small/big amounts. 
 
The “Ultimatum Game” is a measure of emotion regulation (Koenigs & Tranel, 2007; 
Northover et al., 2015a) where participants are playing against a fictional opponent 
who suggest a way to split a sum of money that participants can either accept or 
refuse. The outcome measure was the percentage of moderately unfair (6/4; 7/3) 
offers accepted. 
 
4.2.4 Sociodemographic Measures 
Demographic information related to age and IQ (at follow-up), sex and SES were 
considered and collected as described in Chapter 2. 
 
4.3 Quality Control of Cognitive Data 
Before inclusion, data was analysed for Quality Control (QC) that consisted in 
identifying outliers, looking at testing notes for each participant and checking 
participant’s raw data where needed. Notably, testing notes were comments and 
observation made by the researchers during the child assessment about children level 
of engagement and behaviour during tasks. The initial sample composed of 220 
participants with complete cognitive and childhood irritability data and z-scores were 
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computed to identify outliers, defined as scores over + 3 standard deviations from the 
mean. All outlying participants showed poor commitment to the relevant tasks, as 
indicated either by performance consistently lacking variability and/or by comments in 
testing notes (e.g., participant was not focused, chatting throughout the task; half way 
through participant closed his eyes and was just pressing randomly), with the 
exception of two participants whose outlying scores seemed to have no recorded 
explanation. The scores of these two individuals were then replaced with the most 
extreme score within two standard deviations from the mean, whereas the task scores 
of the remaining outlying participants were removed from the database. Better and 
poorer than average performers also had their testing notes and cognitive 
performance checked on relevant tasks; if a response pattern indicative of poor 
engagement was identified, subjects’ task scores were removed, whereas if the 
pattern of response varied and suggested a certain logic being followed, the 
participant scores were left in. Additionally, where z-scores were within the normal 
range, but testing notes described participants’ poor performance (e.g. “responding 
with eyes closed”), the relevant task scores were removed. Conversely, for vague 
testing notes (e.g. “subject doesn’t seem to be paying attention”) and z-scores within 
the normal range, scores were included in the analyses unchanged. For cases with 
z-scores within the normal range, but no performance variability (suggesting no 
commitment to the task), relevant scores were removed. Finally, data for one subject 
was completely removed as the testing note suggested a generalised struggle across 
all cognitive tasks, which was consistent with generalised outlying scores. The final 
sample was composed of 219 adolescents with complete irritability data. Cognitive 
data available varied from a minimum of 116 participants to a maximum of 208 
participants, this is due to participants’ lack of compliance, technical problems that 
failed to record scores, removal of poor quality of data, as well as testing protocol 
changes. In particular, protocol changes affected the data collection for the UG task 
and the CxR task, the first one was discontinued. This was done to reduce the testing 
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time, whilst introducing new measures to enhance data collection of other relevant 
information. 
 
4.4 Data Analysis   
Analyses were conducted using SPSS version 23 (Corp, 2015). Initially, multiple and 
logistic regressions were performed to explore the association between the measure 
of chronic and severe irritability in childhood and demographic characteristics, whilst 
controlling for the effect of the relevant demographic factors and ADHD symptoms at 
follow-up. Additionally, multiple linear regressions were undertaken in a two-stage 
model to test the hypothesis that childhood chronic and severe irritability predicts 
CPT, TDT and UG (Hot EF tasks) but not WCST nor GnG (Cool EF tasks) 
performance in adolescents. In the first stage, Cool and Hot EFs were individually 
regressed onto childhood chronic and severe irritability; whereas in the second stage 
adjusted models were run controlling for demographic factors, and ADHD and CD 
symptom severity at follow-up. Notably, all variables were normally distributed. 
Consistent with previous literature (e.g., Dennis et al., 2009; Fry, Langley, & Shelton, 
2020; Sjöwall & Thorell, 2018), the effect of the IQ was not partialled out due to the 
variance overlap with EF measures. The Bonferroni correction was performed to 
account for multiple testing, setting the p-value threshold to .006 (number of tests: 8).  
 
4.4.1 Analysis on Choice per Risk task 
Notably, the CxR task measured in adolescence was analysed comparing two groups: 
adolescents with ADHD and adolescents with ADHD and one or more symptoms of 
childhood severe irritability (ADHD vs. ADHD + I), consistently with previous studies 
(Fairchild et al., 2009; Sully et al., 2016; Syngelaki et al., 2009). These irritable and 
non-irritable groups were compared using a t-test on their propensity to gamble on 
the experimental wheels across trials (including the framing wheels). A mixed ANOVA 
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was used to analyse participants’ risky decision-making in a 6 (trial type) x 2 (group: 
ADHD + I vs. ADHD) design. These six trials selected were those where the optimal 
choice was less obvious: trial zero (∆EV = 0.5), trial three (∆EV = -0.5), trial four (∆EV 
= -4), trial six (∆EV = -1), trial eight (∆EV = 0; - frame) and trial nine (∆EV = 0; + frame), 
as undertaken previously (Sully et al., 2016). The four trials excluded all showed a 
lack of variability due to ceiling and flooring effects. 2 (Outcome: loss vs. win) × 2 
(Magnitude: large vs. small) × 3 (Group: ADHD vs. ADHD+I) mixed-design ANOVA 
was also conducted to investigate participants’ choice of risky wheel after losing a big 
or a small amount, or winning big or small, respectively. Significant group effects in 
mixed-design ANOVAs were followed-up using Bonferroni pairwise comparisons. 
Additional mixed-design analyses of covariance for both trial type and behavioural 
outcome were conducted to control for the effect of demographic, and ADHD and CD 
symptoms in adolescents. Notably, sex was not controlled for as all participants who 
were tested on CxR were males. 
  
4.4.2 Bayesian Analyses  
Bayesian analyses were conducted using JASP (version 0.9.2) (Jasp Team, 2018) to 
further validate the main findings obtained using a frequentist approach. The 
Bayesian approach complements the classic statistics by assessing the plausibility of 
either the null hypothesis (H0) or the alternative hypothesis (H1); whereas the classic 
p-value has a much less direct evidence in support of the alternative hypothesis 
(Marsman & Wagenmakers, 2017; Quintana & Williams, 2018). For the current 
Bayesian analysis, since this is the first study looking at cognitive markers of irritability, 
previous knowledge was unavailable to set up prior features in JASP, therefore the 
software’s default options were used to conduct these analyses. Additionally, the 
Bayes Factor (BF)10 is used, that is the ratio of the experimental hypothesis to the null 
hypothesis (Marsman & Wagenmakers, 2017; Quintana & Williams, 2018). The 
values of the BF10 range from 0 to ∞ and they are interpreted following the 
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conventional guidelines (Quintana & Williams, 2018; van Doorn et al., 2019), for which 
a BF10 between 1 and 3 indicates equal support for both the rival hypotheses, BF10 
values ranging from 3 to 10 suggest moderate evidence for H1, and finally BF10 greater 
than 10 and 30 points toward strong and very strong evidence for H1, respectively. 
Any BF10 value above 100 is considered to be extremely in favour of H1 (Quintana & 
Williams, 2018; van Doorn et al., 2019). Conversely, the reciprocal scores provide 
evidence in favour of H0, similarly ranging from anecdotal to extreme support 
(Quintana & Williams, 2018; van Doorn et al., 2019). 
 
As some adolescents (n= 18; 8.2%) did not stop their ADHD medication 24h prior 
testing, sensitivity analyses were performed to see if there was a change in the results 
by excluding these participants.  
 
4.5 Results 
At follow-up, this clinical ADHD sample was composed of 94% males and 46% of 
participants had a low SES. Associations between demographic characteristics and 
childhood chronic and severe irritability revealed that this phenotype was significantly 
associated with lower IQ (unstandardized B= -1.96, p= .025), whereas there was only 
a trend with low SES (OR= 1.36, 95% CI= 1.00, 1.84, p= .049) and there was no 
significant association with age (unstandardized B= .082, p = .542) or sex (OR= .871, 
95% CI= .467/1.624, p= .664). Nonetheless, SES, age and sex were still used as 
covariates. Demographic characteristics by ADHD irritable and non-irritable groups 
are reported in Table 4.1. 
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 ADHD (N= 83) ADHD+I (N= 136) p-value 
IQ 89.64 (13.75) 86.13 (11.7) n.s 
AGE 14.25 (1.82) 13.90 (1.92) n.s 
SES (LOW) 30 (37%) 61 (51%) < .05 
SEX (MALE) 79 (93%) 130 (95%) n.s 
ADHD SYMPTOMS AT 
FOLLOW-UP 
10.9 (4.54) 13.49 (4.20) < .001 
CD SYMPTOMS AT 
FOLLOW-UP 
1.91 (2.33) 3.05 (2.73) < .05 
 
Table 4.1 Clinical and demographic characteristics of the ADHD alone and ADHD & irritability groups. 
Means or number are reported with standard deviations or percentage within brackets.  
 
4.5.1 Multiple regression results 
As shown in Table 4.2, overall childhood irritability did not predict Hot (CPT, TDT and 
UG) or Cool (WCST and GnG) EFs in adolescents with ADHD. This was consistent 
when controlling for demographic factors, and CD and ADHD symptom severity at 
follow-up. A significant association between severe irritability in childhood and WCST 
perseverative error (Cool EF measure) in adolescence did not withstand Bonferroni 
correction (p= .006).
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 N MODEL UNSTANDARDIZED BETA (95% CI) 
COOL EFS 
WCST TOTAL ERRORS N= 173 
Unadjusted Model B= 1.24 (.21, 2.27)* 
Adjusted Model B= 1.02 (-.04, 2.09) 
WCST PERSEVERATIVE ERRORS N= 173 
Unadjusted Model B= .73 (.17, 1.29)* 
Adjusted Model B= .69 (.11, 1.28)* 
GNG RT TO GO SIGNALS N= 185 
Unadjusted Model B= 1.71 (-4.76, 8.17) 
Adjusted Model B= 1.04 (-5.60, 7.67) 
GNG PROBABILITY OF INHIBITION N= 185 
Unadjusted Model B= 1.05 (-1.81, 3.91) 
Adjusted Model B= 1.51 (-1.18, 4.20) 
HOT EFS 
CPT TOTAL NUMBER OF CARDS N= 208 
Unadjusted Model B= 1.31 (-3.05, 5.67) 
Adjusted Model B= 1.49 (-3.17, 6.14) 
TDT RT DIFFERENCE DELAYED - 
IMMEDIATE CHOICE 
N= 176 
Unadjusted Model B= -.91 (-22.8, 21.0) 
Adjusted Model B= -4.94 (-28.5, 18.6) 
TDT AUC N= 176 
Unadjusted Model B= -.02 (-.05, .01) 
Adjusted Model B= -.02 (-.06, .01) 
UG MODERATELY UNFAIR 
OFFERS ACCEPTED 
N= 116 
Unadjusted Model B= -.07 (-.13, -.01)* 
Adjusted Model B= -.05 (-.11, .02) 
Table 4.2 Pattern of associations between severe irritability and Cool and Hot EF measures. 
WCST = Wisconsin Card Sorting Test task, GnG = Go no Go task, CPT = Continuous Performance Task, TDT = Temporal Discounting Task, UG = Ultimatum Game. RT = 
Reaction Time, AUC = Area Under the Curve. Adjusted models were corrected for age, sex, SES, and ADHD and CD symptom severity in adolescence. 
* Significant at < .05
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4.5.2 Choice per Risk results 
The t-test revealed no difference in the propensity to gamble between the non-irritable 
ADHD and irritable ADHD groups (t (1, 149) = -1.243, p= .216). Results of the mixed 
ANOVAs and mixed analyses of covariance are reported in Table 4.3. For both trial 
type and outcome after large/small loss/win, overall there was no main effect of group 
(i.e., no difference between ADHD+I and ADHD groups), and no significant 
interaction. There was a significant main effect of outcome and trial type. Pairwise 
comparisons on outcome suggested that participants who lost a large amount of 
money gambled more in subsequent trials than those who won a large amount (p= 
.004), although the main effect of outcome was no longer significant after adding 
covariates. The pattern of main effect of trial type is reported in Figure 4.1; overall 
adolescents chose the risky wheel significantly less on trial 1 than both trial 2 and 5 
and significantly more than trial 3 and 4. Participants’ decision-making was overall 
significantly riskier on trial 2 than any other trial, except trial 5. Trial 3 and trial 4 do 
not differ to one another, but participants gambled less on these wheels than they did 
on the rest of trials. Finally, adolescents chose the risky wheel more often on trial 5 
than trial 6. Notably, this pattern was overall consistent in unadjusted and adjusted 
models. 
 
Sensitivity analyses excluding adolescents who had not withdrawn their medication 
did not alter the findings, especially once applied the Bonferroni correction (see 
Appendix 4.1, Appendix 4.2, Appendix 4.3). 
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 MODEL (N= 151) ADJUSTED MODEL (N= 121) 
 F p EF size F p EF size 
TRIAL TYPE 
F (5, 149) = 281.41 p < .001 ηp2 = .654 
 
F (5, 119) = 10.46 p < .001 ηp2 = .083 
IRRITABILITY GROUPS 
F (1, 149) = 1.281 p= .260 ηp2 = .009 
 
F (1, 119) = 1.583 p = .211 ηp2 = .014 
TRIAL TYPE * IRRITABILITY 
GROUPS 
F (5, 149) = 1.129 p =.343 ηp2 = .008 
 
F (5, 119) = 2.085 p =.066 ηp2 = .018 
 F p EF size F p EF size 
OUTCOME 
F (3, 149) = 3.711 p = .012 ηp2 = .024 F (3, 119) = 1.469 p = .223 ηp2 = .013 
IRRITABILITY GROUPS 
F (1, 149) = 2.984 p = .086 ηp2 = .020 F (1, 119) = 2.814 p = .096 ηp2 = .024 
OUTCOME * IRRITABILITY 
GROUPS 
F (3, 149) = .969 p = .407 ηp2 = .006 F (3, 119) = 1.699 p = .167 ηp2 = .015 
 
Table 4.3 CxR mixed ANOVAs and mixed analysis of covariance results for trial type and outcome. 
Adjusted models were corrected for age, SES, and ADHD and CD symptom severity in adolescence 
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Figure 4.1 Risky decision-making mean values across 6 different trial types, split into groups. 
Different trial type Δ Expected Values are reported on the x axis, whereas the y axis shows mean values of the number  
of times participants have chosen the experimental wheel per each trial type. –frame and + frame represent the positive  
and negative frame trials, respectively. 
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4.6 Bayesian Results 
4.6.1 Multiple regression Results 
For the Bayesian multiple regressions, the unadjusted models with irritability as sole 
predictor were compared against the null model (Table 4.4). Additionally, adjusted 
models including predictor and covariates (i.e., irritability, age, sex, SES, ADHD and 
CD symptom severity) were compared against the model including covariates only 
(i.e., age, sex, SES, ADHD and CD symptom severity) to see if irritability was a 
predictor of cognitive performance over and above the effect of covariates. This could 
be obtained using Bayes factor transitive property and thus dividing the model 
including predictor and covariates (i.e., irritability, and clinical and demographic 
factors) by the model with covariates only (i.e., age, sex, SES, ADHD and CD 
symptoms) (Quintana & Williams, 2018). Considering the unadjusted models, the BF10 
for the WCST (Cool task) ranged from 3.1 to 4.9, suggesting these results being 3 to 
5 times more likely under H1 than H0. The absolute value of the BF10 for the rest of the 
tasks considered was small, providing either anecdotal evidence for both H0 and H1 
or, more commonly, moderate support for H0 over H1. Adjusted models seemed 
overall to be preferable to the unadjusted models due to improvements in BF10, 
although for the majority of tasks they provided anecdotal evidence for both rival 
hypotheses. An exception is represented by WCST total errors whose BF10 worsened 
from moderate support for H1 to anecdotal evidence. Notably, BF10 for TDT AUC (Hot 
EF) and WCST Perseverative errors (Cool EF) adjusted models was moderately in 
favour of H1.
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COOL AND HOT EFS  MODEL’S BF10 (BF CLASSIFICATION RANGE) 
 
N Null Childhood Irritability Childhood irritability & covariates 
WCST TOTAL ERRORS N= 147 1.000 3.13 (3-10) 1.58 (1-3) 
WCST PERSEVERATIVE ERRORS N= 147 1.000 4.85 (3-10) 3.51 (3-10) 
GNG RT TO GO SIGNALS N= 157 1.000 0.27 (0.1-0.33) 0.46 (0.33-1) 
GNG PROBABILITY OF INHIBITION N= 157 1.000 0.21 (0.1-0.33) 0.33 (0.33-1) 
CPT TOTAL NUMBER OF CARDS N= 175 1.000 0.18 (0.1-0.33) 0.50 (0.33-1) 
TDT RT DIFFERENCE DELAYED – 
IMMEDIATE CHOICE 
N= 150 1.000 0.16 (0.1-0.33) 0.46 (0.33-1) 
TDT AUC N= 150 1.000 0.56 (0.33-1) 3.25 (3-10) 
UG MODERATELY UNFAIR OFFERS 
ACCEPTED 
N= 92 1.000 2.21 (1-3) 0.56 (0.33-1) 
 
Table 4.4  Bayesian results for multiple regressions.  
WCST = Wisconsin Card Sorting Test task, GnG = Go no Go task, CPT = Continuous Performance Task, TDT = Temporal Discounting Task, UG = Ultimatum Game; RT = 
Reaction Time, AUC = Area Under the Curve; BF = Bayes Factor. 
Covariates are age, sex, SES, and ADHD and CD symptom severity at follow-up. 
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4.6.2 Choice per Risk results 
Bayesian mixed ANOVA and mixed analysis of covariance results for the CxR task 
are reported in Table 4.5. For unadjusted models, both the main effects alone and the 
full model with main effects and interaction term were compared to the null model. For 
full models, main effects were included alongside the interaction term, as evidence 
from a previous study indicated that models with interactions without main effects are 
implausible (Rouder, Engelhardt, McCabe, & Morey, 2016). Adjusted models were 
however compared against the model including covariates only, to partial out their 
effect, similar to the previous Bayesian multiple regression analysis (see section 
4.6.1). For risky decision-making across different trials, there was strong support for 
the main effect of trial type only, provided by the extreme BF10, which remained 
consistent after controlling for covariates. The BF10 for adjusted and unadjusted 
models including both main effects and interaction term was extremely in favour of 
the H1 over the H0, although this seemed to be driven by trial type. In fact, the BF10 of 
the full mixed ANOVA model, once accounted for the variance explained by trial type, 
was .004 (BF10 of the full model = 7.827e+176 divided by BF10 of the model with main 
effect of trial type only = 1.792e+179). Similarly, the BF10 of the full mixed ANCOVA 
model, once accounted for the variance explained by trial type, was .061 (8.2e+146 / 
1.346e+148). These results suggest extreme and strong support for H0, respectively. 
In terms of gambling after the outcome of the risky choice, the main effects of outcome 
and ADHD irritable and non-irritable groups were anecdotal, after controlling for 
covariates, whereas the BF10 for the full mixed ANOVA and ANCOVA models 
supported H0 strongly and moderately, respectively. 
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MODELS (N= 121) BF 10 (BF CLASSIFICATION RANGE) 
 Null Model BF10 Unadjusted Model BF10 Adjusted Model  
TRIAL TYPE  1.000 1.792e+179 (BF10 > 100) 1.346e+148 (BF10 > 100) 
CHILDHOOD IRRITABILITY 1.000 0.117 (0.1-0.33)  .109 (0.1-0.33) 
TRIAL TYPE + CHILDHOOD IRRITABILITY + TRIAL 
TYPE ✻ CHILDHOOD IRRITABILITY 
1.000 7.827e+176 (BF10 > 100)  8.2e+146 (BF10 > 100)  
 Null Model BF10 Unadjusted Model BF10 Adjusted Model  
OUTCOME  1.000 3.181 (3-10)  2.75 (1-3) 
CHILDHOOD IRRITABILITY 1.000 0.358 (0.33-1)  0.5 (0.33-1)  
OUTCOME + CHILDHOOD IRRITABILITY + OUTCOME 
✻ CHILDHOOD IRRITABILITY 
1.000 0.075 (0.03-0.1)  0.126 (0.1-0.33) 
 
Table 4.5 Bayesian results for CxR task on trial type and outcome. 
Adjusted models were controlled for age, SES, and ADHD and CD symptom severity at follow-up.  
BF = Bayes Factor.  
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4.7 Discussion 
This is the first longitudinal study testing the hypothesis of an association between 
childhood chronic and severe irritability and adolescents’ Hot executive functioning. 
Overall results obtained using a frequentist approach show that baseline childhood 
chronic and severe irritability does not predict Hot EFs as opposed to Cool EFs in 
adolescence. In fact, all the analyses undertaken led to non-significant results 
following Bonferroni correction. This was independent of the role played by ADHD 
symptom severity or demographic factors, suggesting that childhood severe irritability 
per se does not seem to have any effect on Hot or Cool EF performance in a sample 
of adolescents with ADHD. Bayesian analysis however suggests that these findings 
need further validation as many results provided anecdotal evidence and thus were 
insensitive to detect an effect (Quintana & Williams, 2018; van Doorn et al., 2019). An 
exception is represented by WCST Perseverative errors and TDT AUC which 
provides support for H1. This seems inconsistent with the results obtained using the 
frequentist approach, however it should be noted that Bayesian analyses conducted 
with JASP, yielded slightly different results as this software handles missing using a 
listwise deletion, thus it further reduced the availability of cognitive data. Caution is 
therefore needed when interpreting these favourable results for H1. 
 
Considering the uniqueness of this study, it adds to previous research in the field of 
ADHD and neurocognitive markers of irritability. The results obtained support those 
studies that failed to find significant behavioural differences comparing children with 
severe irritability and controls on cognitive performance (Adleman et al., 2011; 
Dickstein et al., 2007; Perlman et al., 2015; Rau et al., 2008), ultimately rejecting the 
hypothesis that irritability is associated with Hot EFs. They are also consistent with 
previous research in ADHD populations where irritability failed to show an association 
with cognitive markers, over and above ADHD symptom severity (Banaschewski et 
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al., 2012). These results are however in contrast with previous evidence in favour of 
this theory linking irritability and Hot cognitive functions (Brotman, Kircanski, & 
Leibenluft, 2017; Leibenluft, 2017b; Vidal-Ribas et al., 2016). It should be noted that 
this previous research focused on a narrow range of Hot cognitive tasks or used tasks 
that did not actually tap Hot cognitive processing (Adleman et al., 2011; Dickstein et 
al., 2007). Conversely this current study used a broad range of well validated 
measures to assess Cool and Hot EFs. It is therefore possible that the different results 
obtained reflect a more comprehensive assessment that enables a greater insight on 
the impact of severe irritability on cognitive performance. Previous significant results 
were in children with SMD (Adleman et al., 2011; Deveney et al., 2012; Dickstein et 
al., 2007; Rich et al., 2007). Considering the strong overlap of this phenotype with 
ADHD, it is possible that significant associations between SMD and Hot executive 
functioning might have actually been driven by ADHD symptom severity. This is 
further confirmed by previous findings showing ADHD and Emotional Lability being 
associated with the same cognitive parameters (Banaschewski et al., 2012). The 
discussion of these previous findings is also strongly limited by the different 
operationalisations of irritability, referred to as Emotional Lability/Dysregulation, within 
SMD or defined by its emotional and behavioural correlates. These inconsistencies 
prevent me from systematically comparing findings between previous studies, as well 
as between this current study and others as, for reasons detailed in Chapter 2 a 
stringent definition of irritability was used in this thesis. 
These non-significant findings also inform the debate on irritability (Evans et al., 2017) 
by highlighting that, in a sample of adolescents with ADHD, irritability may not be 
clinically relevant from a cognitive perspective over and above ADHD diagnosis and 
symptom severity. However, there could be other pathophysiological mechanisms 
associated with irritability that should be investigated in an attempt to assess the 
clinical relevance of this phenotype at the cognitive level in those with ADHD. 
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As suggested by previous reviews (Brotman, Kircanski, & Leibenluft, 2017; Brotman, 
Kircanski, Stringaris, et al., 2017; Leibenluft, 2017b), severe irritability is intertwined 
with the Frustrative Non-Reward that considers those showing severe irritability as 
having a lower tolerance and an aberrant response to frustration. Thus, it is possible 
that cognitive markers of severe irritability may be strictly connected to this concept 
of FNR, as opposed to broader deficits in reward processing. Previous studies 
investigating responses to blocked reward attainment, with tasks specifically designed 
to induce frustration, showed consistent findings; compared to controls, children with 
severe irritability display a greater emotional response to frustration with a negative 
impact on cognitive performance, supported both at neurophysiological and 
behavioural level (Rich et al., 2011, 2007). These neurophysiological results are also 
supported in a sample of kindergarten aged children with externalising problems 
(Gatzke-Kopp et al., 2015). Additionally, as mentioned in the general introduction, the 
EF model is only one of the disrupted neuropsychological pathways possibly leading 
to ADHD. The default-mode network hypothesis has acquired a greater importance 
in ADHD literature (Liddle et al., 2011; Sonuga-Barke & Castellanos, 2007); failure to 
regulate the default-mode network seems to be characteristics of those with ADHD, 
possibly explaining lapses of attention, performance variability or impulsive behaviour 
interfering with goal-directed activities (Liddle et al., 2011; Sonuga-Barke & 
Castellanos, 2007). Similarly, those with ADHD show consistent problems in the state-
regulation activity, displayed as poor effort regulation, vigilant attention, arousal and 
activation that may disrupt cognitive processes (Sergeant, 2000, 2005; Wahlstedt et 
al., 2009). Thus, future research on the overlap between ADHD and irritability could 
investigate other pathophysiological mechanisms to the EF model to test the impact 
of severe irritability in youths with ADHD. Finally, the negative impact of irritability in 
ADHD could act through a social rather than cognitive pathway. Studies on Emotion 
Dysregulation showed a consistent link with social problems in children with ADHD. 
Cross-sectionally peer problems, functional impairment and comorbid conditions in 
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those with ADHD are partially mediated by Emotion Dysregulation (Anastopoulos et 
al., 2011; Sjöwall & Thorell, 2014); whereas longitudinally irritability in adolescents is 
predictive of poor educational attainment and lower Social Economic Status at 20 
years follow-up (Stringaris et al., 2009). 
 
This study has several strengths. It is innovative as it is the first study looking at 
neurocognitive markers of chronic and severe irritability in ADHD, exploring potential 
pathological mechanisms leading to impairment in this population. It benefits from a 
clear and circumscribed operationalisation of chronic and severe irritability, as 
opposed to looking at facets of this construct (e.g., trait anger, emotional lability, or 
dysregulation). A wide range of well validated cognitive tasks was also used, thus 
Cool and Hot cognitive functioning were accurately tapped, ultimately enhancing the 
possibility to directly compare these two cognitive aspects. Nonetheless, the results 
of this study should be considered in light of several limitations. Firstly, chronic and 
severe irritability is measured through a parent-rated questionnaire, whereas EFs are 
measured in the laboratory. These different measurement systems could possibly 
explain non-significant results due to the lack of consistency between parent-rated 
and lab-assessed measures (Sjöwall & Thorell, 2018). A multi-method approach 
might therefore provide more accurate evidence of the impact of chronic and severe 
irritability on neuropsychological functions in ADHD. Secondly, this is a post hoc study 
and the measures available were originally chosen to address a different aim. Thus, 
a comprehensive scale specifically designed to tap chronic and severe irritability could 
not be used; this measure was derived from available clinical interview subscales. 
Additionally, the EF tasks were initially selected as well validated in ADHD population 
and not as direct measures of cognitive markers of irritability. Thirdly, this study lacks 
both a comparison and a control group which would complement the study of the 
cognitive markers of irritability by looking at the impact of chronic and severe irritability 
on Hot cognitive functioning both in the general population and in other clinical 
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samples. The lack of typically developing controls also limits the possibility to compare 
EF performances, ultimately being unable to refine these analyses to those actually 
showing EF impairments. Fourthly, despite this study was accessible to a large 
number of families with ADHD at baseline, participant drop-out, protocol changes and 
QC checks negatively impacted the availability of cognitive data at follow-up, that was 
further reduced for the Bayesian analysis. Thus, investigating the same research 
questions in a larger sample might enable more definitive conclusion. Finally, it is 
possible that the wide age range of this current sample can have biased these results 
at least in respect to certain tasks. Although chronic and severe irritability was not 
associated with age, age was correlated with cognitive performance on GnG and 
WCST. 
 
In conclusion this is the first study to longitudinally investigate an association between 
reward-related impairments and chronic and severe irritability, as suggested by the 
neuroscientific conceptualisation of this phenotype. Despite the broad range of well 
validated Cool and Hot EF measures used, these results failed to support the initial 
hypothesis; childhood chronic and severe irritability does not seem to be associated 
with later impairments in Hot cognitive processing, in youths with ADHD. This 
conclusion is supported by both the classic frequentist approach and the Bayesian 
approach. This hypothesis was however explored using a variable-centred approach, 
as group performance on individual tasks was considered. The associations between 
chronic and severe irritability and Hot cognitive functioning can also be explored using 
a person-centred approach, thus taking into account the cognitive performance at the 
individual level. This might be beneficial to produce more robust results as it is 
explained more in details in the next subchapter, where the association between 
chronic and severe irritability and Hot EFs using a person-centred approach is 
investigated. 
 
Chapter 4 | page 124 
 
4.8 A person-centred approach to the study of Hot 
cognitive functioning and chronic and severe 
irritability 
 
4.8.1 Introduction 
Counter to my hypotheses, results of the previous study failed to show an association 
between childhood chronic and severe irritability and Hot cognitive markers in 
adolescents with ADHD; these non-significant results however would benefit of further 
investigation to enable a better insight on their interpretation. It could in fact be that 
these non-significant findings are the results of methodological caveats relating to the 
way in which Hot EFs were characterized; applying a different study design to the 
same research question could inform of the robustness of these findings. This is also 
consistent with the concept of “triangulation of evidence”, a highly encouraged 
practice of using a multitude of different approaches to corroborate results, to increase 
the replicability of science, and to avoid artefacts (Munafo & Smith, 2018). 
 
One methodological caveat possibly affecting the results of the previous study could 
be that the decision to look at Hot EF tasks individually might have masked the effect 
of an association between adolescents’ Hot cognitive functioning and childhood 
chronic and severe irritability in this ADHD sample. This stems from previous evidence 
showing small effect sizes associated with the investigation of individual cognitive 
tasks (DeVito et al., 2008; Sjöwall & Thorell, 2018; Willcutt et al., 2005), suggesting 
that looking at participants’ performance across multiple tasks combined might 
increase the power to detect significant effects. As the previous analyses in this 
chapter were the first to compare those with ADHD and chronic and severe irritability 
and those with ADHD alone, inferences about this caveat come from case-control 
studies on cognitive impairments that only show small to medium Cohen’s d effect 
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sizes when comparing ADHD to typically developing controls on individual cognitive 
tasks (DeVito et al., 2008; Sjöwall & Thorell, 2018; Willcutt et al., 2005). More 
specifically, a meta-analysis comparing children with ADHD to controls on Cool EFs 
(behavioural inhibition, sustained attention, set-shifting, planning and working 
memory) single task performance revealed only medium average effect sizes, 
observed especially for motor inhibition, sustained attention, spatial working memory 
and planning (Willcutt et al., 2005). Most importantly, case-control differences on set-
shifting skills showed a small effect size (Willcutt et al., 2005); it should be noted that 
it is the only measure of Cool EFs overlapping with the previous study, as in both 
cases set-shifting abilities were measured using the Wisconsin Card Sorting Test, 
whereas the remaining variables considered by this meta-analysis differ from the ones 
used in this thesis. These case-control differences of small to medium effect sizes are 
also not accounted for by intelligence, population source, ADHD comorbid symptoms 
or academic functioning (Willcutt et al., 2005). Additionally, as suggested by twin and 
family studies, ADHD symptoms and scores on individual Cool EF tasks show a small 
proportion of common genetic influences, possibly explaining their small to medium 
correlation; there is a consistent proportion of variance explained by unique genetic 
and environmental influences for each phenotype (Doyle et al., 2005; Willcutt et al., 
2005). Hot executive functioning has been less systematically investigated, although 
case-control studies suggest those with ADHD performing worse on delay aversion, 
decision-making and risk adjustment than controls with medium and large effect sizes 
(DeVito et al., 2008; Sjöwall & Thorell, 2018). It should however be noted that these 
effect sizes were obtained using different Hot EF tasks, and to a certain extent 
measures (e.g., risk adjustment), to the ones used in this thesis. Importantly, youths 
with ADHD show impairments in emotional functioning, a concept related to irritability, 
compared to controls with just a small effect size (Sjöwall & Thorell, 2018). Despite 
the fact that this evidence comes from a different study design (i.e., case-control 
comparisons) compared to the analyses in this thesis, these findings can still illustrate 
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the effect size caveat when looking at individual cognitive tasks that could even be 
exacerbated when looking within a sample of youths with ADHD. It is therefore 
possible that a specific focus on single Cool and Hot EF tasks within ADHD might 
have exposed this methodological caveat to a greater extent, ultimately leading to 
non-significant findings related to the cognitive markers of chronic and severe 
irritability in this population. Thus, work is needed that focuses on cognitive 
performance across multiple tasks combined to enhance the detection of larger effect 
sizes and this is what the current study aimed to do. 
 
Another methodological caveat is that the previous study of this chapter used a 
variable-centred approach whose intrinsic methodological limitations could have led 
to non-significant results. The same research question about the Hot cognitive 
markers of childhood chronic and severe irritability within adolescence ADHD could 
therefore benefit from a person-centred approach instead. A variable-centred 
approach focuses on individual variables and relationships between them, in the 
attempt of predicting outcomes (Muthén & Muthén, 2000). Thus, this describes the 
approach used previously in this chapter when comparing youths with childhood 
chronic and severe irritability and ADHD to those with ADHD alone, as consistent 
impairments across individuals were looked at the individual cognitive task level. 
Conversely, a person-centred approach is data-driven with a greater focus on 
relationships between individuals, as it aims at grouping individuals into 
homogeneous categories based on their different and similar pattern of 
responses across multiple variables of interest (Muthén & Muthén, 2000). Using a 
person-centred approach as opposed to a variable-centred one is not intrinsically 
better but rather, these approaches can be complementary and used to address the 
same research question from a different perspective (Howard & Hoffman, 2018). 
However, as they are reliant on different methods, using a person-centred approach 
as opposed to a variable-centred one could have methodological advantages. There 
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are four main benefits associated with this approach that are relevant in this chapter: 
1) A person-centred approach is more specific than a variable-centred one due to 
their different assumption of homogeneity (Howard & Hoffman, 2018). This means 
that whilst a variable-centred approach assumes that the sample of interest is 
homogeneous; a person-centred approach assumes that a sample could be 
characterized by different subpopulations of homogeneous individuals. Using a 
person-centred approach could therefore identify sample characteristics with a 
greater level of specificity. Considering the previous study of this chapter, using a 
person-centred approach would enable a deeper insight on the characteristics of the 
current ADHD sample that could consist of subgroup of individuals with different Hot 
cognitive profiles, differently associated with childhood chronic and severe irritability. 
Counter to this, considering the current ADHD sample as unitary by using a variable-
centred approach could have reduced the ability of identifying Hot cognitive markers 
of this chronic and severe phenotype of irritability by reducing the overall variability of 
this sample. 2) A person-centred approach is data-driven, thus with the advantage of 
not being reliant on arbitrary thresholds and biased theoretical constructs, compared 
to a variable-centred one (Lambek et al., 2018; Sjöwall & Thorell, 2018). The ADHD 
sample used in the previous analyses of this chapter was reasonably, but still 
arbitrarily, split into irritable and non-irritable groups of adolescents with ADHD, 
forcing the cognitive variability within these pre-determined groups. Using a person-
centred approach would entail a flexible and assumption-free reorganisation of this 
sample into different categories based on their differences and similarities at the 
cognitive level, possibly providing a greater insight on Hot cognitive markers of 
childhood chronic and severe irritability in adolescents with ADHD. Cut-offs and 
constructs could in fact be clinically useful but quite reductionist and potentially unable 
to identify the underpinnings of complex multifaceted psychiatric conditions such as 
ADHD (Lambek et al., 2018; Marquand, Wolfers, Mennes, Buitelaar, & Beckmann, 
2016). 3) A person-centred approach often follows a data reduction principle as it 
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investigates variance captured by latent variables (Oberski, 2016). This suggests that 
using a person-centred approach would not require the Bonferroni adjustment for 
multiple comparisons which is a conservative measure (Simes, 1986) that could have 
further reduced the power to detect an effect, especially combined with previous 
disadvantages associated with a variable-centred approach. 4) A person-centred 
approach considers a higher proportion of variance compared to a variable-centred 
one, as it encapsulates common variance shared by indicators of the homogeneous 
categories identified (Geiser, 2013). This overall variance is not simply the sum of 
each individual indicator variance, as suggested by the fact that the accuracy of the 
model to identify homogeneous categories of individuals, is not equal to the combined 
accuracy of individual indicators (Asparouhov & Muthén, 2018). Considering Hot 
cognitive tasks individually (i.e., variable-centred approach) could have reduced the 
amount of variance potentially explained by childhood chronic and severe irritability, 
whereas a greater variability could increase both the power of this predictor to detect 
an effect and effect sizes. This is further confirmed by previous works including youths 
with ADHD that report greater effect sizes using a person-centred approach on Cool 
and Hot EFs than when neuropsychological measures are compared either in DSM-
defined or case-control groups (Gomez, Gomez, Winther, & Vance, 2014; Lambek et 
al., 2018; Rommelse, van der Meer, Hartman, & Buitelaar, 2016). Considering these 
methodological caveats related to a variable-centred approach, it appears clear that 
the complementary person-centred one could be beneficial to further investigate the 
relationship between chronic and severe irritability and Hot cognitive functioning. 
 
Previous studies have used a person-centred approach to identify cognitively 
homogeneous subgroups of youths with ADHD (Fair, Bathula, Nikolas, & Nigg, 2012; 
Gomez et al., 2014; Rajendran, O’Neill, Marks, & Halperin, 2015; Rommelse et al., 
2016; Van Hulst, De Zeeuw, & Durston, 2015), although no one to date has 
considered irritability as a class predictor nor considered a wide range of Hot EF tasks, 
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only. These studies in fact focused on both Cool and Hot EFs, and additionally, the 
Hot tasks considered only tapped reward sensitivity and delay aversion (Lambek et 
al., 2018; Van Hulst et al., 2015), rather than a broad range of Hot EFs as those used 
in the current thesis. Findings from these previous studies are also mixed in terms of 
the usefulness of stratifying childhood ADHD based on different cognitive profiles 
(Lambek et al., 2018; Van Hulst et al., 2015). One study identified three classes with 
different profiles of cognitive control and timing in a sample of youths with ADHD, but 
these classes showed very similar profiles on reward sensitivity (Van Hulst et al., 
2015). Conversely, another study was able to distinguish four different cognitive 
profiles ranging from high to very poor performance across all Cool and Hot indicators 
(working memory, set-shifting and delay aversion) (Lambek et al., 2018). Cool EFs 
have been more consistently studied that Hot EFs, and different profiles were found 
for working memory impairments (High, Moderate and Average) (Fair et al., 2012; 
Gomez et al., 2014), Reaction Time variability, output speed, temporal information 
processing and arousal (Fair et al., 2012) within childhood ADHD. Finally, different 
profiles were also reported with qualitatively different impairments on attention, 
neuropsychological functions and level of motor activity in pre-schoolers with ADHD 
(Rajendran et al., 2015). None of these studies using a person-centred approach has 
considered possible predictors of these different cognitive profiles. Only associations 
with clinical and functional outcomes were investigated with mixed findings on the 
prognostic and clinical relevance of the cognitive profiles identified (Fair et al., 2012; 
Gomez et al., 2014; Lambek et al., 2018; Rajendran et al., 2015; Rommelse et al., 
2016; Van Hulst et al., 2015). It is important to note that the majority of evidence 
coming from these previous studies has been obtained applying a Latent Profile 
Analysis (LPA), a widely used technique in a person-centred approach. LPA identifies 
latent classes composed of individuals with similar profiles across a range of 
continuous class indicators (e.g. neuropsychological measures). This technique 
provides information about the most likely class membership for each individual 
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(Nylund & Muthén, 2007), a parameter used to group those with similar profiles 
together based on their observed pattern of responses, ultimately being able to 
minimize differences within each class and maximize differences across classes 
(Nylund & Muthén, 2007). LPA also assumes conditional independence whereby 
within a latent class, all the class indicators are considered to be independent to one 
another and any observed correlation between these indicators are considered to be 
entirely due to the latent class (Nylund & Muthén, 2007). 
 
To summarise, looking at individual cognitive tasks in youths with ADHD is associated 
with small to medium effect sizes and a person-centred approach might be beneficial 
to address the same research questions compared to a variable-centred one, but this 
approach is under-researched in ADHD, especially in the domain of Hot EFs. As 
previous non-significant findings might have been limited by a series of 
methodological caveats, mostly obtained using a variable-centred approach, a further 
investigation using the complementary person-centred approach might be particularly 
beneficial for an accurate interpretation. Therefore, the aim of this current analysis 
was to use Latent Profile Analysis to identify homogeneous Hot cognitive profiles in 
this current sample of adolescents with ADHD and to see if they were predicted by 
childhood chronic and severe irritability. This analysis focused on Hot EFs only, as 
the theoretical rationale links impairments in motivational and reward processing (Hot 
EFs) to chronic and severe irritability specifically. Therefore, distinct profiles in Cool 
EFs are not of interest and were previously used just as control measures (refer to 
section 4.1 for further details). As this is the first study to include a broad range of Hot 
EF tasks, no hypothesis was made in terms of LPA number of profiles; whereas, 
childhood chronic and severe irritability was expected to predict at least one of the 
poor Hot cognitive profiles possibly identified. 
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4.8.2 Methods 
 
Sample 
The original sample was composed of 219 adolescents with ADHD, aged 10-18 years 
(mean age 14.04, s.d. 1.90) whose details are provided in the previous analyses (see 
Chapter 4, section 4.2.1). One subject was found to have missing data on all Hot 
cognitive variables taken into account and it was therefore excluded, leaving a total 
sample size of 218 participants for this exploratory LPA analysis. 
 
Measures 
Childhood chronic and severe irritability measure was derived by extracting relevant 
items from the Oppositional Defiant Disorder and Depression sections of the CAPA 
as previously described (see Chapter 4, section 4.2.2). 
 
The Hot cognitive tasks and variables used are: total card played from the CPT; RT 
differences between delayed and immediate reward choice and the AUC from the 
TDT; behavioural outcome after large/small loss/win from the CxR; and percentage 
of moderately unfair offers accepted from the UG (see Chapter 2 for a full description 
of these tasks). These measures were consistent with the ones considered in the 
previous study of this chapter, with the exception of the CxR task whereby overall 
propensity to gamble and risky decision-making across six different trials were 
excluded. The outcome after a large/small loss/win was in fact the main variable of 
interest; looking at single trials individually in an LPA is also not as informative as 
looking at the overall trend in a mixed ANOVA as done previously. These are the 
reasons that led to the exclusion of CxR overall propensity to gamble and risky 
decision-making across trial types. 
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4.8.3 Statistical Analysis 
All statistical analyses on Hot EF tasks (CPT, TDT, CxR, UG) were performed using 
Mplus software, version 8.21 (Muthén & Muthén, 2018). It should be considered that 
the LPA does not provide an accurate index of absolute fit of the model, although it 
provides indexes of relative fit comparing models with different classes to one another 
that guide the decision on the best class model (Nylund & Muthén, 2007). These 
relative fit indexes can be grouped into both Information Criteria (IC) and likelihood-
based indexes and among these, the most reliable ones are the Bayesian Information 
Criterion (BIC) and Akaike’s Information Criterion (AIC), for the IC, and the Lo-
Mendell-Rubin (LMR) and the Bootstrapped Likelihood Ratio Test (BLRT), for the 
likelihood-based criteria (Nylund & Muthén, 2007). Lower values of both BIC and AIC 
indicate a better fit when comparing competing models; whereas LMR and BLRT 
provide a p-value that indicates if the fit of the model with the higher number of classes 
is significantly better than the neighbouring model (Nylund & Muthén, 2007). Model 
parameters were obtained using the Maximum Likelihood (ML) estimator and high 
starting values were chosen to ensure the validity of each latent profile solution 
(Geiser, 2013). Model entropy was also estimated as a measure of classification 
accuracy; entropy values range between 0 and 1, with values closer to 1 indicating a 
neater class distinction (Asparouhov & Muthén, 2018). LPA model estimations are 
less prone to bias with large values of entropy, suggesting that the classes identified 
are adequately different to one another with negligible or no classification error 
(Asparouhov & Muthén, 2018). An entropy value of at least .60 is shown to identify 
sufficiently separate profiles (Asparouhov & Muthén, 2014). Univariate entropy was 
also estimated as a measure of the contribution of single indicators in discriminating 
the classes; the greater the univariate entropy (ranging from 0 to 1), the more 
informative an individual indicator in identifying different profiles (Asparouhov & 
Muthén, 2018). Although not relevant to the decision regarding the best LPA model, 
the proportion of individuals per class and classification accuracy, which is the 
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average latent class probabilities for most likely latent class membership, were 
reported as they provide a useful descriptive summary of the model profiles. Once the 
best LPA model was chosen, childhood chronic and severe irritability was added as 
profile predictor using the R3STEP procedure, which is an automatic approach to 
estimate the predictive power of this phenotype without changing the latent profile 
formation (Asparouhov & Muthén, 2018; Vermunt, 2010). 
 
4.8.4 Results 
As shown in Table 4.6, both LMR and BLRT suggested that the fit of the 2-class model 
was significantly better than considering the cognitive performance of this current 
sample as cognitively homogeneous. This model was also preferable than a 3-class 
model as indicated by all relative fit indexes considered, with the exception of AIC, 
which is known to be less accurate than both BIC and BLRT (Nylund & Muthén, 2007) 
(Table 4.6). Furthermore, both the overall entropy and the accuracy of participants’ 
classification into different profiles were worse for the 3-class model than for the 
competing 2-class model. The 2-class model was therefore the best solution to fit this 
data, suggesting that adolescents with ADHD showed two distinct Hot cognitive 
profiles. 
 
RELATIVE MODEL FIT INDEXES 2-CLASS MODEL 3-CLASS MODEL 
AIC 4010.775 4008.606 
BIC 4095.387 4123.678 
LMR P-VALUE .000 .714 
BLRT P-VALUE .000 .707 
ENTROPY .78 .74 
% OF PARTICIPANT PER CLASS .50/.50 .43/.42/.15 
CLASS ACCURACY .94/.92 .92/.91/.68 
 
Table 4.6 Two and three-class model fit statistics for LPA on Hot executive functioning 
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AIC = Akaike’s Information Criterion, BIC = Bayesian Information Criterion, LMR = Lo-Mendell-Rubin,  
BLRT = Bootstrapped Likelihood Ratio Test. 
 
Considering the univariate entropy, there was only one measure that had a moderate 
univariate entropy which was CPT total number of cards played (.768); whereas this 
parameter was negligible for all of the remaining individual Hot indicators, ranging 
from less than  .001 to .053. This suggests that only CPT had a consistent contribution 
in defining the 2-class model, whereas the remaining indicators did not have any 
influence in differentiating the two Hot cognitive profiles. This was further confirmed 
by looking at the class characteristics reported in Table 4.7, where mean values were 
very similar across the majority of Hot tasks with the exception of CPT. Participants 
in class 1 were in fact characterised by a smaller number of cards played (i.e., better 
performance) on CPT than those in class 2, suggesting that the Hot cognitive profile 
of those in class 1 was characterised by a greater sensitivity to reward and 
punishment than those in class 2. 
 
 INDICATOR MEANS (S.D.) 
 Profile 1 Profile 2 
CPT CARDS 31.1 (14.73) 88.14 (16.43) 
TDT LN  -.53 (153.71) 20.57 (148.90) 
TDT AUC .62 (.21) .62 (.20) 
CXR LL .55 (.22) .58 (.21) 
CXR SL .54 (.25) .56 (.25) 
CXR LW  49 (.16) .49 (.14). 
CXR SW .52 (.18) .53 (.16) 
UG MU .39 (.34) .64 (.28) 
 
Table 4.7 Descriptive statistics for the two profiles identified by the LPA. 
CPT = Card Playing Task; TDT = Temporal Discounting Task; CxR = Choice per Risk task; UG = 
Ultimatum Game; Cards = total number of cards played; LN = RT differences between late and 
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immediate reward choice; AUC = Area Under the Curve; LL = large loss; SL = small loss; LW = large 
win; SW = small win; MU = Moderately Unfair offers accepted.  
 
Finally, childhood chronic and severe irritability was a significant predictor of neither 
of the two cognitive profiles identified, as revealed by the R3STEP approach (p= 
.334). This suggests that chronic and severe irritability in childhood did not predict 
adolescents’ likelihood of displaying greater or lower sensitivity to reward and 
punishment, as represented by the two cognitive profiles emerged. 
 
4.8.5 Discussion 
Overall results of the Latent Profile Analysis suggest that the cognitive performance 
on Hot executive tasks of adolescents with ADHD can be split into two distinct 
cognitive profiles. However, this distinction seems to be driven only by differences in 
reward and punishment sensitivity as measured by the CPT. Class 1 shows in fact a 
better performance on this task only, compared to class 2; the negligible contributions 
of all other indictors suggests a lack of cross-task variability that ultimately question 
the usefulness of these two profiles. Finally, contrary to the initial hypothesis, 
childhood chronic and severe irritability does not seem to be a predictor of the poorer 
Hot cognitive profile (class 2) and it significantly predicts neither of these Hot cognitive 
profiles. 
 
Comparing these findings to the previous literature, they are in contrast with those 
obtained by Van Hulst and colleagues (2015), who failed to identify ADHD subgroups 
with different reward and punishment sensitivity profiles. However, it should be 
considered that this current study differs from Van Hulst’s (2015) in terms of tasks 
used, number of classes identified, and LPA information considered. Reward and 
punishment sensitivity was measured in their previous research using a modified 
version of the Monetary Incentive Delay (Van Hulst et al., 2015), originally designed 
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as a measure of reward anticipation rather than sensitivity (Knutson, Adams, Fong, & 
Hommer, 2001). During this task, participants just need to guess where a sum of 
money would be by choosing between two stimuli, followed by a rigged outcome 
unrelated to their responses, and the variable of interest was the RT differences in 
rewarded and non-rewarded condition (Van Hulst et al., 2015). The CPT task used in 
this current study engages participants more actively by asking them to decide when 
to stop which reflect a great interest in the behavioural expression of reward and 
punishment sensitivity (i.e., total number of cards played) rather than in a more non-
specific measure; RT is in fact a low-order cognitive process, underlying multiple 
cognitive activities. It should also be noted that in Van Hulst and colleagues’ study 
(2015), two profiles out of the 5-class best fit model identified were excluded due to 
their small sample size, and this arbitrary model reduction could have reduced their 
possibility of identifying different profiles based on reward and punishment sensitivity. 
Finally, in this current analysis, univariate entropy was also considered as an objective 
measure to look at the indicator’s contribution to the profile identification, whereas van 
Hulst and colleagues (2015) did not use similar objective parameters to support the 
negligible role of reward and punishment sensitivity. 
The current findings are also in contrast with a previous study by Lambek and 
colleagues (2018) who found significant profile differences for delay aversion. 
However, it should be considered that delay aversion was a factor score obtained 
combining multiple tasks, whereas in this current study just one individual task tapping 
temporal discounting (i.e. TDT) was used. Furthermore, albeit similar, the concepts of 
delay aversion and temporal discounting are different. Delay aversion refers to the 
motivational effort to avoid delay (Lambek et al., 2018); whereas temporal discounting 
is the devaluation of a reward as a function of delay (Myerson et al., 2006). It should 
however be noted that this is the first study to use LPA on a broad range of Hot EF 
tasks, thus the conceptual and methodological differences when comparing results of 
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this study to previous literature limit the possibility of discussing these findings 
thoroughly. 
 
Additionally, considering that the Hot cognitive profiles identified were based only on 
participants’ score on CPT, it is not surprising that childhood chronic and severe 
irritability was not a significant predictor in this LPA analysis. Findings from the 
previous analysis in section 4.5.1 looking at individual tasks, already showed 
childhood chronic and severe irritability failing to predict adolescents’ performance on 
CPT.  
The lack of common variability in terms of Hot cognitive functioning is more surprising 
than this non-significant association, especially considering the great heterogeneity 
that characterises ADHD at a cognitive level (Nigg et al., 2005). However, as 
mentioned in the general introduction, it should be noted that only a small subset of 
youths with ADHD seem to be cognitively impaired showing a worse performance on 
cognitive tasks compared to controls (Nigg et al., 2005; Sjöwall et al., 2013; Sjöwall & 
Thorell, 2018). Additionally, among those who do show neuropsychological deficits; 
children with ADHD more commonly display impairment in Cool EFs (working 
memory, behavioural inhibition, set-shifting, RT variability) than they do on Hot EFs 
(delay aversion, emotional functioning) (Sjöwall et al., 2013; Sjöwall & Thorell, 2018); 
although it should be considered that Hot EFs are understudied compared to Cool 
EFs. It is therefore possible that this current sample was under-characterised in terms 
of Hot cognitively impaired youths with ADHD, without being able to fully understand 
its extent, as the Hot EF measures used mostly lack standardised norms and a control 
group was not available to define the criteria of impairment. Thus, the possibility of 
investigating the impact of childhood chronic and severe irritability on Hot cognitive 
functioning in this sample of adolescents with ADHD might have been greatly 
reduced. Another possible explanation for the under identification of common 
variance across Hot tasks, relates to Reaction Time variability characteristic of 
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cognitive performance of youths with ADHD (Castellanos et al., 2005). RT variability 
is considered as a moment-to-moment fluctuations in cognitive performance, 
measured within a time frame of multiples of seconds, that are shown to be larger and 
more frequent in individuals with ADHD, leading to greatly variable performance and 
randomness of behaviour (Castellanos et al., 2005). Therefore, it could be that the 
difficulty in extracting shared variance across tasks encountered in this current study 
could be due to the cognitive performance inconsistency at task level, which reflects 
great intra-individual RT variability of those with ADHD. This is also suggested by the 
large and overlapping standard deviations (e.g. TDT RT) observed in this ADHD 
sample as an indication of the overall variability at single time points. 
 
These findings need to be considered in light of several strengths and limitations. The 
great value of this study is that it is the first attempt to conduct an LPA on a broad 
range of Hot cognitive functions, and the first to investigate childhood chronic and 
severe irritability as a possible predictor of these profiles, in a large sample of 
adolescents with ADHD. Even though some of the methodological caveats discussed 
in relation to the analyses in section 4.7 were addressed by using a person-centred 
approach, some of the previous limitations still stand. These mainly refer to the post 
hoc nature of this data; lack of comparison and control groups; the measurement of 
chronic and severe irritability; the choice of EF tasks and measures, well-validated in 
ADHD but possibly inadequate to tap chronic and severe irritability; and finally the 
wide age range that even in this study might have reduced the possibility to detect 
common variance across Hot EF tasks and to investigate the predictive power of 
irritability defined as chronic and severe (refer to the 4.7 section of Chapter 4 for 
further explanation). 
 
In conclusion this is the first study conducting an exploratory LPA on a broad range 
of Hot EF tasks and looking at childhood chronic and severe irritability as a profile 
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predictor, in a clinical sample of adolescents with ADHD. The use of a person-centred 
approach to investigate the same research questions has led to similar conclusions; 
overall these results failed to show great cognitive variability and childhood chronic 
and severe irritability did not predict either of the profiles identified. Investigating 
different EFs, and social and neuropsychological processes might be more relevant 
leading to more promising results. However, considering the pioneering nature of 
these studies, findings are far from conclusive. Similarly, irritability is a cross-
diagnostic symptom, investigating its cognitive markers in both externalising and 
internalising conditions could give better insight about pathophysiological 
mechanisms of this phenotype across different samples. Addressing these aspects in 
future research could improve the theoretical models of ADHD and provide a better 
understanding of the clinical relevance of irritability across conditions, being ultimately 
useful in clinical practice. A person-centred approach could still be particularly 
beneficial in this field, ultimately leading to a better understanding of the architecture 
of complex neurodevelopmental disorders, to identify different aetiological pathways 
and treatment response which the limitations associated to variable-oriented methods 
might constitute a barrier to. 
 
Despite these non-significant results, chronic and severe irritability appears to be 
highly relevant for individuals with ADHD as supported by previous research (see 
Chapter 1, section 1.2.3) and backed up by Chapter 3 results, showing this phenotype 
to be associated with poor clinical outcomes, in this population. This supported the 
investigation of cognitive markers, and whilst at the cognitive-behavioural level results 
have been inconclusive, additional work assuming a different perspective, such as 
looking at biological underpinnings, might yield different results. This is addressed in 
the following chapter of this thesis that aimed to explore shared genetic risk between 
chronic and severe irritability and Hot cognitive functioning, possibly enhancing the 
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understanding of Hot EFs as pathophysiological markers of this clinically relevant 
phenotype.
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Chapter 5  
Irritability common genetic contributions  
to Hot cognitive functioning  
in a sample of adolescents with ADHD 
 
Chapter description  
This chapter addresses the third and final aim of this thesis which is to investigate the 
impact of common genetic risk associated with irritability on Hot, as opposed to Cool, 
cognitive functioning, in a sample of adolescents with ADHD. In this chapter, 
participants from the clinical ADHD sample, whose data was available at follow-up, 
and the United Kingdom (UK) Biobank sample were considered. Details about The 
UK Biobank sample are provided below.
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5.1 Introduction 
As previously discussed, chronic and severe irritability is defined as an intense and 
disproportionate anger reaction, compared to peers, when facing negative stimuli 
(Brotman, Kircanski, & Leibenluft, 2017; Brotman, Kircanski, Stringaris, et al., 2017). 
This phenotype is particularly relevant in Attention Deficit Hyperactivity Disorder being 
very prevalent (up to 92% of those with ADHD report irritable symptoms) (Eyre et al., 
2017) and being associated with worse clinical and functional outcomes than those 
with ADHD alone (Biederman, Petty, et al., 2012; Biederman, Spencer, et al., 2012; 
Shaw et al., 2014). The importance of severe irritability in ADHD is also supported 
from a genetic perspective, as demonstrated by Polygenic Risk Score (PRS) 
analysis/studies. PRS is a composite score of individual common genetic risk for a 
specific phenotype of interest, obtained by summing an individual’s set of risk alleles 
across the genome, weighted by their effect size (Wray et al., 2014). These risk alleles 
are detected by GWAS in the so called “discovery sample”; this is a sample used to 
identify risk alleles associated with the phenotype under investigation, at different 
PRS p-value thresholds (Wray et al., 2014). The presence of these risk alleles is then 
investigated in an independent (i.e., target) sample and they are combined to identify 
each individual’s genetic risk for that specific phenotype (Wray et al., 2014). PRS is 
then used to investigate the relationship between multiple PRSs for different 
phenotypes, or to determine individuals’ susceptibility to a trait or disease as a 
difference in PRS between cases and controls for a given phenotype, or as a 
proportion of variance explained for a continuous trait. Evidence shows an association 
between ADHD PRS and severe irritability, both in general population samples and 
in the clinical sample of individuals with ADHD used in this thesis and assessed at 
baseline (Riglin et al., 2017). Notably in this previous work, severe irritability was 
operationalised in a very similar way to that in this thesis. This reported association 
withstands ADHD and Conduct Disorder symptom correction, suggesting that the 
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effect of ADHD PRS on severe irritability is independent of core and comorbid 
symptoms and that similar biological underpinnings might link these two clinical 
phenotypes (Riglin et al., 2017). 
 
Greater attention has recently been given to cognitive impairments as potential 
pathophysiological mechanisms of severe irritability, in particular Hot executive 
functioning (e.g., reward processing, decision-making) as opposed to Cool executive 
functioning (e.g., set-shifting and behavioural inhibition) (Brotman, Kircanski, & 
Leibenluft, 2017; Brotman, Kircanski, Stringaris, et al., 2017; Leibenluft, 2017b) (this 
is described in details in Chapter 1, section 1.3.3 and Chapter 4 introduction). Both 
Cool and Hot Executive Functions appear to be consistently heritable as 
demonstrated by twin studies. In particular, genetic influences are observed for Cool 
EFs, namely working memory, cognitive flexibility, inhibition, and selective and 
sustained attention both cross sectionally (Ando, Ono, & Wright, 2001; Anokhin, 
Heath, & Myers, 2004; Anokhin, Heath, & Ralano, 2003; Friedman et al., 2008; Kuntsi 
et al., 2006; Lee et al., 2012; Singer, MacGregor, Cherkas, & Spector, 2006) and 
longitudinally (Anokhin, Golosheykin, Grant, & Heath, 2010; Polderman et al., 2007). 
The cognitive performance on these different set of Cool EF tasks seems also to be 
determined by a shared pool of genetic influences that is more heritable than 
individual genetic contributions to single tasks (Ando et al., 2001; Engelhardt, Briley, 
Mann, Harden, & Tucker-Drob, 2015; Friedman et al., 2008; Hagenaars et al., 2016; 
Lee et al., 2012). Candidate genes, mostly dopaminergic and serotonergic genes, 
have also been studied in association with Cool EFs, although overall there has been 
a failure to replicate significant results (Greene, Braet, Johnson, & Bellgrove, 2008). 
Conversely, genetic and environmental influences on Hot EFs have been less 
extensively studied, although a previous twin study found consistent genetic 
contributions to risky decision-making both within and across time (Tuvblad et al., 
2013). Similarly to Cool EFs, specific genetic candidates linked to the dopaminergic 
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system have been found to be associated with Hot cognitive processing (Frank, 
Moustafa, Haughey, Curran, & Hutchison, 2007; Yacubian & Büchel, 2009). In 
particular, the catechol-O-methyltransferase (COMT) enzyme, involved in synaptic 
dopamine degradation, seems to play a key role in reward processing and reward 
learning both at the behavioural and neural level in the general population (Boettiger 
et al., 2007; Foti & Hajcak, 2012; Frank et al., 2007; Yacubian & Büchel, 2009). 
Similarly, the genotype of the serotonin transporter gene was found to affect the 
behavioural and neural sensitivity to decision-making bias (Roiser et al., 2009). 
However, candidate genes are not ideal to study genetic contributions especially for 
complex phenotypes, as they are often chosen a priori, explain overall a very small 
proportion of genetic variance and findings are difficult to replicate (Duncan & Keller, 
2011; Franke, Neale, & Faraone, 2009; Kendler, 2013). Conversely, GWAS and PRS 
studies can provide more robust evidence on genetic influences for a specific 
phenotype without aprioristic assumptions, allowing researchers to look across a 
large number of genes (GWAS) and combining the small risk effects carried by 
individual genes (PRS). These improvements brought by GWAS and PRS methods 
are supported by previous work looking at common genetic risk of cognitive 
functioning using both a GWAS and PRS approaches. GWASs on Cool cognitive 
functioning were able to identify genes enriched in the brain and involved in 
mechanisms such as neuronal development, synaptic function and immune system, 
and neurological conditions, such as Alzheimer’s disease (Davies et al., 2016; 
Debette et al., 2015). Notably none of the genetic candidates previously associated 
with Cool EFs (i.e., memory performance) met the statistical significant threshold in 
GWAS analysis (Debette et al., 2015). Additionally, the heritability of the significant 
Single Nucleotide Polymorphisms identified in the GWAS explained up to 31% of 
genetic variance (Davies et al., 2016). Thus, the combined effect of common genes, 
informed by GWAS results and indexed by PRS, can be a more promising approach 
in investigating genetic influences on cognitive functioning. 
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Like cognitive functioning, preliminary evidence from twin studies suggests that 
severe irritability is also influenced in a consistent proportion (up to 89%, see Chapter 
1, section 1.1.5) by genetic risk factors (Coccaro et al., 1997; Roberson-Nay et al., 
2015; Stringaris, Zavos, et al., 2012). No study to date has however considered 
severe irritability PRS influences on EFs. Previous work has in fact looked at other 
PRSs to investigate cognitive functioning variability in the general population. These 
PRSs were linked to several clinical conditions, such as neuropsychiatric disorders 
(e.g., autism, depression, schizophrenia) and physical health disorders (e.g., Body 
Mass Index, coronary artery disease), finding overall a small proportion of cognitive 
variance explained by these common genetic risks (Bearden & Glahn, 2017; 
Hagenaars et al., 2016). Additionally, no study to date has looked at the contributions 
of severe irritability PRS to cognitive variation in a sample of individuals with ADHD; 
this is particularly relevant considering the overlap of Hot cognitive impairments 
across these two phenotypes, and their co-occurrence (see Chapter 4 for more 
details). The common genetic risk most frequently investigated as a potential source 
of variation in cognitive functioning in those with ADHD is ADHD PRS. For instance, 
a previous study by Martin, Hamshere and colleagues (2015) found that PRS for 
ADHD in a general population sample was significantly associated with performance 
on working memory but not inhibitory control or emotion recognition tasks. A more 
recent community sample study by Nigg and colleagues (2018) confirmed that PRS 
for ADHD does not seem to be linked to behavioural inhibition, although it is 
consistently associated with working memory and vigilance that partially mediate the 
association between genetic liability for ADHD and ADHD diagnosis. However, ADHD 
PRS in relation to cognitive variability was found to explain less than 1% of cognitive 
variation (Martin, Hamshere, Stergiakouli, O’Donovan, & Thapar, 2015). Taken 
together, these findings show that the PRSs considered so far are able to explain only 
a small proportion of cognitive variability, suggesting that there might be other PRS, 
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such as genetic liability for chronic and severe irritability, that could account for a 
larger proportion of cognitive variation, especially in those with ADHD. 
 
To conclude, chronic and severe irritability is common in ADHD and impairing, 
possibly due to its negative impact on cognitive functioning. Both Hot and Cool 
cognitive functions show genetic influences and irritability PRS could explain part of 
cognitive performance differences between individuals. No study to date has however 
looked at PRS associated with irritability, especially in relation to Hot cognitive 
functioning, in ADHD and this is particularly relevant, considering the frequent co-
occurrence of irritability and the Hot cognitive deficits shared by these two 
phenotypes. This study therefore is the first one aiming to see in a sample of 
adolescents with ADHD 1) if irritability PRS was linked to baseline chronic and severe 
irritability measured in childhood; 2) if irritability PRS affected adolescents’ cognitive 
performance on a wide range of Cool and Hot EF tasks. The hypothesis was that 
irritability PRS would be associated with childhood chronic and severe irritability and 
with a poorer cognitive performance on Hot EF tasks only. PRS was computed in this 
current sample of adolescents with ADHD (target sample) using unpublished, but 
publicly available, irritability GWAS data from the UK Biobank sample (discovery 
sample) which has not previously been explored. No published GWAS data could be 
used to compute PRS as no one has specifically tapped severe irritability; previous 
studies looked at phenotypes that are only marginally related to irritability (e.g., 
Emotional Lability/Dysregulation) (Greenwood et al., 2012, 2013; Powers et al., 2016; 
Tielbeek et al., 2017; Ward et al., 2019) (see Chapter 1, section 1.1.1 for more 
information). Despite the lack of cognitive differences found at the behavioural level 
in the previous study of this thesis (see Chapter 4), the current research question is 
nonetheless important. Whilst in the previous study, the focus was on phenotypic 
associations between chronic and severe irritability and cognitive functioning, this 
study aimed to understand the underlying genetic liability of this phenotype. More 
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precisely, the aim was to link irritability common genetic risk to irritable symptom 
severity and to Hot cognitive functioning in ADHD, informing of underlying biological 
processes that can be used to develop clinical interventions. Because of this focus 
switch from behaviour to genetics, this study might still yield significant results, despite 
the non-significant behavioural findings of the previous chapter. 
 
5.2 Methods 
 
5.2.1 Samples 
Discovery sample – UK Biobank sample 
The discovery sample for this analysis was the UK Biobank, an independent 
longitudinal sample and the largest one available for irritability. It is composed of over 
500,000 individuals from the general population, recruited between 2006 and 2010 all 
across Great Britain and who are still being followed up (Sudlow et al., 2015). Those 
who took part in the study had to sign an informed consent and ethical approval for 
this large longitudinal study was obtained by the National Health Service (NHS) 
National Research Ethics service (Ref 16/NW/0274). This population-based cohort 
was composed of participants aged 40 to 69 who underwent a comprehensive and 
multimodal (questionnaires, physical and functional measurement) clinical, cognitive, 
sociodemographic and genetic assessment to understand physical and psychiatric 
health-related outcomes (Sudlow et al., 2015). Notably, the UK Biobank grants open 
access to health data collected. For the present study, 345,231 individuals of both 
sexes were considered in the discovery sample (46.3% were males and 53.7% were 
females) as they all had genome-wide genotyped irritability data available. Notably, 
no additional exclusion criteria were applied. 
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Target sample – ADHD sample 
The target sample was the clinical ADHD sample at follow-up, previously used in this 
thesis, composed of 204 adolescents with an ADHD clinical diagnosis and with 
complete and available data on chronic and severe irritability, cognitive measures, 
and genetic information (see Chapter 4 for further details). Participants had a mean 
age of 14.02 (s.d. 1.87) and 94.1% of them were males. 
 
5.2.2 Measures  
Discovery sample – UK Biobank sample 
Clinical measure. In the UK Biobank sample, the measure of irritability was composed 
of a single self-reported item “are you an irritable person?”, to which 28.1% of 
participants answered “yes” and 71.9% “no”. 
 
Target sample – ADHD sample 
Clinical measures. ADHD research diagnosis was made at baseline and at follow-up 
using the parent-rated version of the CAPA (Angold & Costello, 2000) and the 
DAWBA (Goodman et al., 2000) respectively (see Chapter 2, section 2.2 for more 
details). At baseline, 93.6% of participants met a DSM-IV/5 ADHD research diagnosis 
(American Psychiatric Association, 2013). At follow-up, 81.8% continued to meet a 
DMS-IV/5 ADHD diagnosis, whereas 18.2% no longer met diagnostic criteria. 
A composite score of childhood chronic and severe irritability was computed summing 
responses across 5 items (“Losing Temper”, “Temper Tantrums”, “Touchy or Easily 
Annoyed”, “Angry or Resentful” and “Irritability”) taken from the Depression and the 
Oppositional Defiant Disorder sections of the parent rated CAPA (Angold & Costello, 
2000). The total score ranged from 0 to 4 as no one endorsed irritable mood. Cut-offs 
based on frequency, pervasiveness and duration are applied to definite irritability in 
its severity and chronicity, as done previously (Eyre et al., 2017) (more details are 
provided in Chapter 2, section 2.2.1). 
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Cognitive measures. Cool and Hot EF measures and variables are described in detail 
in Chapter 2. Briefly, two tasks were used to tap Cool EFs: the Wisconsin Card Sorting 
Test and the Go no Go as measures of set-shifting and behavioural inhibition, 
respectively. The variables considered were WCST total errors, WCST perseverative 
errors, GnG RT to go signals and GnG probability of inhibition. In terms of Hot EFs, 
Card Playing Task and Choice per Risk tasks were used to measure sensitivity to and 
risk-taking following different degrees of reward and punishment. Temporal 
Discounting Task and the Ultimatum Game were also used to tap reward devaluation 
and emotion regulation. The Hot EF variables considered were: CPT total card played, 
CxR behavioural outcomes after winning or losing big or small amounts of money, 
TDT RT difference between delayed and immediate reward, TDT AUC, and UG 
percentage of moderately unfair offers accepted. 
 
Sociodemographic measures. Demographic information related to age and IQ at 
follow-up, sex, and Social Economic Status were also collected (see Chapter 2 for 
further details). 
 
5.3 Genotyping and Quality Control of Genetic Data 
 
2.3.3 Discovery sample – UK Biobank sample 
Participants at the UK Biobank were asked to provide a blood sample to be 
genotyped. Genotyping was carried out by Affymetrix Research Services Laboratory 
(High Wycombe, UK) and two extremely similar arrays (the Affymetrix UK BiLEAVE 
Axiom array and Affymetrix UK Biobank Axiom® array) were both used to genotype 
participants (Bycroft et al., 2018). Quality Control for this discovery sample was 
conducted by Affymetrix and the Wellcome Trust Centre for Human Genetics. QC 
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entails the exclusion of participants based on different parameters such as 
missingness, relatedness, sex mismatch, non-British ancestry, population structure 
and many others (Bycroft et al., 2018; The UK Biobank, 2015). A GWAS looking at 
the association between common genetic variants and irritability in the UK Biobank 
was conducted by the Neale Lab research group, who produced the related GWAS 
summary statistics (e.g., genetic variants, p-value and effect size of their association 
with irritability) and made it publicly available on their website (Neale lab, 2018). I 
downloaded this summary statistics data that resulted in 13,791,467 SNP variants 
retained as being associated with irritability and I then performed additional QC 
checks on it. In particular, I applied the following SNP exclusion parameters: SNPs 
with a Minor Allele Frequency (MAF) under 5%; SNPs with imputation quality 
probability (INFO) less than 80%; multi-allelic, duplicate or ambiguous (where it is not 
clear what base is associated with the minor or major allele) SNPs, sex chromosome 
variants, and those with a low confidence interval. This extra and rigorous quality 
check ensured the retainment of good quality genetic data that resulted in 5,933,889 
SNP variants retained. These SNPs were used to compute PRS in the target sample. 
 
2.3.4 Target sample – ADHD sample 
As noted in Chapter 2, either a peripheral blood or saliva sample was collected from 
all SAGE study participants and their parents at baseline for the purpose of genetic 
analysis. This clinical ADHD sample was then genotyped in batches using two 
different arrays (Illumina Human660W-Quad BeadChip and a customised version of 
the PsychChip), and rigorous imputation and QC procedures were performed within 
each batch by Dr Leon Hubbard and Dr Joanna Martin. This was done prior to this 
analysis and as part of a separate ongoing project combining different clinical samples 
of individuals with ADHD and their families (n= 1,988; 919 children with ADHD, 671 
mothers, and 398 fathers), including the clinical ADHD sample used in this thesis, with 
both baseline and follow-up data, (n= 204). Briefly, SNPs were aligned to the 
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Haplotype Reference Consortium data using GenomeHarmoniser, SNPs were 
removed if they had MAF under 1%, genotyping rate less than 95%, or Hardy-
Weinberg Equilibrium (HWE) p< 1×10-6, and individuals were removed if they had 
missingness greater than 5%, sex discrepancy, or were duplicate samples. Then the 
samples were imputed using the Michigan Imputation Server (using Eagle v2.4 for 
phasing, Minimac4 for imputation, and the HRC V1.1 imputation reference panel). 
After imputation, dosage data were converted to best guess genotype data using 
Plink2. Additionally, post-imputation data and individual QC filters were applied as 
follows. SNPs with a MAF less than 1%, INFO less than 80%, ambiguous (Cytosine-
Thymine/Adenine-Guanine) variants, SNPs with inconsistent alleles (i.e., duplicate 
position or multiallelic SNPs) and deviating from HWE at p< 1×10-5 were removed. In 
terms of individual QC, individuals with a genotype probability less than 90% and 
disproportionate level of missingness (i.e., greater than 3%) were also removed. 
Additionally, family relationships were confirmed using the Identity By Descent (IBD) 
index and Mendel analyses in PLINK. SNPs over five Mendel errors (suggesting close 
genetic relatedness) and samples that did not index the expected family structure 
were excluded. The PCAiR method was employed to perform Principal Component 
(PC) Analysis, whilst accounting for the kinship information in the sample (Conomos, 
Miller, & Thornton, 2015); based on this analysis, those with a non-European ancestry 
were excluded. PCAiR was also run on the final set of markers to derive PCs to use 
as covariates. A GWAS of batch was run on unrelated samples. SNPs associated 
with batch (p< .01) were excluded from all batches. A total of 3,335,041 SNPs in this 
comprehensive sample of individuals with ADHD, analysed prior to this current study, 
passed the QC and filter procedures. I supported the production of this data by double 
checking the demographic information on participants’ ethnic background to retain 
only those with a British ancestry to avoid artefacts. 
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5.4 Polygenic Risk Score Calculation 
PRS was also calculated in the comprehensive target sample of individuals with 
ADHD (n= 1,988) which includes the clinical sample used in this thesis and recruited 
at follow-up. This was undertaken by Dr Joanna Martin using the UK Biobank GWAS 
summary statistics as the discovery sample using PLINK software (Purcell et al., 
2007). The discovery sample (described in section 5.2.1) provided SNPs whose risk 
alleles were significantly associated with irritability and only SNPs in common 
between discovery and target samples were retained. Relatively common (i.e., MAF 
greater than 5%) SNPs were clumped considering alleles that were in relative linkage 
equilibrium, thus with an R2 threshold of .2, within a distance threshold of 500 
kilobases. These thresholds ensured the identification of relatively independent set of 
SNPs, while retaining the most significant SNP in each LD (Linkage Disequilibrium) 
block and led to a total of 14,259 SNPs retained (at a PRS threshold of p< .05). 
Additionally, PRS was computed using several p-value thresholds (p< .00001, p< 
.001, p< .01, p< .05, p< .1, p< .5, p< 1) used to select the most associated SNPs 
(Martin, Hamshere, et al., 2015; Riglin et al., 2019; Wray et al., 2014). Finally, PRS 
was calculated for each individual in the target sample, summing their risk alleles for 
each SNPs weighted by the SNP effect size (i.e., log of the odds ratios) in the GWAS 
discovery sample. I then took the PRSs generated previously in this broad target 
sample and extracted the information that was relevant for my smaller sample of 204 
adolescents with ADHD. In particular, I matched each participant’s ID with the 
respective genetic, cognitive, demographic and clinical data and excluded related 
individuals (i.e., siblings) to ensure the production of robust results. I further used the 
information produced by the PRS calculation in this broad ADHD target sample to 
inform my methodological choices (e.g., the PRS main threshold) and I then 
conducted all the data analysis process and result interpretation as follows. 
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5.5 Data analysis 
As this is the first study on common genetic risk of irritability, previous empirical 
evidence informing on the PRS p-value threshold to best capture phenotypic variance 
was not available. A PRS threshold of p< .05 was chosen to define risk alleles for 
primary analyses as opposed to other p-values (p< .00001, p< .001, p< .01, p< .1, p< 
.5, p< 1). This threshold is in line with previous work using PRS linked to different 
phenotypes (e.g., Riglin et al., 2019). It is also a PRS threshold that is not too 
conservative nor too lenient in terms of number of risk alleles included, as observed 
in PRS data extracted from the broader sample of individuals with ADHD (n= 1,988) 
(see Appendix 5.1 for the number of SNPs at each PRS p-value threshold). Notably, 
PRS were standardized using Z-score transformation, by subtracting the sample 
mean from each score and then dividing by the standard deviation. Multiple linear 
regressions were then performed to test the association between irritability PRS with 
chronic and severe irritability as operationalised in the target sample, and irritability 
PRS with Hot and Cool EF measures. These multiple regressions were undertaken 
whilst controlling for the effect of covariates, in particular batch effects and the first 
five PCs. Correlations were conducted looking at associations between irritability PRS 
and clinical symptoms (e.g., ADHD and CD symptoms at follow-up) to see whether 
these phenotypes also needed to be controlled for (see Chapter 2 for information on 
how ADHD and CD scores were obtained). Demographic factors were not considered 
as covariates to avoid overcorrecting, thus reducing the power to detect an effect, 
based on the lack of associations between severe irritability and demographic 
characteristics observed in the previous chapter (see Chapter 4, section 4.5). IQ was 
also excluded for the same reasons explained in Chapter 4 (see section 4.4). All the 
variables were normally distributed. Notably, the first five PCs were used as 
covariates as these captured the majority of ancestry-related variance (see Appendix 
5.2), although sensitivity analyses were performed controlling for all ten PCs. 
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Sensitivity analyses were also conducted considering the remaining PRS p-value 
thresholds (i.e., p< .00001, p< .001, p< .01, p< .1, p< .5, p< 1) to ensure robustness 
of results. Consistent with the sensitivity results obtained in the previous chapter (see 
Chapter 4), analyses were not re-run excluding those who did not suspend their 
medication 24h prior cognitive assessment. Bonferroni correction was applied to 
correct for multiple testing in relation to cognitive functioning (p< .004, number of tests: 
12). 
 
5.6 Results 
Demographic characteristics of this sample are reported in Table 5.1. Of note, based 
on the correlation results, ADHD and CD symptoms at follow-up were not included as 
covariates in multiple regressions due to the lack of association with irritability PRS 
(r= .5, p= .49; r= .01, p= .93, respectively). 
 MEAN (S.D.) N (%) 
AGE 14.02 (1.87)  
IQ 87.70 (12.6)  
SES (LOW)  83 (46.4%) 
SEX (MALES)  192 (94.1%) 
CHRONIC AND SEVERE IRRITABILITY 
SYMPTOMS AT BASELINE 
1.14 (1.09)  
ADHD SYMPTOMS AT FOLLOW-UP 12.69 (4.46)  
CD SYMPTOMS AT FOLLOW-UP 2.61 (2.66)  
 
Table 5.1 Descriptive statistics of the target sample 
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5.6.1 PRS association with chronic and severe irritability symptoms 
Multiple regression results showed that irritability PRS was significantly associated 
with a greater chronic and severe irritability symptom severity (B= .164, 95%CI= 
.013/.315, p= .033). This common genetic risk explained 2.3% of phenotypic variance.   
 
5.6.2 PRS association with cognitive functioning 
As shown in Table 5.2, irritability PRS did not seem to be associated with any of the 
cognitive measures considered, except for CxR gambling after small loss. In 
particular, irritability PRS was related to an increased risk-taking after losing a small 
amount of money and was able to explain 3.5% of CxR gamble after small loss 
variance (R2= .035). However, this association failed to reach statistical significance 
once corrected for multiple comparisons (Bonferroni p-value < .004). 
 
 N 
UNSTANDARDIZED BETA 
(95% CI) 
COOL EFS 
WCST TOTAL ERRORS N= 162 B= .73 (-.43, 1.89) 
WCST PERSEVERATIVE ERRORS N= 162 B= .13 (-.51, .76) 
GNG RT TO GO SIGNALS N= 173 B= .51 (-6.54, 7.56) 
GNG PROBABILITY OF 
INHIBITION 
N= 173 B= -.78 (-3.85, 2.28) 
HOT EFS 
CPT TOTAL NUMBER OF CARDS N= 194 B= -1.09 (-5.84, 3.66) 
TDT RT DIFFERENCE DELAYED - 
IMMEDIATE CHOICE 
N= 165 B= -1.53 (-25.07, 22.00) 
TDT AUC N= 165 B= -.004 (-.04, .03) 
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UG MODERATELY UNFAIR 
OFFERS ACCEPTED 
N= 108 B= -.02 (-.08, .05) 
CXR GAMBLING AFTER LARGE 
LOSS 
N= 143 B= .02 (-.02, .05) 
CXR GAMBLING AFTER SMALL 
LOSS 
N= 143 B= .05 (.01, .09)* 
CXR GAMBLING AFTER LARGE 
WIN 
N= 143 B= -.001 (-.03, .02) 
CXR GAMBLING AFTER SMALL 
WIN 
N= 143 B= -.003 (-.03, .03) 
Table 5.2 Associations between irritability PRS and Hot and Cool cognitive functioning. 
Adjusted models were corrected for the first five PC and batch effects. 
* Significant at < .05 
 
5.6.3 Sensitivity analysis results 
Sensitivity analysis controlling for all ten PCs demonstrated that the results obtained 
were robust (see Appendix 5.3). Similarly, sensitivity analysis using different PRS p-
value thresholds yielded the same results when looking at cognitive functioning (see 
Appendix 5.4), whereas inconsistent findings were obtained for chronic and severe 
irritability symptom severity (Figure 5.1). As shown in Figure 5.1, a significant 
association between irritability PRS and the phenotype of irritability was found  using 
a PRS threshold less than .1 (p= .021), whereas there was a trend towards 
significance for p< .00001, p< .5, and p< 1 PRS thresholds (p= .058, p= .054 and p= 
.072, respectively). Finally using the remaining PRS p-value thresholds did not yield 
significant results. 
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Figure 5.1 Sensitivity analysis of the association between irritability PRS and chronic and severe 
irritability using different PRS p-value thresholds. 
Beta reported refers to Adjusted model, thus including the first five PC and batch effects as covariates. 
Blue bar = main threshold chosen 
* = p significant at < .05; + = trend towards significance 
 
5.7 Discussion 
This is the first study exploring the link between PRS for irritability, the construct of 
chronic and severe irritability, and cognitive functioning in a sample of adolescents 
with ADHD. Taken together these findings provide partial support for the initial 
hypotheses. More specifically, the first hypothesis seems to be supported as irritability 
PRS is shown to be associated with greater chronic and severe irritability symptom 
severity, independent of the effect of covariates. However, irritability PRS does not 
seem to be associated either with Cool or Hot EFs considered, failing to support the 
second hypothesis of this study. 
 
Previous twin studies have shown that the heritability of severe irritability is between 
31% to 89%, depending on age and sex (Coccaro et al., 1997; Roberson-Nay et al., 
2015; Stringaris, Zavos, et al., 2012) (see Chapter 1, section 1.1.5). This current study 
provides for the first-time insight on the genetic architecture of irritability, showing that 
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common genetic variants account for 2.3% of the variability of this phenotype. 
However, this result needs to be considered with caution, considering that sensitivity 
analysis using different PRS p-value thresholds only show partial support. The role of 
common genetic variants for the phenotype of chronic and severe irritability also 
suggests the importance of additive effects, considered by the PRS analysis, although 
as expected, they fail to account for the entirety of the earlier heritability estimate 
found by twin studies. The problem of this missing heritability is not new in genetic 
studies and there might be different explanations for it (Manolio et al., 2009). Firstly, 
it is possible that additional variants related to the irritability risk still need to be 
discovered. More precisely, there might be rare genetic variants (present in less than 
5% of the population) with bigger effect sizes, or more common genetic variants with 
very small effects sizes that GWAS does not have enough power to detect and link to 
the phenotype under consideration (Maher, 2008; Manolio et al., 2009; Plomin, 2013; 
Zuk, Hechter, Sunyaev, & Lander, 2012). Secondly, Copy Number Variants, rare 
mutations in the DNA structure, such as duplication or deletion of DNA strands, might 
also help explaining the missing heritability (Maher, 2008; Manolio et al., 2009). 
Thirdly, GWAS does not consider gene-gene interactions (i.e., epistasis) according to 
which the effects of combined genes is able to account for a bigger proportion of 
genetic variance than each gene alone (Maher, 2008; Manolio et al., 2009). Finally, 
the accuracy of current heritability estimates should also be considered. Previous 
work has found that the current heritability estimates might be overinflated mostly due 
to the assumption that genetic variants have an additional effect, disregarding 
interaction effects (Zuk et al., 2012). If the heritability is smaller, this means that the 
proportion of genetic variance explained by common genetic risk could be larger than 
the one currently detected by genetic studies (Zuk et al., 2012). Thus, despite the 
small proportion of variance explained, these pioneering findings might be beneficial 
to the missing heritability issue, being a starting point for the investigation of additional 
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common and rare variants, interactions effects, and underlying biological mechanisms 
of this clinically relevant phenotype.  
 
Additionally, common genetic variants associated with irritability do not account for 
the cognitive performance variability in those with ADHD, failing to add up to the 
heritability explained by other phenotypes’ PRS found in previous studies (Ando et 
al., 2001; Anokhin et al., 2004, 2003; Friedman et al., 2008; Kuntsi et al., 2006; Lee 
et al., 2012; Singer et al., 2006; Tuvblad et al., 2013). Although non-significant 
associations were expected for Cool EFs, the lack of significant findings for Hot EFs 
was surprising. This might suggest that irritability common genetic risk does not have 
a pleiotropic effect broadly involving cognitive functioning, but rather it might impact 
more specifically a different neurocognitive mechanism underpinning chronic and 
severe irritability. As mentioned in the general introduction (see Chapter 1, section 
1.3.3), frustration and the related Frustrative Non-Reward paradigm are key 
components of chronic and severe irritability (Brotman, Kircanski, & Leibenluft, 2017; 
Brotman, Kircanski, Stringaris, et al., 2017; Leibenluft, 2017b). Thus, the genetic 
underpinning of chronic and severe irritability might specifically affect frustration, as 
opposed to Hot executive functioning more generally. Additionally, irritability PRS 
might be linked to cognitive functioning via gene-environment interactions, that are 
not accounted for by PRS and GWASs (Maher, 2008; Plomin, 2013). The importance 
of the environment in the aetiology of severe irritability has been ascertained by 
previous twin studies (Coccaro et al., 1997; Roberson-Nay et al., 2015; Stringaris, 
Zavos, et al., 2012). Amongst the environmental factors, negative parenting, 
characterised by hostility and conflict, might be particularly relevant for irritability; 
preliminary evidence has shown its impact on children’s irritability symptoms (Oliver, 
2015; Waxmonsky et al., 2016). Parenting seems to be a crucial environmental factor 
also in those with ADHD. The NICE guidelines recommend parent training for those 
with ADHD and comorbid disruptive behaviours (ODD, CD) as it has shown to be 
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effective in reducing such symptoms (National Institute for Health and Care 
Excellence, 2018); as mentioned in the general introduction, irritability can also be 
considered amongst disruptive behaviours. Parenting is also important for children’s 
emotional development and acquisition of self-regulation skills (Kiff, Lengua, & 
Zalewski, 2011; Waxmonsky et al., 2016). These skills are tested during Hot cognitive 
performance since Hot EF tasks take place in emotionally charged scenarios (Zelazo 
& Carlson, 2012; Zelazo & Muller, 2002). Thus, parenting is a factor worth 
investigating in future studies, especially studying its potential interaction with genetic 
liability (such as that captured by PRS) for irritability leading to poor Hot executive 
functioning.   
 
These findings need to be considered in the light of a number of strengths and 
limitations. Firstly, the UK biobank identified irritability with a single item asking people 
whether they considered themselves to be irritable or not. The measure of irritability 
considered in this sample of adolescents with ADHD is more complex, tapping 
multiple items and considering especially the chronic and severe facets of this 
phenotype, disregarded by the UK Biobank. The different operationalisation of 
irritability might have led to biased PRS as the GWAS was conducted on a less 
variable measure of irritability, that was neither chronic nor severe. Secondly, the age 
of the UK biobank sample is much older than the age of this current sample (age 
range: 40-69 vs. 10-18) and from the literature, it appears clear that severe irritability 
is subject to developmental changes over time (Riglin et al., 2019) and tends to 
decrease with age (Copeland et al., 2015; Mayes et al., 2015). Thus, it is not 
surprising that only 28.1% of adults in the UK Biobank endorsed irritable symptoms, 
even without applying severity cut offs, such as pervasiveness, duration, and 
frequency. This suggests that those endorsing a clinically relevant type of irritability 
amongst the UK Biobank sample might be even fewer. The healthy volunteer 
selection bias for the UK biobank sample has been reported by previous work, 
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pointing out that this sample is comprised of individuals with better sociodemographic 
and health-related characteristics than the UK general population (Fry et al., 2017). 
This potentially small proportion of participants in the “case” group might have 
reduced the possibility to detect more clinically relevant SNPs as being associated 
with chronic and severe irritability. Finally, this study might be underpowered overall, 
and this is due to the size of the target sample that it is not as big as it is recommended 
(i.e., around 2,000 individuals) to find a significant effect (Wray et al., 2014). However, 
several previous studies had a potentially underpowered target sample, as they used 
a sample size of less than 2,000 individuals, including those looking at cognitive 
functioning (Gisbert et al., 2019; Hamshere, Langley, et al., 2013; Martin, O’Donovan, 
et al., 2015; Nigg et al., 2018; Riglin et al., 2017; Stergiakouli et al., 2015). This 
suggests that the sample size used in this thesis is in line with previous work. Despite 
the different operationalisation of irritability and sample characteristics, a significant 
association between irritability PRS and chronic and severe irritability was still found. 
This suggests that the UK biobank discovery sample was powerful enough to enable 
the detection of significant findings and that their less variable measure of irritability 
is akin to the chronic and severe irritability operationalised in this thesis, ultimately 
validating the measure used which is a remarkable finding. Previous work has 
reported the necessity of having a big discovery sample to increase the accuracy of 
PRS calculation, and this methodological indication is well represented by the big size 
of UK biobank (Wray et al., 2014). Finally, the sensitivity analysis yielded fairly 
consistent results in linking irritability PRS to chronic and severe irritability phenotype, 
although replicating this study is highly important. 
 
In conclusion this is the first study, conducted on a sample of adolescents with ADHD, 
showing that chronic and severe irritability has an underpinning common genetic risk, 
although the pathway linking genetic liability to chronic and severe symptom severity 
does not seem to involve neither Hot nor Cool cognitive functioning. However, it is too 
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early to discount the contribution of irritability PRS to cognitive functioning in those 
with ADHD as future more powerful studies might find different results. Similarly, 
considering the role of parenting in gene-environment interactions as well as different 
neurocognitive markers such as frustration might yield important findings that can be 
translated into clinical interventions. Additionally, considering the pioneering nature of 
this study, the inconsistency of sensitivity analysis results and the highly different 
characteristics of the discovery and the target sample used, replicating this study is 
also deemed necessary. In particular, future studies should focus on a discovery 
sample of adolescents, with a similar operationalisation of irritability to the one used 
in this study, such as The Avon Longitudinal Study of Parents and Children 
(ALSPAC), a prospective birth cohort study.
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General Discussion 
 
6.1 Result summary 
The overall aim of this PhD was to explore the nature, pathophysiological 
mechanisms, and aetiology of chronic and severe irritability in a sample of youths with 
ADHD, in the attempt to further understand heterogeneity within this population. This 
overarching aim was broken down into smaller ones. In particular, the first study 
reported in Chapter 3 explored the proposed bi-dimensional conceptualisation of 
chronic and severe irritability, consisting of phasic and tonic dimensions. This was 
achieved by looking at different patterns of associations with co-occurring clinical 
symptoms, cross-sectionally, longitudinally and taking into account maternal 
psychopathology. Overall, this study showed that phasic and tonic irritability were both 
present in the current sample of children with ADHD (19.3% and 51.3%, respectively), 
although phasic irritability was rarely endorsed alone (in 3.4% only). Additionally, 
cross-sectional associations revealed that these two dimensions of chronic and 
severe irritability were associated with most of the clinical correlates considered, to 
an equal extent. When looking at longitudinal associations and maternal 
psychopathology, despite initial evidence pointing towards phasic irritability predicting 
externalizing symptoms and tonic predicting internalizing symptoms, these results 
were deemed not to be strong enough to support a distinction between these two 
dimensions. Based on these results, chronic and severe irritability was considered as 
a unidimensional construct in the following studies of this thesis. 
 
Chapter 4 addressed the underpinnings of chronic and severe irritability at the 
cognitive level over time. In line with previous work, it was hypothesized that this 
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phenotype measured in childhood was associated with Hot as opposed to Cool EFs 
in adolescents with ADHD. However, the results obtained suggested that the 
pathophysiological mechanisms of chronic and severe irritability do not involve either 
Cool or Hot cognitive functioning. Similar conclusions were drawn when using a 
person-centred approach. 
 
The third and final aim covered in Chapter 5 explored the genetic architecture of 
chronic and severe irritability and its association with irritable symptom severity and 
cognitive functioning in youths with ADHD. Common genetic risk in the form of 
irritability PRS was found to be associated with baseline chronic and severe irritability 
symptom severity, explaining up to 2.3% of phenotypic variance. However, irritability 
PRS did not impact on cognitive functioning in adolescents with ADHD (Hot or Cool 
EFs), suggesting that impairing biological mechanisms of chronic and severe 
irritability in this population do not act through this cognitive pathway. 
 
6.2 Interpretation of results 
 
6.2.1 Importance of Chronic and Severe Irritability in ADHD 
Overall, the results obtained did not support the clinical usefulness of splitting chronic 
and severe irritability into phasic and tonic dimensions in those with ADHD. This is 
mainly suggested by the a-specific associations of both these dimensions with most 
of the clinical symptoms considered (Chapter 3 results), although future studies 
possibly utilising longitudinal designs and with bigger samples are necessary for 
further validation. Nonetheless, chronic and severe irritability in Chapter 3 appeared 
to identify children with greater psychiatric symptom severity overall. At the 
phenotypic level, these findings also seem in line with previous literature conducted 
on ADHD that showed severe irritability being associated with both internalising and 
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externalising conditions (e.g., Anastopoulos et al., 2011; Rosen et al., 2015) (for more 
details see Chapter 1, section 1.2.3). This supported the importance of exploring 
pathophysiological markers associated with this phenotype in the attempt to possibly 
identify pathways leading to impairment. This was achieved in Chapter 4, which found 
that, counter to the initial hypothesis, Hot cognitive functioning is not a 
pathophysiological marker of chronic and severe irritability. Similar to these findings, 
at the cognitive level, there are other studies that failed to show Hot EFs as 
pathophysiological markers of severe irritability (Adleman et al., 2011; Dickstein et al., 
2007; Perlman et al., 2015; Rau et al., 2008) (for more details see Chapter 4 
introduction). Additionally the studies within this thesis failed to identify biological 
underpinnings specifically linked to chronic and severe irritability at the cognitive level, 
despite genetic factors seemed to be associated with behavioural manifestations of 
this phenotype (Chapter 5). This inconsistency between the relevance of chronic and 
severe irritability at the behavioural level and the failure to identify its 
pathophysiological underpinnings might suggest that this phenotype is simply a 
marker of severity in those with ADHD, as opposed to a relevant pathophysiological 
marker leading to impairment. Thus, one might conclude that considering this 
phenotype within more complex constructs, especially ODD, might be more clinically 
relevant for those with ADHD. This approach is consistent with previous work that has 
been critical of the DMDD diagnosis (Evans et al., 2017) and with the ICD-11 that 
considers irritability as a specifier of ODD diagnosis (World Health Organization, 
2018). 
 
It should be considered, however, that severe irritability in the literature has been 
assessed with different measures and cut-off criteria (e.g., Axelson et al., 2012; 
Dougherty et al., 2014; Mayes et al., 2016), it is often conceptualised within broader 
phenotypes (e.g., ODD, Emotional Dysregulation / Lability) (Evans et al., 2017; Liu et 
al., 2019; Shaw et al., 2014; Sobanski et al., 2010), and this is actually the first study 
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investigating the nature, pathophysiological mechanisms and biological 
underpinnings of chronic and severe irritability in those with ADHD, whilst 
operationalised consistently with previous work (e.g., Copeland et al., 2015; Eyre et 
al., 2017). Thus, considering the pioneering nature of this PhD work, whether chronic 
and severe irritability is only a marker of severity and might be better conceptualised 
within more complex phenotypes in those with ADHD is far from being fully 
understood. Longitudinal studies with large sample sizes and with measures designed 
specifically to tap chronic and severe irritability and its features (i.e., phasic and tonic 
dimensions and pathophysiological markers) are needed and might yield different 
results. This thesis relied on pre-existing data and the measurement of chronic and 
severe irritability and its dimensions was derived post hoc, although this method and 
the operationalisation of chronic and severe irritability was consistent with previous 
work (Copeland et al., 2015; Eyre et al., 2017, 2019). More comprehensive measures 
of chronic and severe irritability are now available and were specifically developed to 
tap this phenotype, such as the Affective Reactivity Index (Stringaris, Goodman, et 
al., 2012). Therefore, future studies should preferably utilise these specific measures, 
as opposed to retrospective ones, or should compare them to ensure they are tapping 
the same constructs. 
 
The use of existing data, rather than that explicitly designed to assess chronic and 
severe irritability, also applies to the cognitive tasks utilised in this PhD project. The 
follow-up data was collected as part of a project with different initial aims than to 
explore chronic and severe irritability; thus, the EF tasks available are validated in 
ADHD but might not have been ideal to specifically tap pathophysiological markers of 
irritability at the cognitive level. Despite the current non-significant findings, the final 
study of this thesis shows that there is a common genetic risk linked to irritability, 
associated with chronic and severe irritability symptom severity in youths with ADHD. 
This suggests that there might be pathophysiological markers still to be discovered 
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that might lead to impairment in those with ADHD, ultimately supporting the relevance 
of chronic and severe irritability in the pathophysiology of this neurodevelopmental 
disorder, as opposed of being just a marker of severity. For instance, as discussed 
previously in Chapter 1 section 1.3.3, response to frustration (i.e., FNR) might be a 
more promising neurocognitive marker of chronic and severe irritability in those with 
ADHD, as it is a paradigm that well represents this phenotype at the neurocognitive 
level and it is supported by preliminary evidence (Deveney et al., 2013; Leibenluft, 
Blair, et al., 2003; Perlman et al., 2015; Rich et al., 2011, 2007). However, 
pathophysiological markers other than Hot cognitive functions could not be explored 
due to the post hoc nature of the available data; focusing on tasks that elicit frustration 
is therefore needed for future studies. Similarly, environmental factors (e.g., 
parenting) linked to chronic and severe irritability as a pathological pathway leading 
to impairment in those with ADHD should also be considered (see Chapter 4 and 
Chapter 5 discussions, and Chapter 1 section 1.3.3). Overall, more research on the 
pathological mechanisms and risk factors associated with this phenotype, consistently 
conceptualised, is therefore necessary to further understand the role of chronic and 
severe irritability in youths with ADHD.  
 
6.2.2 Understanding ADHD heterogeneity 
The a-specific associations of tonic and phasic irritability with a variety of clinical 
correlates and the failure to identify cognitive markers of chronic and severe irritability 
also seem to suggest that this phenotype might not be a relevant source of 
heterogeneity in those with ADHD, both at the clinical and the cognitive level.  
 
A possible explanation involves the heterogeneity of ADHD in terms of core symptoms 
presentation. Previous research has suggested that, compared to the combined and 
inattentive subtypes, the hyperactive-impulsive subtype might be more linked to Hot 
cognitive impairments (Castellanos et al., 2006) as well as Emotional Lability (Skirrow 
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& Asherson, 2013; Sobanski et al., 2010). At follow-up the prevalence of individuals 
with hyperactive-impulsive ADHD subtype was only around 9%, which has prevented 
the conduction of further analysis on this clinical group only. It could be that looking 
at clinical correlates and neurocognitive markers of chronic and severe irritability in 
this specific ADHD subtype might lead to different results. Alternatively, a dimensional 
measure of hyperactive-impulsive symptoms could have been utilised in this thesis to 
explore the link between the hyperactive-impulsive subtype and chronic and severe 
irritability. However, the sample used in this PhD project is composed of youths with 
a clinical ADHD diagnosis, therefore they all show high ADHD symptoms, including 
hyperactivity-impulsivity. Thus, the little variability of symptoms in the hyperactive-
impulsive domain might make it harder to detect differences. Additionally, individuals 
with ADHD within clinical practice have a complex clinical and functional profile, 
focusing on one subset of symptoms would not reflect the complexity of this 
neurodevelopmental disorder, ultimately being less useful for clinicians and those with 
the condition. This is also supported by the proportion of youths with ADHD without 
chronic and severe irritability that was around a third of the clinical sample considered 
throughout the chapters of this thesis. This suggests that this phenotype is common 
in this clinical sample, encompassing all the different ADHD subtypes. Thus, chronic 
and severe irritability is not likely to be relevant only for those with the hyperactive-
impulsive subtype. Looking at just the hyperactive-impulsive subtype would therefore 
consist in splitting up ADHD further, instead of accounting for the heterogeneity of this 
condition as a whole. It is also important to note that the DSM-5 does not support the 
ADHD distinction into subtypes due to their heterotypic continuity over time (American 
Psychiatric Association, 2000, 2013; Cortese & Coghill, 2018; Willcutt et al., 2012). 
Finding ways to reduce this heterogeneity, such as identifying sources of variability, 
instead of looking at different facets of ADHD either with a categorical or dimensional 
perspective, seems to be more clinically relevant and reflective of the heterogeneous 
nature of this neurodevelopmental disorder.  
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Despite the current non-significant findings, there is preliminary evidence about the 
importance of chronic and severe irritability as a source of clinical heterogeneity, 
especially internalising symptoms, in those with ADHD (Eyre et al., 2017, 2019). This 
stems from previous work with a very similar operationalisation of this phenotype as 
the one used in this thesis, and conducted in the same clinical ADHD sample 
considered at baseline and follow-up and used across these current experimental 
chapters (Eyre et al., 2017, 2019). This research found that chronic and severe 
irritability in youths with ADHD is cross-sectionally linked to anxiety and depression 
symptom severity; chronic and severe irritability risk for developing depression 
symptoms was also confirmed longitudinally (Eyre et al., 2017, 2019). Thus, another 
reason for the results of this thesis to not identify irritability related heterogeneity in 
those with ADHD at the cognitive level might lie with the pathophysiological marker 
considered. Empirical evidence shows that threat processing impairments, such as 
orientation bias to threatening stimuli and tendency to interpret ambiguous stimuli as 
threatening, are very common in individuals with severe anxiety (Bar-Haim, Lamy, 
Pergamin, Bakermans-Kranenburg, & Van Ijzendoorn, 2007; Miers, Blöte, Bögels, & 
Westenberg, 2008; Sonuga-Barke, Cortese, Fairchild, & Stringaris, 2016). Similar 
impairments in threat processing are also observed in those with severe irritability and 
are thus suggested as possible pathophysiological markers of this clinical phenotype; 
the rationale being that imminent threat often elicits sullen aggressive responses that 
are often a behavioural display of severe irritability (Brotman, Kircanski, & Leibenluft, 
2017; Leibenluft, 2017b). Thus, it might be worth looking at threat processing as a 
possible source of cognitive heterogeneity linking ADHD, chronic and severe 
irritability and risk for internalizing disorders, especially considering that anxiety and 
depression frequently co-occur and that anxiety tends to precede later depression 
(Thapar et al., 2012). 
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Finally, considering chronic and severe irritability as a marker of severity means that 
those with ADHD and comorbidity irritability are also likely to have a number of other 
co-occurring conditions or behaviours. In individuals with this complex and severe 
clinical profile, chronic and severe irritability might not be as relevant in explaining 
ADHD heterogeneity. For instance, as mentioned in Chapter 4 introduction, disruptive 
behaviours (namely, ODD/CD) in individuals with ADHD seem to be associated with 
greater impairments in Hot EFs compared to those with ADHD alone (Dekkers et al., 
2016; Groen et al., 2013). Thus, a distinction into an ADHD alone and ADHD with 
comorbid disruptive behaviours might account for the heterogeneity at the cognitive 
level more than chronic and severe irritability. However, considering the novelty of 
this thesis more research is needed before discarding chronic and severe irritability 
as a source of clinical and cognitive heterogeneity in those with ADHD. Future studies 
should definitely consider using cognitive tasks specifically designed to tap chronic 
and severe irritability, as well as different pathophysiological pathways (e.g., Hot 
cognitive functioning, threat processing and FNR) that can lead to poor cognitive and 
clinical outcomes in youths with ADHD. 
 
6.3 Implications 
As illustrated in the general introduction, ADHD heterogeneity is problematic, 
especially for the development of tailored interventions (see Chapter 1, section 1.2). 
The role of emotional impairments in this population has long been recognised (e.g., 
Faraone et al., 2019; Shaw et al., 2014) and recently there is an increased interest in 
investigating chronic and severe irritability, a common condition in those with ADHD 
(e.g., American Psychiatric Association, 2013; Brotman, Kircanski, & Leibenluft, 2017; 
Leibenluft, 2011). Among others, the nature, pathophysiological markers and risk 
factors were considered as research priorities for the study of chronic and severe 
irritability (Leibenluft & Avenevoli, 2014). All these aspects were addressed altogether 
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in this thesis for the first time. In addition to having implications in the research field 
by filling in these knowledge gaps and providing initial empirical evidence related to 
the field of ADHD and chronic and severe irritability, this thesis also aimed to 
investigate topics that had a translational element. Thus, this work aimed to further 
inform clinical practice and the development of future interventions. Based on the 
findings obtained across the three individual studies included, there is insufficient 
evidence for clinicians to consider chronic and severe irritability as bi-dimensional 
construct in those with ADHD. Similarly, future interventions are not advised to include 
cognitive training tapping Hot EFs as these results suggest that these are not relevant 
to the pathological pathway associated with chronic and severe irritability in those with 
ADHD. Nonetheless, clinicians should be aware of the high prevalence of chronic and 
severe irritability in those with ADHD and that common genetic risk influences chronic 
and severe irritability symptom severity in this population. Such information might be 
used to improve communication about the nature of ADHD to those with the condition, 
their family members, and relevant professionals (e.g., teachers) in the attempt to 
increase awareness and reduce stigma. 
 
6.4 Strengths and limitations 
The strengths and limitations of this PhD thesis are mostly detailed in each individual 
experimental chapter discussions (see Chapter 3, Chapter 4 and Chapter 5). In 
addition to large sample size, well validated and comprehensive measures, this study 
has further methodological strengths. Firstly, this thesis benefits of innovative 
methods in the field of developmental psychology such as the use of Bayesian 
analysis that were able to compare the results obtained against the experimental 
hypothesis and not only the null hypothesis (Chapter 4). Secondly, the use of both a 
variable-centred and data-driven approach to validate the findings obtained showed 
that results are robust and not method specific (Chapter 4). This methodological 
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choice of replicating the findings observed also fits well in a time where science is 
facing a replication crisis and replication is considered essential to this field (Munafo 
& Smith, 2018). Finally, as mentioned above, the novelty of this thesis is also a 
strength as it aims to fill the knowledge gaps related to the problem of heterogeneity 
in psychiatric research and chronic and severe irritability that is clinically relevant as 
well as understudied.  
 
Limitations should also be considered for the interpretation of these findings. Previous 
research showed that irritability symptoms tend to decrease with age (see Chapter 1, 
section 1.1.3), thus it could be that looking at longitudinal associations to identify 
pathophysiological mechanisms of chronic and severe irritability could have reduced 
the power to detect an effect, due to fewer adolescents with ADHD endorsing this 
phenotype. Additionally, Hot and Cool EF tasks correlate at phenotypical level and 
partially overlap at the neuroanatomical level (see Chapter 1, section 1.3.1). This 
suggests that it might be difficult to pull out Hot compared to Cool cognitive 
processing, although this thesis used well-validated tasks employed in previous 
research on ADHD and shown to be effective in measuring the cognitive aspects 
considered in this thesis. On a similar note, whether or not the cognitive measures 
used in this thesis share genetic risk with chronic and severe irritability is not currently 
known. Focusing on tasks specifically linked to this phenotype at the genetic and/or 
phenotypic level might have enhance the possibility to identify neurobiological and 
cognitive underpinnings of chronic and severe irritability in those with ADHD. 
Additionally, the sample size in this thesis is large at baseline (N = 561) but it is more 
than halved at follow-up (N from 191 to 219, depending on the chapter). Follow-up 
data was nonetheless collected on a sample size that is comparable if not greater 
than samples included in previous longitudinal studies (e.g., Agha, Zammit, Thapar, 
& Langley, 2017a; Deveney et al., 2015; Eyre et al., 2019). However, considering the 
number of multiple comparisons, the longitudinal design, and approaches used, the 
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sample size at follow-up might have not been sufficient to detect an effect about the 
bi-dimensional nature of chronic and severe irritability and its cognitive markers. More 
precisely, in Chapter 3 there was preliminary evidence pointing towards a distinction 
between tonic and phasic irritability that was however negatively impacted by 
correcting for multiple testing (i.e., the Bonferroni correction) which led to insufficient 
evidence. Similarly, in Chapter 4, Bayesian analysis only suggested anecdotal 
evidence for both rival hypothesis without being able to dismiss H0. It is also possible 
that the wide heterogeneity of ADHD at the cognitive level might require larger sample 
size to pull out different cognitive profiles in LPA analysis, although once again the 
sample size of this thesis is in line with previous studies (e.g., Lambek et al., 2018; 
Rajendran et al., 2015; Van Hulst et al., 2015). Further limitations, already outlined in 
Chapter 3, Chapter 4 and Chapter 5 discussions, include the wide age range of this 
clinical ADHD sample both at baseline and follow-up, chronic and severe irritability 
was measured post-hoc, the heterogeneity of cognitive impairments was not fully 
taken into account lacking a control group, and cognitive measures were selected 
based on validated ADHD cognitive impairments as opposed to chronic and severe 
irritability. 
 
6.5 Future directions 
Considering the findings obtained by the studies included in this thesis, it can either 
be that 1) chronic and severe irritability is bi-dimensional and a relevant source of 
heterogeneity in this clinical ADHD sample, but the power to detect an effect is low. 
For instance, preliminary evidence in Chapter 3, suggested a different longitudinal 
pattern for phasic and tonic irritability, however these dimensions did not appear to 
differ after correcting for multiple testing. In addition to the Bonferroni correction, the 
power was reduced due to the sample size reduction at follow-up that was further 
reduced with the Bayesian analysis. 2) chronic and severe irritability is unidimensional 
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and simply a marker of severity, instead of a relevant source of heterogeneity and 
pathophysiological marker, in those with ADHD. Considering the novelty, and the 
strengths and limitations of this PhD project, any interpretation in either direction 
should be cautious; more evidence is thus needed to draw stronger conclusions. 
Future studies should attempt to replicate these findings using a larger prospective 
sample, a more comprehensive measure of severe irritability and its proposed 
constructs, and cognitive tasks specifically designed to tap this phenotype at the 
cognitive level, whilst still looking at external validators (e.g., longitudinal associations 
and maternal psychopathology). This might increase the power to detect a significant 
effect. Similarly, future work should also focus on different neurocognitive markers 
(e.g., FNR and threat processing) and environmental factors (e.g., parenting and peer 
problems) related to chronic and severe irritability that appear to be particularly 
relevant in those with ADHD as well. Using different clinical samples might also be 
useful to explore the different characteristics of chronic and severe irritability 
encompassing different diagnosis, in line with the RDoC approach. Future research 
might benefit from using a multi-method approach consistently with what was done in 
this thesis that employs both a person-centre and a variable-centred approach, as 
well as a frequentist and Bayes approach for data analysis. Additionally, looking at 
multiple level of analysis consistently with this thesis that combines both behavioural, 
cognitive and genetic perspectives should be retained in future work as this would 
offer a comprehensive perspective on the topics covered in this thesis. These 
recommendations would ultimately advance the understanding of ADHD 
heterogeneity and chronic and severe irritability, both very relevant aspects in 
psychiatric research. 
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6.6 Conclusion 
Overall, the conclusion drawn from the results of this thesis is that chronic and severe 
irritability seems to have a unidimensional nature, it is influenced by common genetic 
risk, and Hot cognitive functioning might not be a pathophysiological marker of this 
phenotype leading to impairment in youths with ADHD. These results have 
implications both in the research and clinical field; they help fill knowledge gaps in the 
field of ADHD and chronic and severe irritability and inform clinical practice and future 
interventions. 
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Appendices 
Chapter 4 
The following tables show the results of the same set of analyses (using a frequentist approach) included in Chapter 4, conducted on the clinical 
sample of adolescents with ADHD at follow-up, excluding 18 participants who did not suspend their medication 24h prior testing (n= 201). 
 
Appendix 4.1  
Pattern of associations between severe irritability and Hot and Cool EFs 
 
 N MODEL UNSTANDARDIZED BETA (95% CI) 
COOL EFS 
WCST TOTAL ERRORS N= 162 
Unadjusted Model B= 1.30 (.28, 2.32)* 
Adjusted model B= 1.03 (-.04, 2.10) 
WCST PERSEVERATIVE ERRORS N= 162 
Unadjusted Model B= .81 (.27, 1.35)** 
Adjusted model B= .75 (.17, 1.33)* 
GNG RT TO GO SIGNALS N= 174 
Unadjusted Model B= 2.40 (-.016, 8.81) 
Adjusted model B= 2.27 (-4.32, 8.85) 
GNG PROBABILITY OF INHIBITION N= 174 Unadjusted Model B= 1.20 (-1.67, 4.07) 
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 Adjusted model B= 1.68 (-1.04, 4.39) 
HOT EFS 
CPT TOTAL NUMBER OF CARDS N= 191 
Unadjusted Model B= 1.89 (-2.45, 6.24) 
Adjusted model B= 2.05 (-2.60, 6.69) 
TDT RT DIFFERENCE DELAYED - IMMEDIATE 
CHOICE 
N= 164 
Unadjusted Model B= -.70 (-22.7, 21.3) 
Adjusted model B= -5.58 (-29.3, 18.2) 
TDT AUC N= 164 
Unadjusted Model B= -.02 (-.05, .01) 
Adjusted model B= -.023 (-.05, .01) 
UG MODERATELY UNFAIR OFFERS 
ACCEPTED 
N= 107 
Unadjusted Model B= -.07 (-.13, -.01)* 
Adjusted model B= -.05 (-.12, .01) 
Adjusted models were corrected for age, sex, SES, and ADHD and CD symptom severity in adolescence. 
* Significant at < .05 
** Significant at < .01 
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Appendix 4.2  
Mixed ANOVAs and mixed ANCOVA results for trial type and outcome 
 
 MODEL (N= 142) ADJUSTED MODEL 
 F p EF size F p EF size 
TRIAL TYPE F (5, 140) = 272.96 p < .001 ηp2 = .661 F (5, 116) = 11.27 p < .001 ηp2 = .094 
IRRITABILITY GROUPS F (1, 140) = .870 p= .353 ηp2 = .006 F (1, 116) = 1.948 p = .166 ηp2 = .018 
TRIAL TYPE * IRRITABILITY 
GROUPS 
F (5, 140) = 1.010 p =.410 ηp2 = .007 F (5, 116) = 1.916 p =.090 ηp2 = .017 
 F p EF size F p EF size 
OUTCOME F (3, 140) = 3.082 p = .027 ηp2 = .022 F (3, 113) = 1.395 p = .244 ηp2 = .013 
IRRITABILITY GROUPS F (1, 140) = 1.610 p = .207 ηp2 = .011 F (1, 113) = 2.173 p =.143 ηp2 = .020 
OUTCOME * IRRITABILITY 
GROUPS 
F (3, 140) = .464 p = .708 ηp2 = .003 F (3, 113) = 1.328 p =.265 ηp2 = .012 
Adjusted models were corrected for age, SES, and ADHD and CD symptom severity in adolescence 
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Appendix 4.3  
Risky decision-making mean values across six different trial types by group 
 
Δ Expected Values are reported on the x axis, whereas the y axis shows mean values of the number of times participants have 
chosen the experimental when per each trial type. –frame and + frame represent the positive and negative frame trials, respectively.
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Chapter 5 
The following tables and figures integrate the methods and illustrate sensitivity 
analysis results related to Chapter 5. 
 
Appendix 5.1 
Number of SNPs by PRS p-value thresholds 
PRS P-VALUE THRESHOLDS NUMBER OF SNPS 
1.0 81154 
0.5 60845 
0.1 22337 
0.05 14259 
0.01 5192 
0.001 1333 
0.00001 174 
 
Appendix 5.2 
Scree Plot of Eigenvalues associated with the ten PCs 
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When combined, the first five PCs explained up to 58.3% of the ancestry-related 
variance, whereas the remaining five did not appear to have a substantial contribution 
all having an eigenvalue less than 1. 
 
Appendix 5.3 
Sensitivity analysis results correcting for all ten PCs. 
 
 UNSTANDARDIZED BETA (95% CI) 
CLINICAL MEASURE 
CHRONIC AND SEVERE IRRITABILITY B= .16 (.01, .32)* 
COGNITIVE MEASURES 
WCST TOTAL ERRORS B= .69 (-.49, 1.86) 
WCST PERSEVERATIVE ERRORS B= .08 (-.56, .72) 
GNG RT TO GO SIGNALS B= .82 (-6.31, 7.95) 
GNG PROBABILITY OF INHIBITION B= -.72 (-3.80, 2.36) 
CPT TOTAL NUMBER OF CARDS B= -1.76 (-6.52, 3.00) 
TDT RT DIFFERENCE DELAYED - 
IMMEDIATE CHOICE 
B= -2.92 (-26.8, 20.9) 
TDT AREA UNDER THE CURVE B= -.001 (-.03, .03) 
UG MODERATELY UNFAIR OFFERS 
ACCEPTED 
B= -.02 (-.09, .05) 
CXR GAMBLING AFTER LARGE LOSS B= .02 (-.02, .05) 
CXR GAMBLING AFTER SMALL LOSS B= .04 (.002, .09)* 
CXR GAMBLING AFTER LARGE WIN B= -.001 (-.03, .02) 
CXR GAMBLING AFTER SMALL WIN B= -.006 (-.04, .02) 
 
Beta values are reported for Adjusted model that, other than the ten PCs, also includes batch effects. 
* significant at p < .05. 
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Overall irritability PRS was significantly associated with chronic and severe irritability 
symptoms but neither with Cool nor Hot EF measures, except for CxR gambling after 
small loss. This association failed to reach statistical significance after the Bonferroni 
correction, ultimately confirming results obtained when correcting only for the first five 
PCs.
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Appendix 5.4 
Sensitivity analysis on the association between irritability PRS with Cool and Hot EFs at different 
PRS p-value thresholds 
-10
-9
-8
-7
-6
-5
-4
-3
-2
-1
0
1
2
3
WCST T.E. WCST P.E. GNG RT GNG
Inhibition
CPT Cards TDT RT TDT AUC UG M.U. CxR LL CxR SL CxR LW CxR SW
U
n
st
an
d
ar
d
iz
ed
 B
et
a
Cognitive measures
p < 0.00001 p < 0.001 p < 0.01 p < 0.1 p < 0.5 p < 1
* ** *
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the Beta value reported refers to the Adjusted model corrected for the first five PCs and batch effects. 
* = significant at p < .05. 
 
This graph shows that irritability PRS did not seem to be associated with neither Cool 
nor Hot EFs consistently across all the different PRS p-value thresholds. Exceptions 
are represented by the associations between irritability PRS with CxR gambling after 
large loss at p< .01 PRS threshold and irritability PRS with CxR gambling after small 
loss at p< .1 p< .5 and p< 1 PRS thresholds. However, all of these associations are 
no longer significant after Bonferroni correction, consistently with the initial results. 
